Top Stories
Colorado’s Life Sciences Ecosystem Raised $1.47 Billion in 2023
By: Colorado BioScience Association Date: 12/21/2023
For Immediate Release: December 21, 2023 Fundraising Success Demonstrates Colorado’s Resilience Duri...
Learn MoreJoin CBSA for Diversity, Equity, and Inclusion Workshops in June + July
By: Colorado BioScience Association Date: 05/31/2023
CBSA is committed to advancing Diversity, Equity, and Inclusion (DEI) in Colorado's life sciences co...
Learn MoreColorado BioScience Association to Recognize Outstanding Companies and Leaders at Annual Awards Celebration
By: Colorado BioScience Association Date: 10/31/2022
Aktiv Pharma Group, BioIntelliSense, and Umoja Biopharma Selected as Finalists for Company of the Ye...
Learn MoreColorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors
By: Colorado BioScience Association Date: 04/25/2022
Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Teru...
Learn MoreWeekly Policy Blog: EPA Releases Final Rule for EtO Sterilization Facilities
By: Colorado BioScience Association Date: 03/18/2024
On March 14, the Environmental Protection Agency (EPA) released its update to the National Emission...
Learn MoreWeekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub
By: Colorado BioScience Association Date: 03/11/2024
Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub...
Learn MoreGet weekly updates from Colorado’s leading source
for life sciences news and information.
Weekly Policy Blog: EPA Releases Final Rule for EtO Sterilization Facilities
By: Colorado BioScience Association Date: 03/18/2024
On March 14, the Environmental Protection Agency (EPA) released its update to the National Emission Standards for Hazardous Air Pollutants (NESHAP) final rule for ethylene oxide (EtO) commercial steri...
Learn MoreWeekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub
By: Colorado BioScience Association Date: 03/11/2024
Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...
Learn MoreWeekly Policy Blog: CBSA’s 2024 Day at the Capitol
By: Colorado BioScience Association Date: 03/04/2024
CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...
Learn MoreFitzsimons Innovation Community Partners with the Colorado Hub for Health Impact Campaign
By: Colorado BioScience Association Date: 03/04/2024
Colorado’s health and life sciences industry gets a nationwide spotlight. If it has to do with health and innovation in Colorado, Fitzsimons Innovation Community is bound to be a part of it. We are es...
Learn MoreNew Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State
By: Colorado BioScience Association Date: 02/27/2024
For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...
Learn MoreWeekly Policy Blog: PDAB Initiates Upper Payment Limit Rulemaking Process for the First Time
By: Colorado BioScience Association Date: 02/26/2024
On Friday, February 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) decided to initiate an “upper payment limit” (UPL) rulemaking process for the autoimmune disease drug Enbrel...
Learn MoreWeekly Policy Blog: PDAB Deems One of Two Drugs “Unaffordable” in Recent Affordability Decisions
By: Colorado BioScience Association Date: 02/19/2024
On Friday, February 16, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its second and third affordability reviews, following its first decision on December 8 that the cys...
Learn MoreWeekly Policy Blog: Legislative Session Update
By: Colorado BioScience Association Date: 02/05/2024
The first few weeks of the Colorado legislative session require intensive engagement at the Capitol and comprehensive review of proposed legislation by CBSA's Policy + Advocacy team to support a colla...
Learn MoreFitzsimons Innovation Community Presents Our Third Annual Innovation Report
By: Colorado BioScience Association Date: 02/05/2024
A look at the accomplishments, progress, and innovation behind the buzz. At Fitzsimons Innovation Community, we know January is one of the best times to look forward, set goals, and make plans for the...
Learn MoreWeekly Policy Blog: Take Action to Protect America’s Innovation Economy
By: Colorado BioScience Association Date: 01/29/2024
CBSA urges you to take action now to protect America’s innovation economy! The federal government is considering the use of “march-in rights” (where it could compel a patent-owner to license an invent...
Learn MoreWeekly Policy Blog: Urge Congress to Fix R&D Expensing
By: Colorado BioScience Association Date: 01/22/2024
CBSA and our partners at BIO urge you to act now! Encourage members of Congress to pass a tax package before the end of January that includes restoration of immediate R&D expensing to protect our...
Learn MoreWeekly Policy Blog: Start of the 2024 Colorado Legislative Session
By: Colorado BioScience Association Date: 01/16/2024
Colorado’s 2024 legislative session kicked off on Wednesday, January 10th, and will continue for 120 days until May 8th. The Legislature: For the sixth year, Democrats have total control o...
Learn MoreWeekly Policy Blog: CBSA Releases 2023 Policy + Advocacy Report
By: Colorado BioScience Association Date: 01/08/2024
Colorado BioScience Association (CBSA) has released its 2023 CBSA Policy + Advocacy Report, which summarizes CBSA’s engagement during the Colorado legislative session, the regulatory process to implem...
Learn MoreZ Biotech Celebrates 10 years of Innovation and Partnership at Fitzsimons Innovation Community.
By: Colorado BioScience Association Date: 01/08/2024
Back in December of 2013, Jian Zhang, Ph.D. and Founder and CEO of Z Biotech, was doing advanced research in glycobiology and just starting his company. He was a one-man show, and, in 2014, opened wit...
Learn MoreAccelerating Health Innovation
By: Colorado BioScience Association Date: 12/21/2023
Through Diversity, Equity, and Inclusion in Colorado’s Life Sciences Community Colorado BioScience Association empowers people in our life sciences community through Diversity, Equity, and Inclusion t...
Learn MoreColorado’s Life Sciences Ecosystem Raised $1.47 Billion in 2023
By: Colorado BioScience Association Date: 12/21/2023
For Immediate Release: December 21, 2023 Fundraising Success Demonstrates Colorado’s Resilience During a Challenging Year for U.S. Life Sciences Financings DENVER – Colorado BioScience Association ann...
Learn MoreWeekly Policy Blog: PDAB Deems Trikafta “Not Unaffordable” in First Affordability Decision
By: Colorado BioScience Association Date: 12/11/2023
On Friday, December 8, the Colorado Prescription Drug Affordability Board (PDAB or Board) completed its first affordability review and unanimously voted that the selected drug, a cystic fibrosis drug...
Learn MoreChanging the Game for a Thriving Local Economy
By: Colorado BioScience Association Date: 12/04/2023
Fitzsimons Innovation Community awarded for work in economic vitality Last month, the Adams County Regional Economic Partnership (AC-REP) hosted its second annual Gamechangers Awards event. This event...
Learn MoreFOR IMMEDIATE RELEASE
By: Colorado BioScience Association Date: 11/21/2023
Colorado BioScience Association Celebrates Colorado’s Growth as a Leading Life Sciences Hub at 20th Annual Awards Celebration PharmaJet Honored as Company of the Year, Foresight Diagnostics Named Risi...
Learn MoreCBSA Congratulates Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 11/20/2023
Colorado Office of Economic Development and International Trade (OEDIT) has announced the newest recipients of state-funded Advanced Industries Accelerator Grants! Colorado BioScience Associ...
Learn MoreWeekly Policy Blog: Congratulations to CBSA’s 2023 Legislators of the Year
By: Colorado BioScience Association Date: 11/20/2023
On November 15, 2023, CBSA held its 20th Annual Awards Celebration presented by AGC Biologics. This annual celebration highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem, br...
Learn MoreWeekly Policy Blog: Join CBSA in Asking Congress to Address the R&D Tax Now
By: Colorado BioScience Association Date: 11/13/2023
Join CBSA in asking Congress to support leading-edge health innovation by American life sciences companies. We are asking Congress to remove a “tax on innovation” by restoring the immediate expensing...
Learn MoreU.S. EDA Grant to Grow Life Sciences Startups
By: Colorado BioScience Association Date: 11/09/2023
Partnership Led by Innosphere Ventures Lands Major Federal Grant The U.S. Economic Development Administration validated Colorado’s collaborative approach to building a major national and interna...
Learn MoreWeekly Policy Blog: Opposition to CMS’ Proposed Medicaid Drug Rebate Program (MDRP) Rule
By: Colorado BioScience Association Date: 11/06/2023
CBSA and other members of the Council of State Bioscience Associations (CSBA) have submitted a letter to the Centers for Medicare & Medicaid Services (CMS) expressing our deep concern with a recen...
Learn MoreWeekly Policy Blog: CBSA Has Concerns About Inconsistency of Preliminary Data Review Process for Drugs Under Affordability Review by PDAB
By: Colorado BioScience Association Date: 10/30/2023
CBSA has serious concerns about the Colorado Prescription Drug Affordability Board’s inconsistent approach to the preliminary data review process for drugs under affordability review in the first coho...
Learn MoreWeekly Policy Blog: USITC Report Released on TRIPS COVID-19 IP Waiver Expansion
By: Colorado BioScience Association Date: 10/23/2023
In June 2022, World Trade Organization (WTO) member states agreed to waive certain WTO intellectual property protections for COVID-19 vaccines. The U.S. Trade Representative (USTR) has been considerin...
Learn MoreWeekly Policy Blog: CBSA Co-Hosts Facility Tours for State Legislators and Local Leaders
By: Colorado BioScience Association Date: 10/16/2023
Weekly Policy Blog: CBSA Co-Hosts Facility Tours for State Legislators and Local Leaders This month CBSA partnered with both Terumo Blood and Cell Technologies (Terumo BCT) and AGC Biologics to host...
Learn MoreNEWS RELEASE
By: Colorado BioScience Association Date: 10/13/2023
For Immediate Release: October 13, 2023 Colorado BioScience Association to Honor Life Sciences Companies at 20th Annual Awards Celebration, Presented by AGC Biologics En...
Learn MoreWeekly Policy Blog: CBSA Urges Congress to Pass the PASTEUR Act
By: Colorado BioScience Association Date: 09/25/2023
Earlier this month, CBSA participated in PASTEUR Advocacy Day, joining Biotechnology Innovation Organization (BIO) and other organizations, including Infectious Diseases Society of America, Cystic Fib...
Learn MoreEfforts to Control Prescription Drug Pricing Harm Collaborative Work to Advance Patient Care with Health Innovations
By: Colorado BioScience Association Date: 09/18/2023
Elyse Blazevich, President & CEO, Colorado BioScience Association Colorado’s life sciences community and our state leaders share an unwavering commitment to improving patient lives and making sure...
Learn MoreFitzsimons Debuts White Paper on Choosing an Innovation Community, Focus on Talent
By: Colorado BioScience Association Date: 09/18/2023
Fitzsimons Innovation Community presents a new white paper, entitled Choosing an Innovation Community, from a group of thought leaders in the Colorado bioscience and economic development communities....
Learn MoreWeekly Policy Blog: FDA Guidances on 510(k) Submissions; Actuarial Review of Biomarker Testing Coverage Bill
By: Colorado BioScience Association Date: 09/11/2023
FDA Issues Three Guidances on Premarket Notification [510(k)] Program On September 7, 2023, the U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) issu...
Learn MoreWeekly Policy Blog: CMS Announces Drugs Subject to Price Controls Under the IRA
By: Colorado BioScience Association Date: 09/05/2023
On August 29, 2023, the Centers for Medicare and Medicaid Services (CMS) announced the first ten prescription drugs that will be subject to price controls in Medicare under the Inflation Reduction Act...
Learn MoreWeekly Policy Blog: CBSA and Partners Provide Recommendations to Improve CMS’ Transitional Coverage for Emerging Technologies (TCET) Proposal
By: Colorado BioScience Association Date: 08/28/2023
CBSA advocates for policies that improve patient access to life-saving novel technologies. This week, CBSA signed on to a letter responding to the long-awaited proposed Transitional Coverage for Emerg...
Learn MoreFitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision
By: Colorado BioScience Association Date: 08/28/2023
Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision New Partnership Will Accelerate Delivery of Lab Space to Market AURORA, Colo. (August 24, 2023) – Fitzsimons Innovation...
Learn MoreGrowing Colorado’s Promising Startups: Innosphere Ventures
By: Colorado BioScience Association Date: 08/18/2023
Fort-Collins-based Innosphere Ventures began making an impact for Colorado’s early-stage companies a quarter-century ago. The organization’s focus is to support the business development of early-stage...
Learn MoreWeekly Policy Blog: PDAB Releases Stakeholder Engagement Guide on Affordability Review Process
By: Colorado BioScience Association Date: 08/14/2023
As the Colorado Prescription Drug Affordability Board (PDAB) begins affordability reviews of the five prescription drugs selected earlier this month, it is reaching out to stakeholders to request thei...
Learn MoreWeekly Policy Blog: PDAB Selects Drugs for Affordability Reviews
By: Colorado BioScience Association Date: 08/07/2023
On Friday, August 4, the Colorado Prescription Drug Affordability Board (PDAB) selected five drugs for affordability reviews: Enbrel, Genvoya, Cosentyx, Stelara, and Trikafta. PDAB staff plan to begin...
Learn MoreA Pioneering Spirit: Female Leaders Advancing Innovation
By: Colorado BioScience Association Date: 08/04/2023
Making Colorado a leading location for health innovation requires visionaries, risk takers, problem solvers, and program builders. Women hold these pivotal roles in our state, guiding major institutio...
Learn MoreForging the Life Sciences Frontier
By: Colorado BioScience Association Date: 08/04/2023
Colorado has one of the best talent pools in the United States, top-tier research institutions, a major international airport, a favorable tax climate, a mountain-enhanced quality of life, and support...
Learn MoreWeekly Policy Blog: Congressional Activity Before August Recess
By: Colorado BioScience Association Date: 07/31/2023
Congress moved forward with its efforts to address drug shortages, drug pricing, pharmacy benefit managers (PBMs), and transparency ahead of the August recess. This policy post covers the discussion d...
Learn MoreFitzsimons Innovation Community - Building a Life Sciences Pipeline: Room to Grow
By: Colorado BioScience Association Date: 07/31/2023
For the past few months, the Fitzsimons Innovation Community blog has been focused on how and why Colorado is such a great home for growing life sciences organizations. This month’s topic is the benef...
Learn MoreWeekly Policy Blog: PAHPA Reauthorization Advances Without Government Price Fixing
By: Colorado BioScience Association Date: 07/24/2023
Congress took important action on pandemic preparedness last week, advancing the Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization bills in both the Senate and the House ahead of its e...
Learn MoreWeekly Policy Blog: Drug Pricing and Affordability Update
By: Colorado BioScience Association Date: 07/17/2023
Drug pricing and affordability continue to be key issues at both the state and federal levels as new legislation is considered and implementation of legislation that has already passed is underway....
Learn MoreWeekly Policy Blog: Ethylene Oxide – EPA’s Proposed Rules
By: Colorado BioScience Association Date: 07/10/2023
Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways. It is one of the most common and proven ways to sterilize medical devices. EtO’s proven effectiveness means t...
Learn MoreWeekly Policy Blog: Federal Update- Four New Pieces of Legislation Introduced
By: Colorado BioScience Association Date: 07/03/2023
CBSA advocates for policies that allow patients to receive access to critical life-saving novel technologies. We applaud members of Colorado’s Congressional delegation for supporting patient access to...
Learn MoreFitzsimons Innovation Community – Building a Life Sciences Pipeline: Life Sciences Leadership
By: Colorado BioScience Association Date: 07/03/2023
Fitzsimons Innovation Community’s monthly blog, Building a Life Sciences Pipeline, explores life sciences leadership and the connectivity that exists between Colorado’s research, healthcare, and innov...
Learn MoreCBSA Advocates for Medicare Coverage of Emerging Technologies
By: Colorado BioScience Association Date: 06/26/2023
Weekly Policy Blog: CBSA Advocates for Medicare Coverage of Emerging Technologies CBSA advocates for policies that improve patient access to critical life-saving novel technologies. The bipartisan Ens...
Learn MoreFederal Funding for Health Innovation: NCI and BARDA Council of State Bioscience Associations Summer Meeting Presentations
By: Colorado BioScience Association Date: 06/21/2023
During the Council of State Bioscience Associations' (CSBA) annual Summer Meeting, (National Cancer Institute) NCI and Biomedical Advanced Research and Development Authority (BARDA) pre...
Learn MoreFitzsimons Innovation Community – Building a Life Sciences Pipeline: Talent
By: Colorado BioScience Association Date: 06/05/2023
Fitzsimons Innovation Community’s monthly blog, Building a Life Sciences Pipeline, looks at the intangibles that attract top life sciences talent to Colorado. A Destination for Work and Play The state...
Learn MoreJoin CBSA for Diversity, Equity, and Inclusion Workshops in June + July
By: Colorado BioScience Association Date: 05/31/2023
CBSA is committed to advancing Diversity, Equity, and Inclusion (DEI) in Colorado's life sciences community to help everyone find their place in our life sciences ecosystem, build diverse and inclusiv...
Learn MoreWeekly Policy Blog: CBSA Strongly Urges Congress to Enact Legislation to Modernize Diagnostic Testing
By: Colorado BioScience Association Date: 05/30/2023
For years, Congress has been urged by a growing coalition of state life sciences associations, patient groups, and other stakeholders, to enact legislation that will modernize the Food & Drug Admi...
Learn MoreBoettcher Foundation Awards $1.88 Million in Biomedical Research Grant Funding to Colorado Researchers
By: Colorado BioScience Association Date: 05/25/2023
Foundation announces 2023 Class of Boettcher Investigators DENVER, May 25, 2023 — Boettcher Foundation today announced the 2023 class of Boettcher Investigators—eight top Colorado researchers selected...
Learn MoreColorado BioScience Association Welcomes New Appointees to Board of Directors
By: Colorado BioScience Association Date: 05/23/2023
Robin Harper Cowie of Biodesix, Inc. and Lyndsey Linke of SiVEC Biotechnologies, Inc. Represent the Momentum of State’s Life Sciences Community Denver – Colorado BioScience Association (CBSA), which c...
Learn MoreCBSA Congratulates Advanced Industries Accelerator Grant Recipients + Celebrates Program Renewal
By: Colorado BioScience Association Date: 05/19/2023
Colorado Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Assoc...
Learn MoreCBSA Hosts Annual All Member Meeting + Networking Event
By: Colorado BioScience Association Date: 05/17/2023
Colorado BioScience Association hosted its annual All Member Meeting + Networking Event Thursday, May 11, at the St. Julien Hotel in Boulder. The vibrant event brought together members and our communi...
Learn MoreWeekly Policy Blog: CBSA Urges Congress to Repeal R&D Amortization and Restore Immediate R&D Expensing
By: Colorado BioScience Association Date: 05/15/2023
Colorado BioScience Association (CBSA) continues our work to advocate for U.S. tax policies that enable investment in critical life-saving innovation and to generate strengthened support for restorati...
Learn MoreWeekly Policy Update: Legislative Session Closes Today
By: Colorado BioScience Association Date: 05/08/2023
The 2023 legislative session, the First Regular Session of the 74th General Assembly closes today, Monday, May 8th, the 120th day of session. During the final weeks of session, the CBSA team, th...
Learn MoreFitzsimons Innovation Community – Building a Life Sciences Pipeline: Environment
By: Colorado BioScience Association Date: 04/27/2023
Calling Colorado’s Life Sciences Economy Home Fitzsimons Innovation Community companies choose Colorado as a home for many reasons, and the sunshine and skiing are further down on the list than you mi...
Learn MoreInnosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2023 Cohort
By: Colorado BioScience Association Date: 04/26/2023
For Immediate Release: April 26, 2023 Innosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2023 Cohort Denver...
Learn MoreWeekly Policy Blog: PDAB Bill & Biomarker Bill Updates
By: Colorado BioScience Association Date: 04/24/2023
CBSA's Policy + Advocacy team continues to focus on policy priorities critical to our ecosystem in the remaining weeks of the Colorado legislative session. With just over two weeks left, CBSA has take...
Learn MoreWeekly Policy Blog: CBSA’s 2023 Medical Device Symposium
By: Colorado BioScience Association Date: 04/17/2023
On April 13, CBSA members and MedTech leaders gathered at the annual Colorado BioScience Association Medical Device Symposium to discover emerging and cutting-edge trends in medical breakthroughs, gai...
Learn MoreCBSA Hosts Annual Medical Device Symposium
By: Colorado BioScience Association Date: 04/17/2023
Innovative medical technologies are transforming patient care around the world and MedTech in Colorado is growing strong with more than 2,200 devices in development or distribution. Many of the most p...
Learn MoreWeekly Policy Blog: CBSA Testifies in Support of HB23-1260
By: Colorado BioScience Association Date: 04/10/2023
CBSA is proud to advocate for a pro-business environment that supports life sciences innovation through our Policy + Advocacy leadership. CBSA Vice President and Counsel for Policy + Advocacy, Amy Goo...
Learn MoreFitzsimons Innovation Community – Building a Life Sciences Pipeline: Access to Capital
By: Colorado BioScience Association Date: 04/03/2023
In Fitzsimons Innovation Community’s blog series, Building a Life Sciences Pipeline, hear how the CU Healthcare Innovation Fund provided strategic value for Arrive Health, and how they’ve been success...
Learn MoreWeekly Policy Blog: CBSA Advocates for Return of Immediate R&D Expensing
By: Colorado BioScience Association Date: 04/03/2023
CBSA is working to generate support for the bipartisan American Innovation & Jobs Act of 2023 (S. 866), sponsored by Senators Maggie Hassan (D-NH) and Todd Young (R-IN). This federal bill, which w...
Learn MoreColorado BioScience Association Releases 2023 Peak Talent Report
By: Colorado BioScience Association Date: 03/30/2023
38,000 Highly Skilled Life Sciences Workers Support State’s Thriving Life Sciences Ecosystem DENVER, March 30, 2023 — Colorado BioScience Association (CBSA) announces its comprehensive new report, Pea...
Learn MoreWeekly Policy Blog: Teacher Externship Program for STEM Disciplines (HB23-1198)
By: Colorado BioScience Association Date: 03/27/2023
CBSA supports HB23-1198, Teacher Externship Program for Science Technology Engineering and Math (STEM) Disciplines, a bill sponsored by Representative Brianna Titone. It requires the Colorado Departme...
Learn MoreWeekly Policy Blog: CBSA’s 2023 Day at the Capitol
By: Colorado BioScience Association Date: 03/20/2023
On March 17, CBSA’s annual Day at the Capitol event returned in person. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which h...
Learn MoreWeekly Policy Blog: PDAB Bill Advances, Plus CBSA Advocates on Federal Issues
By: Colorado BioScience Association Date: 03/13/2023
On March 10, CBSA testified in the House Health and Insurance Committee in opposition to HB23-1225, Extend And Modify Prescription Drug Affordability Board (PDAB). While CBSA shares the bill sponsors’...
Learn MoreFitzsimons Innovation Community - Building a Life Sciences Pipeline: Cell and Gene Therapy Momentum
By: Colorado BioScience Association Date: 03/06/2023
Ideas become cures when academia and industry connect. Human or animal cells on blue background. Concept Early stage embryo Medicine scientific concept, Stem cell research and treatment, 3D illustrati...
Learn MoreWeekly Policy Blog: Governor Polis' Healthcare Legislative Package
By: Colorado BioScience Association Date: 03/06/2023
On March 2, Governor Jared Polis held a press conference to announce a legislative package that he says will save people money on healthcare and increase transparency within the healthcare system. He...
Learn MoreWeekly Policy Blog: HELP Copays Act (H.R. 830)
By: Colorado BioScience Association Date: 02/27/2023
On February 6, 2023, the federal Help Ensure Lower Patient (HELP) Copays Act (H.R. 830) was reintroduced in the U.S. House of Representatives by Representative Earl “Buddy” Carter (R-GA) and referred...
Learn MoreWeekly Policy Blog: COVID-19 Public Health Emergency to Terminate on May 11
By: Colorado BioScience Association Date: 02/20/2023
On February 9, the Department of Health and Human Services (HHS) Secretary Xavier Becerra announced that the federal Public Health Emergency (PHE) for COVID-19 will expire at the end of the day on May...
Learn MoreColorado Life Sciences Incubation Program
By: Colorado BioScience Association Date: 02/15/2023
The Colorado Life Sciences Incubation Program offers startups who are developing or commercializing technologies, products, devices, and life-saving breakthroughs the combined expertise and insights o...
Learn MoreInnosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce 2023 Colorado Life Sciences Incubation Program
By: Colorado BioScience Association Date: 02/15/2023
State Funding from an Advanced Industries Business Accelerator Grant Supports Program DENVER, February 15, 2023 — Innosphere Ventures, Colorado BioScience Association (CBSA), and Colorado BioScience I...
Learn MoreWeekly Policy Blog: CBSA Supports Drug Coverage for Serious Mental Illness Bill (HB23-1130)
By: Colorado BioScience Association Date: 02/10/2023
CBSA supports HB23-1130, a bill that aims to help people suffering from a serious mental illness by addressing private payers’ step therapy requirements and Medicaid’s Preferred Drug List review proce...
Learn MoreCBSA President & CEO Elyse Blazevich Honored by the Denver Business Journal
By: Colorado BioScience Association Date: 02/09/2023
Congratulations to CBSA President and CEO Elyse Blazevich! The Denver Business Journal named Elyse to its prestigious 40 Under 40 List, released this week. The DBJ names a class of 40 Under 40 each ye...
Learn MoreFitzsimons Innovation Community: Building a Life Sciences Pipeline
By: Colorado BioScience Association Date: 02/06/2023
The life sciences ecosystem in Colorado has experienced tremendous growth over the past decade, and the momentum will continue to build. The region is on a trajectory to crack the top five innovation...
Learn MoreWeekly Policy Blog: CBSA Supports Biomarker Testing Coverage Bill (HB23-1110)
By: Colorado BioScience Association Date: 02/03/2023
CBSA is supporting HB23-1110, an important bill introduced in Colorado this year that would require insurance coverage for biomarker testing supported by nationally recognized clinical practice guidel...
Learn MoreWeekly Policy Blog: SB23-066 Advanced Industry Acceleration Programs Heads to First Committee
By: Colorado BioScience Association Date: 01/27/2023
CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Accelerator Grant Programs this session through SB23-066, working with our advanced industries partners and Colorado’s...
Learn MoreFitzsimons Innovation Community Sees Record Momentum and Breakthroughs
By: Colorado BioScience Association Date: 01/25/2023
Fitzsimons Innovation Community recently released its Second Annual Innovation Report, Discoveries Meet Momentum, focusing on the Community momentum that allows innovators to take their discoveries an...
Learn MoreWeekly Policy Blog: Governor Polis’ 2023 State of the State Address
By: Colorado BioScience Association Date: 01/20/2023
Governor Jared Polis gave his 2023 State of the State address to the Colorado General Assembly on Tuesday, January 17th, where he laid out his goals for his second term: “When Colorado reaches our 150...
Learn MoreWeekly Policy Blog: Start of the 2023 Colorado Legislative Session
By: Colorado BioScience Association Date: 01/13/2023
Colorado’s 2023 legislative session kicked off on Monday, January 9th, with swearing in, certification of election results, and opening day speeches from legislative leaders. Governor Jared Polis took...
Learn MoreWeekly Policy Blog: CBSA Releases 2022 Policy + Advocacy Report
By: Colorado BioScience Association Date: 01/09/2023
CBSA leads Policy + Advocacy to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in our ecosy...
Learn MoreColorado BioScience Institute Unveils New Brand and Website
By: Colorado BioScience Association Date: 01/05/2023
Energetic Identity Emphasizes Investment to Cultivate and Diversify State’s Life Sciences Workforce, From Classroom, to Campus, to Career. Denver – Colorado BioScience Institute (The Institute) today...
Learn MoreWeekly Policy Blog: $1.7 Trillion Omnibus Spending Package Signed into Law
By: Colorado BioScience Association Date: 12/22/2022
Updated on 1/3/2023 President Biden signed a $1.7 trillion omnibus spending package into law on December 29th, narrowly averting a government shutdown. In his tweet announcing this news, the Pre...
Learn MoreCutting-Edge Discoveries In Action
By: Colorado BioScience Association Date: 12/19/2022
Fitzsimons Innovation Community members are working on world-changing developments in bioscience and healthcare, and they’re doing it in workspace customized to their projects. It’s been a remarkable...
Learn MoreIntroducing Amy Berenbaum Goodman
By: Colorado BioScience Association Date: 12/16/2022
Colorado BioScience Association is thrilled to welcome Amy Berenbaum Goodman to our team in a newly expanded role, Vice President and Counsel for Policy + Advocacy. Amy Berenbaum GoodmanVice Presiden...
Learn MoreColorado BioScience Association Welcomes Amy Berenbaum Goodman as Vice President and Counsel for Policy + Advocacy
By: Colorado BioScience Association Date: 12/15/2022
Goodman to Advance Federal and State Policies that Support Life Sciences Innovation Denver – Colorado BioScience Association (CBSA) announces the appointment of Amy Berenbaum Goodman as Vice President...
Learn MoreColorado Life Sciences Companies Raise $1.6 Billion in 2022
By: Colorado BioScience Association Date: 12/15/2022
Researchers and Startups Received Increased Funding from Federal Grants and Pre-Seed/Seed Rounds DENVER – Colorado BioScience Association today announced annual fundraising totals for the state’s life...
Learn MoreNew Data on Prescription Drug Prices and Inflation
By: Colorado BioScience Association Date: 12/09/2022
Prescription drug prices lag inflation, according to new information from the Altarum November 2022 Health Sectors Economic Indicators Briefs. With inflation top of mind for policymakers at the state...
Learn MoreVital Transformation Study Examines New Proposals to Alter Accelerated Approvals
By: Colorado BioScience Association Date: 12/02/2022
CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team continues to monitor and review legislation that could directly affect life sciences...
Learn MoreFitzsimons Innovation Community Wins CBSA Building Momentum Award
By: Colorado BioScience Association Date: 11/28/2022
CBSA Building Momentum Award Announcement Fitzsimons Innovation Community is the inaugural recipient of the Colorado BioScience Association’s new Award: Building Momentum. This award recognizes invest...
Learn MoreCBSA Urges Passage of PASTEUR Act During Lame Duck Session
By: Colorado BioScience Association Date: 11/25/2022
CBSA urges Congress to pass important legislation, the Pioneering Antimicrobial Subscriptions to End Up-Surging Resistance Act (PASTEUR Act) during the “lame-duck” session. There is limited time to pa...
Learn MoreCBSA Congratulates Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 11/18/2022
Colorado’s Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Associat...
Learn MoreColorado BioScience Association Recognizes Legislators of the Year at 19th Annual Awards Celebration
By: Colorado BioScience Association Date: 11/18/2022
Colorado BioScience Association (CBSA) recognized two state legislators for their leadership on issues critical to life sciences at the 19th Annual Awards Celebration Presented by AGC Biologics on Nov...
Learn MoreColorado BioScience Association Celebrates the Momentum in State’s Life Sciences Community at 19th Annual Awards Celebration: BioIntelliSense Named Company of the Year, Enveda Biosciences Honored as Rising Star
By: Colorado BioScience Association Date: 11/17/2022
Denver, November 17, 2022 – Colorado BioScience Association celebrated the Colorado companies, organizations, and individuals who are building momentum for Colorado’s life sciences community with thei...
Learn MoreWeekly Policy Update: Key Takeaways from the 2022 Midterm Election
By: Colorado BioScience Association Date: 11/11/2022
In Colorado State races, Democrats prevailed across the state. In fact, Democratic leaders expanded their political power and won by wide margins in all the statewide races. They increased their alrea...
Learn MoreRemembering Colorado House Minority Leader Hugh McKean, an Advocate for Colorado’s Life Sciences Ecosystem
By: Colorado BioScience Association Date: 11/06/2022
Colorado BioScience Association (CBSA) sends our condolences to the family, friends, and colleagues of Representative Hugh McKean, the Colorado House Minority Leader. Our team and board are deeply sad...
Learn MoreColorado BioScience Association to Recognize Outstanding Companies and Leaders at Annual Awards Celebration
By: Colorado BioScience Association Date: 10/31/2022
Aktiv Pharma Group, BioIntelliSense, and Umoja Biopharma Selected as Finalists for Company of the Year; Enveda Biosciences, Think Bioscience, and Watchmaker Genomics Honored as Finalists for Rising St...
Learn MoreWeekly Policy Update: Recent State Budget Forecasts
By: Colorado BioScience Association Date: 10/28/2022
CBSA monitors budget forecasts to assess how the economy, overall employment, and state revenue forecasts could impact CBSA’s State Policy Priorities and our Policy + Advocacy strategy for the upcomin...
Learn MoreElevation Diagnostics Supports People and the Planet with Precision Testing
By: Colorado BioScience Association Date: 10/24/2022
Elevation Diagnostics addresses the growing demand for fast, accurate diagnostic testing in our community. With our flagship location at Fitzsimons Innovation Community, we are committed to providing...
Learn MoreWeekly Policy Update: President Biden Signs New Drug Pricing Executive Order
By: Colorado BioScience Association Date: 10/21/2022
President Biden signed an Executive Order on Friday, October 14th directing Health and Human Services (HHS) to explore additional actions to lower prescription drug costs. This order is on top of...
Learn MoreWeekly Policy Blog: CBSA Engages on Transitional Coverage for Emerging Technologies (TCET)
By: Colorado BioScience Association Date: 10/14/2022
The Centers for Medicare & Medicaid Services (CMS) are currently working to develop a new rule that could provide Medicare patients faster access to innovative, lifesaving, and life-enhancing medi...
Learn MoreWeekly Policy Blog: CBSA Continues Engagement on the WTO TRIPS Waiver
By: Colorado BioScience Association Date: 10/07/2022
In a few months, member states of the World Trade Organization (WTO) will decide whether to expand the TRIPS waiver to include COVID-19 therapeutics and diagnostics. Colorado BioScience Association is...
Learn MoreVictories for Innovation: Congress Reauthorizes the SBIR/STTR and User Fee Programs
By: Colorado BioScience Association Date: 09/30/2022
CBSA celebrates policy victories for Colorado's life sciences community and America’s innovators, scientists, and entrepreneurs. Congress reauthorized critical SBIR/STTR and User Fee programs. Without...
Learn MoreFitzsimons Innovation Community Companies Demonstrate Momentum
By: Colorado BioScience Association Date: 09/23/2022
Fitzsimons Innovation Community has been a partner of the Rocky Mountain Life Sciences Investor & Partnering Conference since its inception, recognizing the importance of this gathering to showcas...
Learn MoreWeekly Update: Biden Administration Cancer Moonshot Initiative; Bi-Partisan Majority Support in Congress - Multi-Cancer Early Detection Screening Coverage Act (S.1873/ H.R. 1946)
By: Colorado BioScience Association Date: 09/23/2022
President Biden’s Cancer Moonshot Initiative On the 60th anniversary of President Kennedy’s “We Choose to Go to the Moon” speech, President Biden gave an update on his Cancer Moonshot Initiative, whic...
Learn MoreCBSA Remains Active on the Critical Need to Reauthorize Vital SBIR/STTR Programs for Life Sciences
By: Colorado BioScience Association Date: 09/16/2022
Act Today and Tell Your Member of Congress to Support Vital SBIR/STTR Programs for Life Sciences The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs ar...
Learn MoreWeekly Policy Blog: Colorado BioScience Political Action Committee Fuels Policy + Advocacy Engagement and Impact
By: Colorado BioScience Association Date: 09/09/2022
The Colorado BioScience Political Action Committee (CBSA PAC), a bipartisan state political action committee, provides opportunities to educate candidates for the state legislature about our life scie...
Learn MoreColorado BioScience Association Announces Record-Breaking Attendance at Vail Investor Conference
By: Colorado BioScience Association Date: 09/06/2022
Rocky Mountain Life Sciences Investor & Partnering Conference to Welcome More than 200 Attendees Denver – Colorado BioScience Association (CBSA) will highlight the future of health innovation at t...
Learn MoreWeekly Policy Blog: August Prescription Drug Affordability Review Board (PDAB) Meeting
By: Colorado BioScience Association Date: 09/02/2022
On August 26, CBSA and our partners participated in the state Prescription Drug Affordability Review Board (PDAB) meeting, which was open to the public. The PDAB was created in 2021 when the state leg...
Learn MoreInVitria’s Technology Eliminates Risks and Protects Patients
By: Colorado BioScience Association Date: 08/29/2022
InVitria was founded with a mission to eliminate the need for blood-derived raw materials in biomanufacturing and drug formulation, primarily targeting the growing demand for human and animal serum in...
Learn MoreWeekly Policy Blog: Ethylene Oxide – Critical in Protecting Patient Health
By: Colorado BioScience Association Date: 08/26/2022
Ethylene Oxide (EtO or EO) is a colorless gas used commercially in a wide variety of ways, including the production of textiles, personal care items, and the sterilization of medical devices, cosmetic...
Learn MoreColorado BioScience Association Appoints Emily Martini as Vice President, Partnerships
By: Colorado BioScience Association Date: 08/22/2022
Martini to Lead Strategic Partnerships, Initiatives, and Programs in Newly Created Role Denver – Colorado BioScience Association (CBSA) announces the appointment of Emily Martini as Vice President of...
Learn MoreWeekly Policy Blog: President Biden Signs Inflation Reduction Act into Law
By: Colorado BioScience Association Date: 08/17/2022
On August 16, 2022, President Biden signed the Inflation Reduction Act, a bill aimed at addressing high inflationary costs. The massive bill increases corporate taxes and includes measures designed to...
Learn MoreWeekly Policy Blog: Deadline Approaches to Reauthorize User Fee Agreements
By: Colorado BioScience Association Date: 08/12/2022
CBSA and our national partners support the renewal of the critically important User Fee Agreements, including the Pharmaceutical Drug User Fee Act (PDUFA) and the Medical Device User Fee Act (MDUFA)....
Learn MoreCBSA Remains Active on Critical Federal Legislation
By: Colorado BioScience Association Date: 08/05/2022
Act Today and Tell Your Member of Congress: Oppose Government Price Setting Congress is negotiating sweeping legislation that impacts life sciences. The current reconciliation bill includes language t...
Learn MoreWeekly Policy Blog: CBSA’s Continued Advocacy on Important Federal Policy Initiatives
By: Colorado BioScience Association Date: 07/29/2022
Congress is negotiating sweeping legislation that impacts life sciences. Colorado BioScience Association (CBSA) remains active on these important legislative proposals, which include supporting the re...
Learn MoreFitzsimons Innovation Community Invests to Meet Market Needs
By: Colorado BioScience Association Date: 07/26/2022
Fitzsimons Innovation Community has maintained a fast pace of development over the past 10 years, building capacity to meet market needs. With an increase in the demand for move-in ready life sciences...
Learn MoreWeekly Policy Update: SBIR/STTR Critical to Life Sciences – Support Our Work on Reauthorization
By: Colorado BioScience Association Date: 07/22/2022
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to advance high-...
Learn MoreWeekly Policy Update: Where We Stand Today on Reauthorization of SBIR/STTR
By: Colorado BioScience Association Date: 07/08/2022
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are vital for our life sciences community. They provide early non-dilutive funding to help advance...
Learn MoreWeekly Policy Update: CBSA Urges Repeal of Harmful R&D Amortization Provision
By: Colorado BioScience Association Date: 07/01/2022
Earlier this month, Colorado BioScience Association (CBSA) partnered with Biotechnology Innovation Organization (BIO) and sent a letter to Congress urging immediate legislative action to repeal the ha...
Learn MoreInvenux Accelerates Solutions for the Future of Rare Disease Patients
By: Colorado BioScience Association Date: 06/24/2022
Invenux, LLC, a privately held clinical stage biopharmaceutical company, is propelling its research and clinical trials forward to treat sickle cell disease in the U.S. and worldwide. By developing a...
Learn MoreManager’s Amendment in FDA Safety and Landmark Advancements (FDASLA) Act Would Include and Allow Drug Importation
By: Colorado BioScience Association Date: 06/24/2022
Earlier this month, Colorado BioScience Association (CBSA) engaged on the U.S. Food and Drug Administration’s (FDA) Safety and Landmark Advancements (FDASLA) Act. CBSA and our national partners suppor...
Learn MoreWeekly Policy Update: CBSA Engages on FDA Safety and Landmark Advancements (FDASLA) Act
By: Colorado BioScience Association Date: 06/17/2022
Colorado BioScience Association (CBSA) and our national partners support the critically important reauthorization of the U.S. Food and Drug Administration’s (FDA) prescription drug, generic drug, bios...
Learn MoreColorado Governor Jared Polis Signs Reauthorization and Expansion of Advanced Industries Tax Credit Into Law
By: Colorado BioScience Association Date: 06/03/2022
Colorado BioScience Association thanks Governor Jared Polis for signing the Advanced Industries Tax Credit, House Bill 1149, into law. “This legislation supports the incredible breakthroughs driving C...
Learn MoreColorado BioScience Association Applauds the 2022 Class of Boettcher Investigators
By: Colorado BioScience Association Date: 06/01/2022
Boettcher Foundation awards $1.88 million in biomedical research grant funding to Colorado researchers DENVER, June 1, 2022 — Colorado BioScience Association (CBSA) congratulates the 2022 class of Boe...
Learn MoreValidus Cellular Therapeutics Gains Momentum in Cellular Therapy
By: Colorado BioScience Association Date: 05/27/2022
Validus Cellular Therapeutics, Inc. is pioneering the use of cellular therapy for the treatment of drug-resistant, chronic bacterial infections. Cellular therapy approaches have been successful for on...
Learn MoreWeekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs Update
By: Colorado BioScience Association Date: 05/27/2022
A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...
Learn MoreHistoric $200 Million Commitment to the University of Colorado Anschutz Medical Campus Fuels Advancements in Treatments and Cures
By: Colorado BioScience Association Date: 05/25/2022
The University of Colorado Anschutz Medical Campus today announced the creation of the Gates Institute, a state-of-the-art facility that will focus on rapidly translating laboratory findings...
Learn MoreInnosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce the Colorado Life Sciences Incubation Program 2022 Cohort
By: Colorado BioScience Association Date: 05/23/2022
Early-Stage Companies in Biotech, Medical Device, Oral Health/Teledentistry, and Health Technology Selected to Take Part in Year-Long, State-Funded Program Denver and Fort Collins, Colo.- Innosphere V...
Learn MoreCBSA Congratulates Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 05/20/2022
Colorado’s Office of Economic Development and International Trade (OEDIT) announced the newest recipients of state-funded Advanced Industries Accelerator Grants this week. Colorado BioScience Associat...
Learn MoreWeekly Policy Update: Legislative Session Closes – CBSA Reviews Policy Accomplishments
By: Colorado BioScience Association Date: 05/13/2022
The 2022 legislative session, the Second Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that began with the legislature having significant financial...
Learn MoreState Tax Credit Expanded: A Win for Our Community
By: Colorado BioScience Association Date: 05/11/2022
CBSA is pleased to share news of a significant win at the State Capitol for our life sciences community. Late last night, the legislature voted to reauthorize the Advanced Industries Tax Credit Progra...
Learn MoreWeekly Policy Update: Legislative Session Enters the Final Weeks
By: Colorado BioScience Association Date: 04/29/2022
The legislative session is scheduled to end on Wednesday, May 11th, or in about 12 days. As we enter the final stretch, the CBSA team continues to weigh in on key legislation and advocate on behalf of...
Learn MoreAtara Biotherapeutics Fosters Hope for Those Impacted by Cancer, Autoimmune Diseases
By: Colorado BioScience Association Date: 04/26/2022
Atara Biotherapeutics is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumor...
Learn MoreWhat is Happening in Life Sciences Valuations?
By: Colorado BioScience Association Date: 04/25/2022
Guest Post by Peter Adams, Executive Director, Rockies Venture Club Anyone who has been watching valuations in life sciences deals over the past couple of years knows that median valuations in life sc...
Learn MoreColorado BioScience Association Appoints Leaders from Amgen and Validus Cellular Therapeutics to Lead Board of Directors
By: Colorado BioScience Association Date: 04/25/2022
Executives from JP Morgan Chase & Company, AGC Biologics, Innosphere Ventures, GelSana, and Terumo Blood and Cell Technologies Join Board Denver – Colorado BioScience Association (CBSA), which cre...
Learn MoreWeekly Policy Update: Congressional Tax Package Could Support Further Industry Growth
By: Colorado BioScience Association Date: 04/22/2022
CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...
Learn MoreWhy Do So Many Angel/VC Investors Misunderstand Life Sciences Investing?
By: Colorado BioScience Association Date: 04/18/2022
Guest Post by Peter Adams, Executive Director, Rockies Venture Club I am often surprised when I meet investors who claim that they invest in just about anything but life sciences. Last year heal...
Learn MoreWeekly Policy Update: Medical Device User Fee Amendments (MDUFA)
By: Colorado BioScience Association Date: 04/15/2022
CBSA and our national partners support the renewal of the critically important Medical Device User Fee Amendments (MDUFA). After months of negotiations among the FDA and industry advocacy groups, incl...
Learn MoreWeekly Policy Update: Small Business Innovation Research and Small Business Technology Transfer Programs
By: Colorado BioScience Association Date: 04/08/2022
A longstanding policy priority for CBSA is supporting our ecosystem’s need for increased access to capital. Through our Capital + Growth efforts, we work closely with public and private partners to ac...
Learn MoreWeekly Policy Update: TRIPS Waiver Update
By: Colorado BioScience Association Date: 04/01/2022
Colorado BioScience Association continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver, due the harmful precedent the waiving of IP...
Learn MoreCBSA Thanks AGC Biologics, Our Sustaining Sponsor
By: Colorado BioScience Association Date: 03/31/2022
Thank you to CBSA Sustaining Sponsor, AGC Biologics! AGC Biologics deepened its investment in CBSA and Colorado’s life sciences ecosystem with our highest level of sponsorship. We are thrilled by the...
Learn MoreGreffex Transforms Vaccine and Gene Therapy Work
By: Colorado BioScience Association Date: 03/25/2022
Greffex™ is a privately held, multi-national company that developed a novel genetic platform for the development and production of vaccines. The GREVAX™ Universal Platform delivers vaccines in a faste...
Learn MoreWeekly Policy Update: Advocacy on Congressional Tax and Investment Policies
By: Colorado BioScience Association Date: 03/25/2022
Colorado BioScience Association is watching legislative proposals at the federal level that would be harmful to business. These proposals would have impacts on Qualified Small Business Stock and tax c...
Learn MoreWeekly Policy Update: Accelerated Approvals Reform Bill Introduced
By: Colorado BioScience Association Date: 03/11/2022
CBSA is committed to keeping our community updated on issues that impact life sciences. Our Policy + Advocacy team is reviewing newly proposed legislation that could directly affect life sciences comp...
Learn MoreSupport Needed: Colorado Coalition’s Application for the Build Back Better Grant
By: Colorado BioScience Association Date: 03/07/2022
Colorado BioScience Association is asking for your support. The Colorado Coalition, which includes CBSA, is working to secure up to $100 million in funding for life sciences and cleantech in our state...
Learn MoreWeekly Policy Update: President Biden Delivers First State of the Union Address
By: Colorado BioScience Association Date: 03/04/2022
Earlier this week, President Biden delivered his first State of the Union address as President to a joint session of Congress. While the speech was primarily focused on the conflict in Ukraine, the Pr...
Learn MoreColorado Life Sciences Incubation Program: New Program for Colorado-Based Startups
By: Colorado BioScience Association Date: 03/03/2022
Colorado BioScience Association is proud to launch a new incubation program for early-stage companies in partnership with Innosphere and our sister organization, Colorado BioScience Institute. The yea...
Learn MoreLabXchange Provides Value: Colorado BioScience Institute and Amgen Foundation Support Teacher Trainings in Colorado
By: Colorado BioScience Association Date: 03/02/2022
Through the generous support of the Amgen Foundation, the Colorado BioScience Institute collaborates with Harvard University’s LabXchange to provide teacher trainings in Colorado. LabXchange sat down...
Learn MoreWeekly Policy Update: HB22-1149 Advanced Industries Investment Tax Credit Heads to First Committee
By: Colorado BioScience Association Date: 02/25/2022
CBSA is proud to lead the advocacy efforts to reauthorize the Advanced Industries Investment Tax Credit this session through HB22-1149. The bill is sponsored by Rep. Shannon Bird, Rep. Mike Lynch, and...
Learn MoreColorado Research Partners Cultivates Future of Fructose Inhibitors
By: Colorado BioScience Association Date: 02/18/2022
Colorado Research Partners is a pharmaceutical company in the Fitzsimons Innovation Community that brings enthusiasm to curbing the effects of nonalcoholic fatty liver disease using their fructose inh...
Learn MoreWeekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol
By: Colorado BioScience Association Date: 02/18/2022
During our annual Day at the Capitol event, members heard about CBSA's state advocacy efforts and the issues impacting Colorado's life sciences ecosystem this legislative session. Lieutenant Governor...
Learn MoreInnosphere Ventures, Colorado BioScience Association, and Colorado BioScience Institute Announce New Incubation Program to Grow Life Sciences Startups
By: Colorado BioScience Association Date: 02/17/2022
State Funding from Advanced Industries Business Accelerator Grant to Support Program DENVER, February 17, 2022 — Innosphere Ventures, Colorado BioScience Association (CBSA), and Colorado BioScience In...
Learn MoreWeekly Policy Update: State Regulation of Ethylene Oxide
By: Colorado BioScience Association Date: 02/11/2022
The regulatory environment regarding the usage of Ethylene Oxide (EtO) for the sterilization of medical devices is constantly evolving. Colorado state legislators are drafting a proposal that would cr...
Learn MoreWeekly Policy Update: Biden Administration Relaunches “Cancer Moonshot”
By: Colorado BioScience Association Date: 02/04/2022
Earlier this week, President Biden relaunched the Cancer Moonshot initiative which was originally created while he was serving as Vice President in 2016. And today also happens to be World Cancer Day...
Learn MoreThe Colorado BioScience Institute and St. Vrain Valley Schools Receive $435,200 Grant to Advance Workforce Pathways
By: Colorado BioScience Association Date: 02/02/2022
FREDERICK, Colorado – The Colorado BioScience Institute and St. Vrain Valley Schools have been awarded a $435,200 Workforce Innovation Grant from the Weld County Workforce Development Board in su...
Learn MoreWeekly Policy Update: State Opioid Fee
By: Colorado BioScience Association Date: 01/28/2022
CBSA is tracking the development of a policy proposal from legislators that would mandate a fee on opioid manufacturers and distributors, along with manufacturers of other controlled substances includ...
Learn MoreFitzsimons Innovation Community Bioscience 5 Development Officially Underway
By: Colorado BioScience Association Date: 01/24/2022
Fitzsimons Innovation Community is making progress on the buildout of their newest bioscience facility, for cell and gene therapy. With Fitzsimons Innovation Community and CU Anschutz Medical Campus i...
Learn MoreWeekly Policy Update: Medicaid's 340B Program
By: Colorado BioScience Association Date: 01/21/2022
As the General Assembly wraps up its second week back in session, the Colorado BioScience Association is tracking the development of a policy proposal from legislators that could have significant impa...
Learn MoreWeekly Policy Update: Start of the Colorado Legislative Session
By: Colorado BioScience Association Date: 01/14/2022
The Colorado State Legislature returned this past Wednesday to start the second regular session of the 73rd General Assembly. Even before the legislature’s return, Colorado BioScience Association has...
Learn MoreWeekly Policy Update: December State Budget Forecast
By: Colorado BioScience Association Date: 01/07/2022
In December, the Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented strong budget forecasts which are a positive sign for the state’s...
Learn MoreCBSA President and CEO Is Recognized in Colorado Inno as a Top Tech Hire 2021
By: Colorado BioScience Association Date: 01/06/2022
CBSA President and CEO, Elyse Blazevich, has been recognized in Colorado Inno as a top tech hire. Elyse strategically advances CBSA’s work to build a pro-innovation environment for life sciences in Co...
Learn MoreCBSA Champions Life Sciences in 2021 with End of Year Highlights
By: Colorado BioScience Association Date: 12/28/2021
Colorado’s reputation as a leading location for health innovation continues to accelerate. In 2021, we broke the top 10 in a new ranking of top North American life sciences hubs, climbing to #8. We ac...
Learn MoreWeekly Policy Update: Build Back Better Act Stalled in the Senate
By: Colorado BioScience Association Date: 12/23/2021
Over the weekend Democratic Senator Joe Manchin of West Virginia announced that he would be voting ‘no’ on the Build Back Better Act (BBBA). His concerns with the legislation are primar...
Learn MoreWeekly Policy Update: FDA Commissioner Nominee Confirmation Hearing
By: Colorado BioScience Association Date: 12/17/2021
Last month, President Biden announced Robert Califf, M.D. as his nominee for Commissioner of the Food and Drug Administration (FDA). Dr. Califf’s confirmation hearing was held this week by the Senate...
Learn MoreColorado Life Sciences Companies Raise a Record $2.4 Billion in 2021
By: Colorado BioScience Association Date: 12/14/2021
Major IPOs, Venture Capital Funding, and Government Funding Accelerate Health Innovation DENVER – Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing comm...
Learn MoreEssent Biologics and Amnion Foundation Partner to Provide Germinal-Origin Cells to Further Drug Discovery and Regenerative Medicine Research
By: Colorado BioScience Association Date: 12/14/2021
Distribution Agreement Will Allow Access to Innovative Full-Term Placenta-Derived Cells to Support Ground-Breaking Research Centennial, Colo. — December 14, 2021 — Essent Biologics™, a leading supplie...
Learn MoreWeekly Policy Update: Business Implications from Pending Legislative & Regulatory Activities + CBSA USPTO Roundtable
By: Colorado BioScience Association Date: 12/10/2021
In addition to the ongoing conversations in the Senate related to the House of Representatives’ version of the $1.75 trillion Build Back Better Act (BBBA), the federal government will be seeking stric...
Learn MoreWeekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments Remains Under Consideration by the World Trade Organization
By: Colorado BioScience Association Date: 12/03/2021
CBSA continues to monitor the international debate on the Trade-Relations Aspects of Intellectual Property Rights (TRIPS) Waiver. Our monitoring of the waiver is due the harmful precedent waving of IP...
Learn MorePathways Bioscience Seeks to Optimize Aging
By: Colorado BioScience Association Date: 11/29/2021
Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging. By use of a dietary supplement with naturally occurring plant-based ingredients,...
Learn MoreWeekly Policy Update: World Antimicrobial Awareness Week + Cures 2.0 & PASTEUR Act
By: Colorado BioScience Association Date: 11/24/2021
World Antimicrobial Awareness Week, hosted by the World Health Organization last week, focused on increasing awareness of global antimicrobial resistance (AMR). and encou...
Learn MoreCBSA Applauds Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 11/19/2021
Colorado BioScience Association applauds CBSA members and honorees from across our state's innovation ecosystem who were awarded Advanced Industries Accelerator Grants by Colorado’s Office of Economic...
Learn MoreWeekly Policy Update: Qualified Small Business Stock Implications within the Build Back Better Act
By: Colorado BioScience Association Date: 11/19/2021
In addition to the price-setting policies and investment implications related to the capital gains tax rate and IRA provisions, the House version of the Build Back Better...
Learn MoreWeekly Policy Update: CBSA Hosts Ecosystem Briefing and Roundtable Discussion with Belgian Ambassador Jean-Arthur Régibeau
By: Colorado BioScience Association Date: 11/12/2021
This week, CBSA was honored to host a dynamic briefing and roundtable discussion for Belgian Ambassador Jean-Arthur Régibeau. Our community appreciated the opportunity to...
Learn MoreBond Pet Foods Develops The World's First Animal-Free Chicken Protein For Dog And Cat Nutrition
By: Colorado BioScience Association Date: 11/11/2021
Proprietary approach brews chicken protein through biotechnology and fermentation, instead of harvesting conventionally on farm and field Bond Pet Foods, Inc., the Boulder-based company working with b...
Learn MoreCBSA Website Wins National Award
By: Colorado BioScience Association Date: 11/08/2021
The Colorado BioScience Association website recently received national recognition by the w3 Awards organization, which celebrates digital excellence. Our site was honored in the industry association...
Learn MoreWeekly Policy Update: Agreement Reached on Drug Pricing Policies within the Budget Reconciliation Package
By: Colorado BioScience Association Date: 11/05/2021
Late last week, the White House released a framework for the budget reconciliation package, known as the Build Back Better Act. The original package had a total cost of $3.5 trillion. The latest frame...
Learn MoreWeekly Policy Update: New CBSA President & CEO Brings Direct Experience with State and Federal Policy Priorities
By: Colorado BioScience Association Date: 10/29/2021
The CBSA Board of Directors announced the appointment of Elyse Blazevich as our President & CEO on October 27. The Association is fortunate to have som...
Learn MoreColorado BioScience Association Appoints Elyse Blazevich, Medical Device Company Founder and Business Leader, as President & CEO
By: Colorado BioScience Association Date: 10/27/2021
Blazevich Steps into New Role During Period of Significant Momentum for Life Sciences in Colorado Denver – Colorado BioScience Association (CBSA) announces the appointment of medical device company fo...
Learn MoreWeekly Policy Update: Medicare Coverage of Innovative Technology (MCIT) Pathway
By: Colorado BioScience Association Date: 10/22/2021
The Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) submitted comments last week to the Centers for Medicare...
Learn MoreClearSight Seeks to Restore Vision and Improve the Quality of Life for Millions
By: Colorado BioScience Association Date: 10/22/2021
ClearSight is developing innovative solutions for ophthalmologists that aim to change the standard of care for many patients. Utilizing a micropattern and patented design, the first intraocular lens C...
Learn MoreWeekly Policy Update: Legislators of the Year Announced + TRIPS Waiver Update
By: Colorado BioScience Association Date: 10/15/2021
Legislators of the Year CBSA recognized four state legislators for their leadership on issues critical to life sciences, earlier this week at the Innovation Forward Forum + Awards Cele...
Learn MoreColorado BioScience Association Recognizes Legislators of the Year at Innovation Forward: Forum + Awards Celebration
By: Colorado BioScience Association Date: 10/13/2021
Four State Legislators Honored for their Leadership on Issues Important to Life Sciences Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the Innovat...
Learn MoreColorado BioScience Association Highlights Health Innovators at Innovation Forward: Forum + Awards Celebration
By: Colorado BioScience Association Date: 10/13/2021
LightDeck Diagnostics Named Company of the Year, Artisan Bio Honored as Rising Star of the Year Denver – Colorado BioScience Association (CBSA) honored Colorado’s life sciences community at the ...
Learn MoreLife Sciences Companies Pitch at Innovation Forward: Forum + Awards Celebration on October 12 for $7,500 Prize
By: Colorado BioScience Association Date: 10/08/2021
Colorado BioScience Association is excited to welcome our life sciences ecosystem back to in-person education + networking. We’re planning the largest gathering of our community since early 2020. We a...
Learn MoreWeekly Policy Update: Tax and Investment Implications within the Budget Reconciliation Package
By: Colorado BioScience Association Date: 10/01/2021
In addition to the price-setting policies from H.R. 3, which are already included in House Democrats' version of the 10-year, $3.5 trillion spending plan, two tax policies along with ch...
Learn MoreZalgen Labs Develops and Deploys Solutions to Emerging Viral Threats
By: Colorado BioScience Association Date: 09/27/2021
Zalgen Labs is making a difference for patients around the world with solutions to viral threats and neglected tropical diseases. They specialize in the design and production of superior biological mo...
Learn MoreWeekly Policy Update: State Budget Forecast
By: Colorado BioScience Association Date: 09/24/2021
The Governor's Office of State Planning and Budgeting (OSPB), along with nonpartisan Legislative Council staff, presented similar budget forecasts during their quarterly presentations to the...
Learn MoreWeekly Policy Update: Congressional Drug Pricing Effort Advances
By: Colorado BioScience Association Date: 09/17/2021
House Democrats are in the process of including the policies contained within H.R. 3 into their 10-year, $3.5 trillion spending plan that they hope to pass using the budget reconciliation process. Cu...
Learn MoreColorado BioScience Association to Celebrate Leading Life Sciences Companies at Awards Celebration
By: Colorado BioScience Association Date: 09/16/2021
LightDeck Diagnostics, Proov, and OnKure Named as Company of the Year Finalists; Artisan Bio, Enveda Biosciences, and Foresight Diagnostics Named Rising Star of the Year Finalists Denver – Colorado Bi...
Learn MoreWeekly Policy Update: Biden Administration Releases Drug Pricing Plan
By: Colorado BioScience Association Date: 09/10/2021
The Biden Administration through the Department of Health and Human Services (HHS) published a white paper detailing multiple policy strategies to address prescription drug costs, the paper is in resp...
Learn MoreWeekly Policy Update: New Survey Provides Limited Insight into Coloradans' views on Healthcare
By: Colorado BioScience Association Date: 09/03/2021
Consumers for Quality Care (CQC) who state they are a coalition of advocates and former policymakers working to provide a voice for patients in the health care debate as they demand better care, relea...
Learn MoreGelSana Therapeutics Provides Breakthrough in Hydrogel Technology
By: Colorado BioScience Association Date: 08/30/2021
GelSana Therapeutics, Inc. is fabricating next-generation wound healing hydrogels that offer faster healing with less inflammation, especially for chronic wounds such as diabetic ulcers. The GelSana t...
Learn MoreWeekly Policy Update: Congressional Drug Pricing Efforts + CBSA Medical Device Symposium
By: Colorado BioScience Association Date: 08/27/2021
H.R. 3 Impact House Speaker Nancy Pelosi originally released H.R 3, the Lower Drug Costs Now Act in 2019, the Act went on to pass out of the chamber by a slim bipartisan margin where it then faced pre...
Learn MoreColorado BioScience Association Announces Appointment of Vice President
By: Colorado BioScience Association Date: 08/24/2021
Michael Crews to Advocate for Life Sciences Priorities at the State and Federal Level DENVER – Colorado BioScience Association (CBSA) today announced a key hire, new Vice President Michael Crews. Crew...
Learn MoreWeekly Policy Update: TRIPS Waiver for COVID-19 Vaccines and Treatments still under consideration by the World Trade Organization
By: Colorado BioScience Association Date: 08/23/2021
Earlier this year the Colorado BioScience Association (CBSA) along with 300 other global biotechnology companies and associations signed onto a declaration outlining the harm of a proposed waiver of t...
Learn MoreWeekly Policy Update: CBSA Applauds Senator Bennet’s Leadership on Early Cancer Detection Legislation
By: Colorado BioScience Association Date: 08/16/2021
Last week, Colorado U.S. Senator Michael Bennet hosted a roundtable discussion on his Medicare Multi-Cancer Early Detection Screening Coverage Act. Kathleen (Kiki) Traylor, M.D., State Affairs Directo...
Learn MoreCBSA Applauds Rep. Jason Crow for Supporting Health Innovation in Our State
By: Colorado BioScience Association Date: 08/09/2021
Colorado BioScience Association (CBSA) applauds Representative Jason Crow (D-CO) for re-introducing the Small Business Innovation Voucher Act with Representative Tim Burchett (R-TN). This bipartisan l...
Learn MoreCBSA Presents on Thriving Life Sciences Community to ACE Delegation
By: Colorado BioScience Association Date: 08/09/2021
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. Last week, CBSA’s President and CEO Jennifer Jones Paton presented at a session of The ACE 13 ev...
Learn MoreEvent Series The Leader Within Highlights Inspiring Stories of Leadership
By: Colorado BioScience Association Date: 07/30/2021
In 2021, Colorado Bioscience Association and the Medtronic Women’s Network teamed up to create The Leader Within – a virtual event series to hear from local life sciences leaders in an exclusive setti...
Learn MoreWeekly Policy Update: CBSA Lays Groundwork for Upcoming 2022 Session
By: Colorado BioScience Association Date: 07/27/2021
Colorado BioScience Association (CBSA) leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal polici...
Learn MoreA Message from President & CEO Jennifer Jones Paton on her Transition from CBSA
By: Colorado BioScience Association Date: 07/26/2021
Dear Colorado Life Sciences Community, After almost five years at Colorado BioScience Association and more than two years as President & CEO, I have decided to transition from my role at CBSA to f...
Learn MoreColorado BioScience Association Announces Departure of President & CEO, Jennifer Jones Paton
By: Colorado BioScience Association Date: 07/26/2021
Board of Directors to Begin Comprehensive Search for Replacement DENVER – Colorado BioScience Association (CBSA) announced Jennifer Jones Paton’s plans to transition from her President & CEO role....
Learn MorePolicy + Advocacy: End-of-Session Report
By: Colorado BioScience Association Date: 07/15/2021
CBSA leads Policy + Advocacy efforts to support a collaborative, pro-innovation environment for life sciences in Colorado. We work to advance state and federal policies that support the companies in o...
Learn MoreA Letter from Our President & CEO
By: Colorado BioScience Association Date: 07/12/2021
Colorado Life Sciences Community: Our ecosystem continues to demonstrate remarkable growth and innovation as we enter the second half of 2021. Medtronic broke ground on a new campus in Lafayette at th...
Learn MoreForesight Diagnostics Transforms Standard of Care for Disease Surveillance
By: Colorado BioScience Association Date: 06/29/2021
Foresight Diagnostics, an emerging leader in blood-based lymphoma disease monitoring, is transforming patient care with groundbreaking cancer surveillance technology. The Foresight team can identify p...
Learn MoreWeekly Policy Update: CBSA Signs BIO CEO Declaration on Global Access to COVID-19 Vaccines and Treatments and the Role of Intellectual Property
By: Colorado BioScience Association Date: 06/28/2021
Colorado BioScience Association (CBSA) and close to 300 other global biotechnology companies and associations have come together in opposition to waiving IP protections for COVID-19 vaccines and treat...
Learn MoreWeekly Policy Update: PASTEUR Act, COVID-19 Intellectual Property, and June Economic Forecast
By: Colorado BioScience Association Date: 06/21/2021
CBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics Last week Senator Michael Bennet introduced new bipartisan legislation in the U.S. Senate that would s...
Learn MoreA Letter from CBSA President & CEO Jennifer Jones Paton: 2021 Legislative Session
By: Colorado BioScience Association Date: 06/14/2021
Dear Colorado Life Sciences Community, Colorado BioScience Association builds a collaborative, pro-innovation environment for life sciences innovation. Through our Policy + Advocacy efforts, we work a...
Learn MoreLegislative Session Closes – CBSA Reviews Policy Accomplishments
By: Colorado BioScience Association Date: 06/14/2021
The 2021 legislative session, the First Regular Session of the 73rd General Assembly, has concluded. It was an unprecedented session that started during the heights of the COVID-19 pandemic and ended...
Learn MoreJoin Our Team at Colorado BioScience Association
By: Colorado BioScience Association Date: 06/08/2021
It’s an incredible time to champion life sciences. Big thinkers and bold leaders from Colorado are saving and changing lives around the world with health innovations, products, and solutions. Our comm...
Learn MorePolicy Wins for Colorado Life Sciences Community with SB 175 Amendments
By: Colorado BioScience Association Date: 06/07/2021
As the legislative session nears an end, health care and prescription drug bills are still being negotiated. Last week, Colorado SB 175 passed the House floor on a second reading on Friday. CBSA thank...
Learn MoreWeekly Policy Update: Two State Bills Move Forward That Could Adversely Impact Life Sciences Ecosystem
By: Colorado BioScience Association Date: 06/01/2021
The end of the 2021 Colorado legislative session is quickly approaching. The last possible day (June 12) is less than two weeks away and it’s possible that the General Assembly could even wrap up befo...
Learn MoreColorado BioScience Association Celebrates the 2021 Class of Boettcher Investigators
By: Colorado BioScience Association Date: 05/25/2021
Boettcher Foundation awards $1.41 million in biomedical research grant funding to Colorado researchers Colorado BioScience Association (CBSA) congratulates six leading Coloradoresearchers who are the...
Learn MoreExxel Pharma: Small Molecule Therapy, Big Impact
By: Colorado BioScience Association Date: 05/25/2021
Exxel Pharma is a development stage company that combines world-class leadership, expert technological know-how and experience from the pharmaceutical industry to develop medicines for significant unm...
Learn MoreWeekly Policy Update: State Bills Advance to Create More Small Business Support Programs
By: Colorado BioScience Association Date: 05/21/2021
Two state bills advanced this week that would create new programs to support Colorado small businesses. These proposals are part of a larger $800 million state stimulus package that targets aide to ce...
Learn MoreCBSA Congratulates Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 05/19/2021
Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...
Learn MoreWeekly Policy Update: CBSA Hosts Congressional Briefing on the Impacts of Reference Pricing
By: Colorado BioScience Association Date: 05/14/2021
CBSA partnered with We Work for Health Colorado this week to host a briefing for Colorado congressional offices about the impacts of international reference pricing on our innovation ecosystem. Duane...
Learn MoreCBSA Congratulates Emily Roberts on New Role, Launches Search for Replacement CBSA
By: Colorado BioScience Association Date: 05/11/2021
Emily Roberts has accepted a position at CBSA member company Genentech on the issue advocacy team. CBSA congratulates Emily on this exciting next step in her career. She has made a sig...
Learn MoreWeekly Policy Update: Drug Review Board Legislation Passes State Senate
By: Colorado BioScience Association Date: 05/07/2021
Senate Bill 175 (Prescription Drug Affordability Review Board) passed the Colorado Senate today on a vote of 19-16. The bill would create a prescription drug review board in Colorado that is charged w...
Learn MoreWeekly Policy Update: Colorado Legislature Finalizes State Budget
By: Colorado BioScience Association Date: 04/30/2021
The Colorado legislature finalized the state budget today, which will now be sent to Governor Polis for his signature. In addition to funding day-to-day operations of the state government, the $34.6 b...
Learn MoreCPC Works to Propel Beyond Research, Engage Community Directly
By: Colorado BioScience Association Date: 04/26/2021
CPC is a non-profit, mission-driven Academic Research Organization (ARO) that supports all phases of clinical research. Their academically led team provides fullservice support, offering scientific ov...
Learn MoreColorado BioScience Association Appoints New Board Members
By: Colorado BioScience Association Date: 04/26/2021
Colorado BioScience Association (CBSA) today announced the appointment of seven new members to its board of directors, Jim Kasic, CEO of EndoShape and Chairman of Boulder IQ; Anil Mathai, Vice Preside...
Learn MoreColorado’s Life Sciences Ecosystem Achieves Record Q1 Fundraising
By: Colorado BioScience Association Date: 04/19/2021
Colorado BioScience Association (CBSA) today announced the state’s life sciences community raised an unprecedented $704 million in the first quarter of 2021. Capital from public, private, and federal...
Learn MoreCBSA Urges CMS to Implement MCIT Rule Without Delay
By: Colorado BioScience Association Date: 04/19/2021
In January, CMS finalized a new rule called Medicare Coverage of Innovative Technologies (MCIT). The rule provides immediate national Medicare coverage for FDA-designated breakthrough devices and diag...
Learn MoreWeekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities
By: Colorado BioScience Association Date: 04/16/2021
Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...
Learn MoreYour Help Needed Now: Tell Colorado Legislators to Protect Life Sciences Innovation
By: Colorado BioScience Association Date: 04/09/2021
The Colorado state legislature is considering a bill that creates a state drug review board with the power to set payment rates for medicines in Colorado. The unelected board could set price limits wi...
Learn MoreWeekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse
By: Colorado BioScience Association Date: 04/09/2021
CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...
Learn MoreWeekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal
By: Colorado BioScience Association Date: 04/02/2021
Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...
Learn MorePhosphoSolutions Drives Scientific Breakthroughs with Research Antibodies
By: Colorado BioScience Association Date: 03/29/2021
PhosphoSolutions specializes in producing high-quality research antibodies for the neuroscience community. The company's research antibodies provide critical information on drug effectiveness that dri...
Learn MoreWeekly Policy Update: State Leaders Solicit Input on Colorado’s Stimulus Funding
By: Colorado BioScience Association Date: 03/26/2021
Colorado and local governments are expected to receive billions of dollars from the 2021 American Rescue Plan. In an effort to better understand the needs and current economic challenges facing the st...
Learn MoreNovartis Gene Therapies News
By: Colorado BioScience Association Date: 03/26/2021
Work in Progress to Support Jobseekers and Identify New Candidates for Facility Novartis Gene Therapies, formerly AveXis, plans to wind down its Longmont facility in July. Novartis Gene Therapies has...
Learn MoreRobust Speaker Line-Up and Pitch Event Winner at CBSA-Amgen Healthcare Innovation
By: Colorado BioScience Association Date: 03/23/2021
The CBSA-Amgen Healthcare Innovation Event took place this week filled with engaging speakers and a robust audience. Thank you to our sponsors Amgen, Amgen Ventures and CBSA sustaining spons...
Learn MoreWeekly Policy Update: CBSA Testifies on Local Impact of Drug Pricing Bill
By: Colorado BioScience Association Date: 03/19/2021
This week CBSA testified in opposition to Senate Bill 175 in the Senate Health & Human Services Committee. The bill would create a prescription drug review board in Colorado that’s charged with re...
Learn MoreWeekly Policy Update: CBSA Engages on Key Legislation
By: Colorado BioScience Association Date: 03/12/2021
CBSA took new positions on several bills in the 2021 legislative session. Here is a recap of what happened this week. New Funding for Advanced Industries Grant Program: On Tuesday, the legislature pas...
Learn MoreColorado Vaccine Distribution Update
By: Colorado BioScience Association Date: 03/12/2021
The Colorado Department of Public Health & Environment (CDPHE) confirmed to CBSA that members of our life sciences workforce involved in the research, development, manufacturing and distribution o...
Learn MorePolicy + Advocacy: Legislature Passes New Funding for Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 03/09/2021
On Tuesday, the Colorado General Assembly passed Senate Bill 42, which includes a one-time, $10 million infusion for the Advanced Industries Accelerator Grant Program. Governor Polis is expected to si...
Learn MoreWeekly Policy Update: CBSA Shares Survey Insights
By: Colorado BioScience Association Date: 03/05/2021
The CBSA Policy + Advocacy team works to engage state and federal policymakers on issues that are critical to our members and Colorado’s life sciences ecosystem. Last month, CBSA conducted a survey to...
Learn MoreThe Colorado Molecular Correlates Laboratory Puts Quality First
By: Colorado BioScience Association Date: 02/26/2021
The Colorado Molecular Correlates Laboratory is dedicated to the development and implementation of predictive, prognostic and diagnostic molecular biomarker testing that will permit selection of cance...
Learn MoreWeekly Policy Update: CBSA Takes Positions on New State Legislation
By: Colorado BioScience Association Date: 02/26/2021
The Colorado state legislature returned on February 16th to continue the 2021 session, and there have already been almost 300 bills introduced so far. CBSA’s Policy + Advocacy team has been hard at wo...
Learn MoreCBSA Joins Patient Community to Raise Awareness about Rare Diseases
By: Colorado BioScience Association Date: 02/25/2021
This week, CBSA joined the Colorado Rare Action Network for Colorado Rare Disease Day. The virtual event was an opportunity to educate state legislators and the public about the challenges rare diseas...
Learn MoreWeekly Policy Update: Governor Polis Delivers the State of the State
By: Colorado BioScience Association Date: 02/19/2021
On Wednesday, Governor Jared Polis delivered his State of the State address. He started by acknowledging the challenges Colorado and the country have faced over the past year in the midst of a global...
Learn MoreWeekly Policy Update: Colorado Legislative Session Resumes Next Week
By: Colorado BioScience Association Date: 02/12/2021
The Colorado state legislature returns next Tuesday to resume the first regular session of the 73rd General Assembly. Here are a few of the issues CBSA is focused on this session. Advanced Industries...
Learn MoreWeekly Policy Update: Congressional Democrats Use Budget Reconciliation, Creating Path for COVID Relief Package
By: Colorado BioScience Association Date: 02/05/2021
On Friday, the U.S. Senate and the U.S. House of Representatives passed a budget resolution, advancing the process of budget reconciliation that will allow Democrats to pass President Joe Biden’s COVI...
Learn MoreWeekly Policy Update: Colorado Releases Solicitation to Operationalize Canadian Drug Importation Program
By: Colorado BioScience Association Date: 01/28/2021
In 2019, the Colorado General Assembly passed SB19-005, which authorized the Department of Health Care Policy & Financing (HCPF) to seek approval from the federal government to create a Canadian d...
Learn MoreCerebral Therapeutics Advances Neurological Science and Patient Outcomes
By: Colorado BioScience Association Date: 01/25/2021
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: President Biden Takes Immediate Action
By: Colorado BioScience Association Date: 01/22/2021
On January 20, President Joe Biden signed a series of executive orders, just hours after taking his oath of office. In addition to reversing some of the steps taken by the Trump Administration over th...
Learn MoreWeekly Policy Update: CMS Finalizes New Pathway for Medicare Coverage of Innovative Technologies
By: Colorado BioScience Association Date: 01/15/2021
The Centers for Medicare and Medicaid Services (CMS) published a final rule this week that creates a new, voluntary pathway for immediate, national Medicare coverage for medical technologies approved...
Learn MoreWeekly Policy Update: Small Business Administration Releases New Details for Paycheck Protection Program
By: Colorado BioScience Association Date: 01/08/2021
The Small Business Administration (SBA) released new guidance this week for the next round of Paycheck Protection Program (PPP) loans. Congress authorized $284.45 billion to go towards PPP loans as pa...
Learn MoreCBSA Highlights Colorado Case for U.S. International Trade Commission
By: Colorado BioScience Association Date: 01/08/2021
CBSA submitted a letter to the U.S. International Trade Commission this week calling attention to a complaint made by Ventria Bioscience, Inc., an important member of Colorado's life sciences communit...
Learn MoreWeekly Policy Update: CBSA Prepares for the 2021 Legislative Session
By: Colorado BioScience Association Date: 01/05/2021
On January 13, the Colorado General Assembly will convene for a short time to address urgent business and then take a temporary recess, with the aim of returning to the state Capitol on February 16 to...
Learn MoreCongress Passes New COVID Relief Package: What it Means for Colorado Life Sciences
By: Colorado BioScience Association Date: 12/21/2020
Late last night Congress passed a $900 billion coronavirus aid package that will provide emergency economic relief and stimulate the nation’s economy. This is the first COVID-19 relief measure that Co...
Learn MoreNeurexis Therapeutics Works to Solve an Unmet Healthcare Need
By: Colorado BioScience Association Date: 12/21/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: December Revenue Forecast Shows More Money Than Expected to Support Recovery
By: Colorado BioScience Association Date: 12/18/2020
Today the Governor’s Office of State Planning & Budgeting and the state’s Legislative Council presented their December economic and revenue forecasts to the General Assembly’s Joint Budget Committ...
Learn MoreColorado BioScience Association Annual Awards Celebration: Video Highlights
By: Colorado BioScience Association Date: 12/15/2020
Colorado’s life sciences community gathered on December 9 to toast the companies and organizations driving health innovation forward. CBSA President & CEO Jennifer Jones Paton and CBSA Board Chair...
Learn MoreColorado’s Life Sciences Ecosystem Raises $1.2 Billion in 2020
By: Colorado BioScience Association Date: 12/14/2020
Leadership During COVID-19 Accelerated Interest and Investment in Colorado DENVER – Colorado BioScience Association today announced the fourth year Colorado’s life sciences community has raised more t...
Learn MoreWeekly Policy Update: COVID-19 Vaccine Distribution in Colorado
By: Colorado BioScience Association Date: 12/11/2020
The last week has been groundbreaking for science and health innovation. On Friday, December 11, the U.S. FDA granted Emergency Use Authorization (EUA) for a COVID-19 vaccine developed by Pfizer and B...
Learn MoreCBSA Applauds Senator Bennet for Legislation to Ensure Patient Access to Leading-Edge Diagnostics
By: Colorado BioScience Association Date: 12/11/2020
Yesterday Senator Michael Bennet introduced new legislation in the U.S. Senate that aims to ensure timely Medicare coverage for new, innovative tests that detect multiple types of cancer before sympto...
Learn MoreOEDIT Convenes State Legislators for Session on Advanced Industries
By: Colorado BioScience Association Date: 12/10/2020
On Wednesday, the Colorado Office of Economic Development and International Trade (OEDIT) partnered with CBSA and the six other advanced industries to host an informational session for state legislato...
Learn MoreColorado BioScience Association Honors Life Sciences Leaders Driving Innovation Forward at Annual Awards Celebration
By: Colorado BioScience Association Date: 12/10/2020
Inscripta Wins Company of the Year, Edgewise Therapeutics Named as Rising Star Denver, December 10, 2020 – Colorado BioScience Association celebrated the companies and organizations driving new health...
Learn MoreWeekly Policy Update: Colorado Special Session Recap
By: Colorado BioScience Association Date: 12/04/2020
The Colorado General Assembly met for a three-day Special Session this week to pass an economic stimulus package that provides support and relief to certain small businesses, education providers, and...
Learn MoreCBSA Convenes Experts + Advocates to Discuss the Promise of Genomic Medicine
By: Colorado BioScience Association Date: 12/04/2020
This week CBSA partnered with the Colorado Cancer Caucus and the Biotechnology innovation Organization (BIO) to host a discussion on the promise of genomic medicine for oncology and rare, genetic dise...
Learn MoreCongratulations, Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 11/23/2020
Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...
Learn MoreWeekly Policy Update: Colorado Special Legislative Session + Interim Final Rule on Most Favored Nation Payment Model
By: Colorado BioScience Association Date: 11/20/2020
Yesterday Governor Polis called a Special Session of the General Assembly to discuss an economic stimulus package that he said cannot wait until January. The session is scheduled to begin on November...
Learn MoreGlobal Impact: Z Biotech Advances Glycoscience Research
By: Colorado BioScience Association Date: 11/20/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreGovernor Presents Budget Proposal to State Legislature's Joint Budget Committee
By: Colorado BioScience Association Date: 11/13/2020
Earlier this month, Governor Polis released his $35 billion budget proposal for fiscal year 2021-22. The request included three key elements to boost Colorado’s economy and support critical investment...
Learn MoreWeekly Policy Update: Colorado Dept. of Labor Releases Final Rules on Equal Pay Transparency
By: Colorado BioScience Association Date: 11/13/2020
In September, the Colorado Department of Labor and Employment (CDLE) published proposed rules on Equal Pay Transparency providing guidance for implementation of the state’s new Equal Pay for Equal Wor...
Learn MoreColorado Life Sciences Leaders Meet with Governor Jared Polis
By: Colorado BioScience Association Date: 11/09/2020
Colorado BioScience Association (CBSA) brought leaders from Colorado’s life sciences community together to meet with Governor Polis, Lt. Governor Primavera, and their staff. The group had the opportu...
Learn MoreWeekly Policy Update: Key Takeaways from the Colorado Election
By: Colorado BioScience Association Date: 11/06/2020
Colorado voters were highly motivated in this year’s election. In fact, the state experienced record turnout, with over 80% of eligible voters participating in the election. As predicted, Colorado con...
Learn MoreWeekly Policy Update: Polis Releases FY 2021-22 Budget Request, Prioritizes Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 11/02/2020
Today Governor Polis submitted his budget request for the 2021 – 2022 fiscal year. The proposal calls for $35.4 billion in total funds and includes three key elements that the administration believes...
Learn MoreCBSA and BIO Host Webinar: Developing + Distributing a COVID-19 Vaccine
By: Colorado BioScience Association Date: 10/26/2020
CBSA partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the ecosystem’s work to develop and deliver a safe and effective COVID-19 vaccine. The discussion featured a...
Learn MoreAΩA Honor Medical Society Funds Research + Education Fellowships for Future Medical Leaders
By: Colorado BioScience Association Date: 10/25/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: CBSA Virtual Roundtable with Congresswoman Diana DeGette
By: Colorado BioScience Association Date: 10/23/2020
This week CBSA held a virtual roundtable with Congresswoman Diana DeGette, who represents Colorado’s first Congressional district. It was a great opportunity to showcase the critical health innovation...
Learn MoreWeekly Policy Update: Polis Administration Holds Stakeholder Meeting on Canadian Drug Importation Program
By: Colorado BioScience Association Date: 10/16/2020
On Thursday, the Department of Health Care Policy and Financing held a virtual stakeholder meeting to provide an update on the progress of Colorado’s Canadian drug importation program. The program was...
Learn MoreCBSA Takes Positions on Statewide Ballot Measures Impacting Life Sciences Ecosystem
By: Colorado BioScience Association Date: 10/12/2020
Colorado BioScience Association (CBSA) leads Policy + Advocacy for Colorado’s life sciences community. We work for a pro-innovation policy environment to accelerate the growth of our life sciences eco...
Learn MoreWeekly Policy Update: Colorado Life Sciences Leaders Update Senator Bennet on Critical COVID-19 Innovations
By: Colorado BioScience Association Date: 10/09/2020
This afternoon CBSA hosted a virtual roundtable with Senator Michael Bennet to provide updates on the innovative work underway in Colorado to defeat COVID-19. In his opening comments, the Senator talk...
Learn MoreAmgen Foundation Support brings LabXchange Training to Colorado Teachers
By: Colorado BioScience Association Date: 10/06/2020
Through the generous support of the Amgen Foundation, the Colorado BioScience Institute (Institute), in collaboration with the Harvard LabXchange creators, will begin training Colorado teachers on Lab...
Learn MoreWeekly Policy Update: Colorado Dept. of Labor & Employment Issues Proposed Rules on Equal Pay Transparency
By: Colorado BioScience Association Date: 10/04/2020
On September 29, the Colorado Department of Labor and Employment (CDLE) published proposed Equal Pay Transparency Rules (“EPT Rules”) providing guidance for implementation of the state’s new Equal Pay...
Learn MoreColorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum
By: Colorado BioScience Association Date: 10/01/2020
For Immediate Release: October 1, 2020 Colorado BioScience Association Welcomes Community to Colorado Life Sciences Innovation Forum Two-Day Event Includes Unveiling of 2020-2021 BioScien...
Learn MoreIMD Path Thinks Outside of the Box, Brings Strong Culture
By: Colorado BioScience Association Date: 09/25/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: FDA Moves Forward with Final Rule on Drug Importation
By: Colorado BioScience Association Date: 09/25/2020
Yesterday the FDA issued their final rule and guidance on the importation of prescription drugs. They were first proposed last December, and CBSA worked with other state bioscience associations to sub...
Learn MoreWeekly Policy Update: State Releases Updated Economic and Revenue Forecast
By: Colorado BioScience Association Date: 09/18/2020
This morning, the Joint Budget Committee (JBC) heard presentations on the September economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB)....
Learn MoreWeekly Policy Update: President Moves Forward with Most-Favored-Nation Drug Pricing Policy
By: Colorado BioScience Association Date: 09/14/2020
On Sunday, President Trump issued an Executive Order on a drug pricing policy called “most-favored-nation.” The order directs the Secretary of Health and Human Services (HHS) to develop and implement...
Learn MoreColorado Partners with Google and Apple to Launch Contact Tracing App
By: Colorado BioScience Association Date: 09/11/2020
At a press conference on Tuesday, Governor Jared Polis announced that Colorado will partner with Google and Apple on a contact tracing app for COVID-19. By the end of September, any resident with a sm...
Learn MoreWeekly Policy Update: CMS Issues Proposed Rule to Improve Coverage for Breakthrough Technologies
By: Colorado BioScience Association Date: 09/04/2020
This week the Centers for Medicare & Medicaid Services (CMS) released the long-awaited proposed rule on "Medicare Coverage of Innovative Technologies." The proposed rule would make significant cha...
Learn MoreWeekly Policy Update: CBSA Member PharmaJet Hosts Visit with Senator Cory Gardner
By: Colorado BioScience Association Date: 08/28/2020
CBSA member PharmaJet hosted a visit with U.S. Senator Cory Gardner this week to showcase their needle-free technology for vaccine and therapeutic delivery. It was a great opportunity for the company...
Learn MoreCBSA - All Member Meeting 2020
By: Colorado BioScience Association Date: 08/24/2020
CBSA brought our life sciences community together for our annual All-Member Meeting on August 19, led by CBSA Board Chair Bob Reddy of Medtronic and CBSA President and CEO Jennifer Jones Paton. Bob an...
Learn MoreWeekly Policy Update: CBSA Engages Congressional Delegation to Protect Life Sciences Innovation
By: Colorado BioScience Association Date: 08/21/2020
CBSA continues to engage the Colorado Congressional delegation around an executive order that the President announced on July 24 that would limit payment for Medicare Part B drugs to the lowest price...
Learn MoreWeekly Policy Update: President Trump Issues ‘Buy American’ Executive Order
By: Colorado BioScience Association Date: 08/16/2020
President Trump recently issued an executive order intended to increase federal support for the domestic manufacture of “essential medicines,” “medical countermeasures,” and “critical inputs” through...
Learn MoreWeekly Policy Update: CBSA Advocates for Additional Relief for Life Sciences Startups + Growth Companies
By: Colorado BioScience Association Date: 08/07/2020
CBSA supports H.R. 7917, the IGNITE American Innovation Act, bipartisan legislation recently introduced to ensure innovative and entrepreneurial companies can access the necessary liquidity to continu...
Learn MoreWeekly Policy Update: CBSA Meets with Congressional Offices on the VALID Act
By: Colorado BioScience Association Date: 07/31/2020
CBSA and our members met with Senator Michael Bennet and Rep. Diana DeGette’s offices this week to discuss the Verifying Accurate Leading-edge IVCT Development (VALID) Act, recent federal legislation...
Learn MoreClinImmune Labs Change Patient Outcomes in Unique Ecosystem
By: Colorado BioScience Association Date: 07/27/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: Energize Colorado Gap Fund Launches August 2020
By: Colorado BioScience Association Date: 07/24/2020
The Energize Colorado Gap Fund was created by Senate Bill 222 and will provide more than $25 million in small business loans and grants to boost small businesses impacted by COVID-19. Sole propr...
Learn MoreIndustry Experts Update State Policymakers on COVID-19 Efforts
By: Colorado BioScience Association Date: 07/17/2020
Colorado BioScience Association is proud of how our life sciences ecosystem has responded to the outbreak of COVID-19. We have seen our members come together to address the crisis and commit resources...
Learn MoreWeekly Policy Update: Federal Lawmakers Introduce Diagnostic Testing Bills
By: Colorado BioScience Association Date: 07/17/2020
Recently, Colorado Representative Diana DeGette and Indiana Representative Larry Bucshon introduced two bills to increase diagnostic testing capabilities at public health laboratories, in hospitals, a...
Learn MoreWeekly Policy Update: Read CBSA's 2020 Legislative Session Report
By: Colorado BioScience Association Date: 07/10/2020
On June 15, the Second Regular Session of the 72nd General Assembly adjourned sine die, marking the end of a truly historic legislative session. During the first two months of the session, we saw the...
Learn MoreColorado BioScience PAC Educates State Candidates on Life Sciences Priorities
By: Colorado BioScience Association Date: 07/06/2020
Last Tuesday was Colorado’s primary election, where voters decided on candidates for races including the U.S. Senate, U.S. House of Representatives, the state legislature, and other races like distric...
Learn MoreArtisanBio Cell Therapies Engineers Talent and Innovation
By: Colorado BioScience Association Date: 06/29/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreWeekly Policy Update: New Small Business Loan and Grant Programs Signed into Law
By: Colorado BioScience Association Date: 06/26/2020
On Tuesday, Governor Polis signed two state bills into law that will provide support for Colorado small businesses through low-interest loans and grants from the state. Both bills passed with bipartis...
Learn MoreWeekly Policy Update: State Releases June Economic & Revenue Forecast
By: Colorado BioScience Association Date: 06/19/2020
Today, the Joint Budget Committee (JBC) heard presentations on the June economic and revenue forecast from Legislative Council Staff and the Office of State Planning and Budgeting (OSPB). The takeaway...
Learn MoreCBSA Advocates to Sustain a Supportive Tax Environment for Ecosystem
By: Colorado BioScience Association Date: 06/15/2020
Just days before the end of the session, Colorado state legislators introduced House Bill 1420, a controversial measure that would eliminate critical tax breaks and relief for Colorado businesses of a...
Learn MoreWeekly Policy Update: Legislative Session Comes to a Close - Final Week Round Up
By: Colorado BioScience Association Date: 06/12/2020
The legislative session continued for a third week with a wave of controversial bills, including the introduction of House Bill 1420, which would eliminate critical tax breaks and relief for Colorado...
Learn MoreNew Data Demonstrates Life Sciences Ecosystem Growth, Impact in Colorado
By: Colorado BioScience Association Date: 06/11/2020
Numbers Signal Steady Jobs, Salary, and Funding Gains DENVER – Colorado BioScience Association shares newly released employment and federal funding data on life sciences in Colorado, demonstrating eco...
Learn MoreCBSA Board Welcomes AGC Biologics
By: Colorado BioScience Association Date: 06/08/2020
Colorado BioScience Association warmly welcomes AGC Biologics to our state. Last week, the global CDMO announced it will invest $100 million in a large-scale biopharmaceutical manufacturing facility i...
Learn MoreWeekly Policy Update: Congress Passes New Law Creating More Flexibility in the Paycheck Protection Program
By: Colorado BioScience Association Date: 06/05/2020
On Friday, President Trump signed into law the Paycheck Protection Program Flexibility Act. The new law addresses many concerns raised by the small business community about the Paycheck Protection Pro...
Learn MoreCBSA Hosts Virtual Roundtable with Congressman Ed Perlmutter
By: Colorado BioScience Association Date: 06/05/2020
This week, CBSA hosted a roundtable with Congressman Ed Perlmutter, who represents Colorado’s seventh Congressional district. It was a great opportunity for members of our community to ask questi...
Learn MoreAGC Biologics Chooses Colorado, Invests $100 Million in Boulder Facility
By: Colorado BioScience Association Date: 06/01/2020
On behalf of Colorado’s life sciences community, CBSA is pleased to welcome Global CDMO AGC Biologics to our state. The company invested $100 million in a 300,000-square-foot facility in Boulder and w...
Learn MoreCongratulations, Advanced Industries Accelerator Grant Recipients
By: Colorado BioScience Association Date: 06/01/2020
Colorado BioScience Association congratulates CBSA members awarded proof-of-concept and early-stage capital grants by Colorado’s Office of Economic Development and International Trade (OEDIT). A total...
Learn MoreAAVCOVID Vaccine Program from Mass. Eye and Ear and Mass General Enters Manufacturing Agreement with Gene Therapy Leader AveXis, a Novartis Company
By: Colorado BioScience Association Date: 06/01/2020
AveXis, a Novartis Company, agrees to contribute the use of its gene therapy manufacturing expertise to help produce and scale novel vaccine that uses adeno-associated virus (AAV) vector for clinical...
Learn MoreWeekly Policy Update: State Legislature Resumes - Week One Round Up
By: Colorado BioScience Association Date: 05/29/2020
On May 26, the Colorado state legislature resumed the 2020 session with a condensed list of bills. Here’s a quick recap of key bills that were heard this week. House Bill 1195, Consumer Digital Repair...
Learn MoreInnovative Industries Internship Program Update
By: Colorado BioScience Association Date: 05/26/2020
Since last fall, CBSA has been advocating for an extension of the Innovative Industries Internship Program, which is set to expire July 1 of this year. The program incentivizes employers to find, hire...
Learn MoreCBSA + BIO Host Webinar on COVID-19 Innovation Pipeline
By: Colorado BioScience Association Date: 05/26/2020
On May 21, Colorado BioScience Association (CBSA) partnered with the Biotechnology Innovation Organization (BIO) to host a webinar about the COVID-19 global development pipeline and how Colorado’s lif...
Learn MoreDARTNet Pairs Technology and Research to Advance Medical Knowledge
By: Colorado BioScience Association Date: 05/26/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreColorado BioScience Association Congratulates New Class of Boettcher Investigators
By: Colorado BioScience Association Date: 05/22/2020
$1.88 million in biomedical research grant funding for 2020 Class DENVER, May 22, 2020 — The Boettcher Foundation has selected eight researchers to receive funding through the Boettcher Foundation’s W...
Learn MoreIn the Weeds: Joint Budget Committee + Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/21/2020
Since early May, the Joint Budget Committee (JBC) has been working to balance the state budget and review recommendations from the committee staff and the Governor’s Office of State Planning and Budge...
Learn MoreGood News: Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/20/2020
We are excited to share good news about the Advanced Industries Accelerator Grant Program. Yesterday, the General Assembly’s Joint Budget Committee (JBC) decided to preserve the program and maintain a...
Learn MoreJoint Budget Committee Delays Action Again on Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/18/2020
Last week, the Colorado General Assembly’s Joint Budget Committee (JBC) continued their work to balance the state budget and considered many of the remaining budget cut recommendations for each state...
Learn MoreWeekly Policy Update: CBSA Provides Feedback on New Proposal for Antimicrobial Drug Development
By: Colorado BioScience Association Date: 05/15/2020
Senator Michael Bennet is planning to introduce legislation that would create new incentives for the development of innovative antimicrobial drugs, called the Pioneering Antimicrobial Subscriptions to...
Learn MoreCBSA Hosts Member Discussion with Congressman Jason Crow
By: Colorado BioScience Association Date: 05/07/2020
On Wednesday, CBSA hosted a discussion with Congressman Jason Crow, who represents Colorado’s sixth Congressional district. The Congressman gave an update on his efforts to provide relief for small bu...
Learn MoreAdditional Support Needed: Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/04/2020
On Tuesday, the General Assembly’s Joint Budget Committee (JBC) delayed a vote on the Advanced Industries Accelerator Grant Program. The newest recommendation from budget committee staff would elimina...
Learn MoreWeekly Policy Update: CBSA Fights to Protect the Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/01/2020
Earlier this week, staff analysts for the Joint Budget Committee (JBC) presented revised figure setting documents to guide the JBC as they work to balance the budget over the coming weeks. The documen...
Learn MoreYour Support Needed Now – Advanced Industries Accelerator Grant Program
By: Colorado BioScience Association Date: 05/01/2020
Colorado is facing massive budget shortfalls due to the COVID-19 pandemic. This puts the flagship funding program for life sciences in Colorado at risk. The Advanced Industries Accelerator Grant Progr...
Learn MoreMeet Avidity, The "Connection" Company
By: Colorado BioScience Association Date: 04/27/2020
Colorado BioScience Association interviews a Fitzsimons Innovation Community company every month. Read this month’s feature!
Learn MoreCBSA Hosts Virtual Town Hall with Senator Cory Gardner
By: Colorado BioScience Association Date: 04/27/2020
On Monday, CBSA hosted a virtual town hall with Senator Cory Gardner. More than 65 members and leaders of Colorado’s life sciences community came together to ask questions and offer feedback about the...
Learn MoreWeekly Policy Update: Governor Polis Issues Safer at Home Executive Order
By: Colorado BioScience Association Date: 04/24/2020
On Sunday, Governor Polis issued a new Executive Order to move Colorado to the Safer at Home phase. The Safer at Home Order phases in the reopening of certain businesses over the next week, while cont...
Learn MoreWhat the New Federal Relief Package Means for Life Sciences
By: Colorado BioScience Association Date: 04/23/2020
On April 23, the U.S. House of Representatives passed the Paycheck Protection Program and Health Care Enhancement Act, and the following day President Trump signed the bill into law. The $484 billion...
Learn MoreColorado BioScience Association Appoints Executives from Medtronic, Amgen to Lead Board of Directors
By: Colorado BioScience Association Date: 04/20/2020
Bob Reddy of Medtronic Enabling Technologies, Dr. Kiki Traylor of Amgen Named Board Chair and Vice Chair Denver – Colorado BioScience Association (CBSA) today welcomed new officers and members to...
Learn MoreWeekly Policy Update: As Congress Considers Next Phase of Relief, CBSA Invites Members to Weigh In
By: Colorado BioScience Association Date: 04/17/2020
Just days after President Trump signed the CARES Act into law, Members of Congress were already talking about the need for a fourth relief package to help ease the economic pain created by the pandemi...
Learn MoreWeekly Policy Update: Colorado General Assembly Sets Tentative Date to Resume Session
By: Colorado BioScience Association Date: 04/10/2020
The Colorado General Assembly’s top-ranking lawmakers from each party met on Wednesday to discuss a number of big issues they’re facing. First, legislative leadership determined that the General Assem...
Learn MoreSenator Bennet, FDA Updated on Colorado COVID-19 Innovations
By: Colorado BioScience Association Date: 04/06/2020
CBSA continues to work with federal, state and local officials to advocate for our life sciences ecosystem and facilitate connections for companies and organizations working on COVID-19. On Monday, we...
Learn MoreBeginning Today – New Loans Available for Small Businesses Under CARES Act
By: Colorado BioScience Association Date: 04/03/2020
There’s immediate relief for small businesses affected by COVID-19 under the CARES Act. New loans are available through the Paycheck Protection Program beginning today, Friday, April 3, for small comp...
Learn MoreCARES Act Stimulus Package: What it Means for Life Sciences in Colorado
By: Colorado BioScience Association Date: 03/27/2020
This afternoon, President Trump signed into law S. 3548, the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The $2 trillion relief package is the largest economic stimulus measure in mode...
Learn MoreLife Sciences + Statewide Stay-at-Home Order
By: Colorado BioScience Association Date: 03/26/2020
Colorado is now under a Stay-at-Home-Order issued by Governor Jared Polis. The order requires everyone in Colorado to stay in their place of residence, except for certain necessary activities, essenti...
Learn MoreLife Sciences and Stay-at-Home Orders
By: Colorado BioScience Association Date: 03/24/2020
The City and County of Denver and the City of Boulder issued stay-at-home orders on Monday following the Governor’s directive on in-person workforce reduction during the COVID-19 pandemic. CBSA antici...
Learn MoreUrgent – Open Positions with the State and Children’s Hospital
By: Colorado BioScience Association Date: 03/24/2020
Colorado BioScience Association is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s team is aski...
Learn MoreCOVID-19: Life Sciences and the Governor’s In-Person Workforce Reduction Order
By: Colorado BioScience Association Date: 03/23/2020
On Sunday, Governor Polis issued an Executive Order that requires all non-critical businesses in the state to reduce their in-person workforce by 50% due to the COVID-19 pandemic. It requires all non-...
Learn MoreWeekly Policy Update: CBSA Supports Life Sciences Ecosystem in the Fight Against COVID-19
By: Colorado BioScience Association Date: 03/20/2020
During these challenging times, CBSA is focused on supporting our ecosystem and its response to the COVID-19 pandemic. We continue to engage with our local, state, and federal elected officials to ens...
Learn MoreWeekly Policy Update: Colorado State Legislature Suspends Session for Two Weeks
By: Colorado BioScience Association Date: 03/13/2020
To do their part in slowing the spread of COVID-19, the Colorado General Assembly met on Saturday, March 14th and passed a Joint Resolution to temporarily adjourn until March 30. The legislature also...
Learn MoreCBSA on COVID-19
By: Colorado BioScience Association Date: 03/13/2020
Businesses and organizations here in Colorado and around the world are all managing through the impact of COVID-19 on their business operations and personal lives. Our ecosystem’s work to drive health...
Learn MoreCOVID-19: CBSA Business Resource Guide
By: Colorado BioScience Association Date: 03/09/2020
Last updated: April 6, 2020 Urgent: CBSA is working with policymakers and business leaders to support our ecosystem during the COVID-19 pandemic and offer our community’s expertise. The Governor’s tea...
Learn MoreWeekly Policy Update: State Legislators Introduce Bill to Extend Innovative Industries Internship Program
By: Colorado BioScience Association Date: 03/06/2020
State legislators introduced a bill this week to extend the Innovative Industries Internship Program for another five years. The program was created in 2015 to meet the critical needs of Colorado’s lo...
Learn MoreColorado BioScience Association Offers FDA Leader’s Perspective During Keynote at Medical Device Symposium
By: Colorado BioScience Association Date: 03/04/2020
Dr. Jeffrey Shuren to Join Conference Live via Video from Washington, D.C. DENVER – Colorado BioScience Association (CBSA) welcomes FDA’s Dr. Jeffrey Shuren via video conference to today’s annual Medi...
Learn MoreWeekly Policy Update: CBSA Meets with Federal Policymakers to Discuss Coverage + Payment for Breakthrough Technologies
By: Colorado BioScience Association Date: 02/28/2020
CBSA was in DC this week representing Colorado’s life sciences ecosystem as part of the AdvaMed Fly-in. It was a great opportunity to meet with the Colorado delegation offices and advocate for federal...
Learn MoreWeekly Policy Update: Health Care Stakeholders Convene to Discuss Total Cost of Care Legislation
By: Colorado BioScience Association Date: 02/21/2020
At a stakeholder meeting on Tuesday the Colorado Hospital Association walked through their draft proposal for a total cost of care model in Colorado. Based on programs already operating in Oregon and...
Learn MoreWeekly Policy Update: Drug Price Transparency and Drug Importation Bills Pass Health Committees
By: Colorado BioScience Association Date: 02/14/2020
CBSA was at the Colorado State Capitol again this week to voice our concerns about legislation focused on drug price transparency and prescription drug importation. House Bill 1160, Drug Price Transpa...
Learn MoreWeekly Policy Update: CBSA Represents Colorado’s Life Sciences Ecosystem in Senate Committee Hearings
By: Colorado BioScience Association Date: 02/07/2020
This week, CBSA weighed in on Senate Bill 10, Repeal Ban on Local Government Regulation of Plastics, to ensure life-saving medicines and medical devices are not impacted by local regulations on single...
Learn MoreDenver Business Journal Covers New Partnership to Fund Early-Stage Life Sciences Companies
By: Colorado BioScience Association Date: 02/07/2020
Colorado BioScience Association and Rockies Venture Club recently announced a new effort to fund early-stage life sciences companies in Colorado, funded by an Advanced Industries Accelerator Grant fro...
Learn MoreColorado BioScience Association Highlights Life Sciences Impact at the State Capitol OEDIT Executive Director Betsy Markey Keynotes CBSA’s Annual Day at the Capitol
By: Colorado BioScience Association Date: 02/04/2020
DENVER – Colorado BioScience Association (CBSA) brings leaders from Colorado life sciences companies and organizations to the State Capitol today, February 4, 2020, to share innovation stories with le...
Learn MoreWeekly Policy Update: CBSA Opposes Expanded Prescription Drug Importation Program
By: Colorado BioScience Association Date: 01/31/2020
Last week Senator Joann Ginal introduced Senate Bill 119, Expand Canadian Prescription Drug Import Program. The bill builds on legislation that was enacted last session, that directed the Dept. of Hea...
Learn MoreWeekly Policy Update: Drug Price Transparency Bills Introduced in the House and Senate
By: Colorado BioScience Association Date: 01/24/2020
Over the past week, state legislators have introduced two drug price transparency bills that could impact our life sciences community. The first bill (SB20-107) was introduced in the Senate by Sen. Jo...
Learn MoreNew Investments Boost Colorado's Life Sciences Community
By: Colorado BioScience Association Date: 01/23/2020
FOR IMMEDIATE RELEASE Rockies Venture Club and Colorado BioScience Association partner to fund Colorado Life Sciences startups in a new program backed by OEDIT Denver, CO - The Rockies Venture Club an...
Learn MoreWeekly Policy Update: New Legislation Impacting Colorado’s Life Sciences Ecosystem
By: Colorado BioScience Association Date: 01/17/2020
The CBSA team is hard at work advocating on behalf of Colorado’s life sciences ecosystem. After the first full week of the legislative session, here’s an update on where we’re engaging and why. CBSA L...
Learn MoreCBSA CEO Honored by the Denver Business Journal
By: Colorado BioScience Association Date: 01/16/2020
Congratulations to CBSA President and CEO Jennifer Jones Paton! The Denver Business Journal named Jennifer to its prestigious 40 Under 40 list, released this week. The DBJ names a class of 40 Under 40...
Learn MoreWeekly Policy Update: Colorado Policymakers Outline Top Priorities for 2020 Session
By: Colorado BioScience Association Date: 01/10/2020
Colorado lawmakers returned to the Capitol on Wednesday for the start of the 2020 legislative session, where both parties laid out their top priorities. After calling for civility and bipartisanship,...
Learn MoreWeekly Policy Update: CBSA’s Priorities for the 2020 Legislative Session
By: Colorado BioScience Association Date: 01/02/2020
January 8th marks the first day of Colorado’s 2020 legislative session, but CBSA has already been hard at work advocating on behalf of our members and the patients they serve. This session, we will co...
Learn MoreCongress Votes to Repeal Medical Device Excise Tax
By: Colorado BioScience Association Date: 12/19/2019
This week Congress voted to pass a full and permanent repeal of the medical device excise tax as part of legislation to fund the federal government through the rest of the current fiscal year. This is...
Learn MoreColorado Life Sciences Companies Raise $750 Million in 2019 Pfizer Acquisition of Array BioPharma Brings Ecosystem Total to $12.1 Billion
By: Colorado BioScience Association Date: 12/17/2019
DENVER – Colorado’s life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of Boul...
Learn MoreWeekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation
By: Colorado BioScience Association Date: 12/16/2019
Weekly Policy Update: CBSA Comments on 2020 Drug Price Transparency Draft Legislation On Monday, CBSA sent a comment letter to Rep. Dominique Jackson and Rep. Dylan Roberts outlining our comment...
Learn MorePolicy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program
By: Colorado BioScience Association Date: 12/02/2019
Policy Update: CBSA Submits Recommendations to Improve the SBIR/STTR Program Earlier this year, CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility, and Sharklet...
Learn MoreColorado BioScience Association Recognizes Denver Partners for Bold Brand and New Website
By: Colorado BioScience Association Date: 11/25/2019
Brand update delivers results for CBSA and Colorado’s life sciences ecosystem Denver – Colorado BioScience Association (CBSA) recognizes two Denver-area firms, Primavera Group and Watermark, for gener...
Learn MorePolicy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award
By: Colorado BioScience Association Date: 11/22/2019
Policy Update: CBSA Presents Sen. Cory Gardner with ALSIC 2019 Champion of Health Care Innovation Award CBSA was proud to present Senator Cory Gardner with the American Life Sciences Innovation Counci...
Learn MorePolicy Update: CBSA and Health Scholars Host State Rep. Shannon Bird
By: Colorado BioScience Association Date: 11/18/2019
CBSA Annual Awards Dinner Celebrates the Life of Adam Rubenstein
By: Colorado BioScience Association Date: 11/12/2019
CBSA celebrated the life of Adam Rubenstein at the 16th Annual Awards Dinner.
Learn MorePolicy Update: Colorado Votes
By: Colorado BioScience Association Date: 11/11/2019
Policy Update: Colorado Votes Colorado voters decided on two major ballot measures on Election Day 2019. Proposition DD asked voters to legalize sports betting in Colorado and create a 10 percent tax...
Learn MoreColorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner
By: Colorado BioScience Association Date: 11/08/2019
Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner Biodesix Named Company of the Year, Securisyn Medical Honored as Rising Star Denver,...
Learn MorePolicy Update: Governor Jared Polis Releases Budget Proposal for FY 2020-21
By: Colorado BioScience Association Date: 11/01/2019
Governor Jared Polis Releases Budget Proposal for FY 2020-21 Governor Jared Polis released his 2020-21 budget proposal on Friday, underscoring priorities that include expanding the state’s preschool p...
Learn MoreColorado BioScience Association Reveals New Website, Bold Brand
By: Colorado BioScience Association Date: 11/01/2019
For Immediate Release: October 31, 2019 Colorado BioScience Association Reveals New Website, Bold Brand Highlights Co-Opportunity, Colorado’s Collaborative, Pro-Innovation Environmen...
Learn MoreCBSA Co-opportunity Means…
By: Colorado BioScience Association Date: 10/30/2019
Health innovations from Colorado make a global impact.
Learn MoreWeekly Policy Update: CBSA Co-Hosts Aurora Facility Tour for State Senator Rhonda Fields
By: Colorado BioScience Association Date: 10/25/2019
This week CBSA partnered with CSL Behring to host state Senator Rhonda Fields for a tour of the CSL Plasma Collection Center in Aurora. On the tour, the collection center managers were able to show Se...
Learn MoreColorado BioScience Association Welcomes New Appointees to the Board of Directors
By: Colorado BioScience Association Date: 10/25/2019
Colorado BioScience Association Welcomes New Appointees to the Board of Directors For Immediate Release: October 25, 2019 Colorado BioScience Association Welcomes New Appointees to the Board of Direct...
Learn MoreWeekly Policy Update: CBSA Partners with LivaNova to host Rep. Brianna Titone
By: Colorado BioScience Association Date: 10/18/2019
This week CBSA partnered with LivaNova to host state Rep. Brianna Titone for a tour and employee town hall at the company’s Arvada facility. It was a great opportunity to showcase the devices that are...
Learn MoreWeekly Policy Update: State Releases Draft Proposal for Public Health Insurance Option
By: Colorado BioScience Association Date: 10/11/2019
On Monday, the Colorado Division of Insurance and the Department of Health Care Policy and Financing released a draft report on the development of the state’s plan for a public health insurance...
Learn MoreWeekly Policy Update: CBSA Urges Congress to Reject Proposals that Adopt Foreign Price Controls
By: Colorado BioScience Association Date: 10/04/2019
CBSA is committed to ensuring patients have access to the treatments they need. We appreciate the bipartisan efforts underway by the Trump Administration and Congress to provide patients relief from h...
Learn MoreWeekly Policy Update: House Speaker Nancy Pelosi Releases Proposal on Prescription Drug Pricing
By: Colorado BioScience Association Date: 09/23/2019
On September 19, House Speaker Nancy Pelosi released a long-anticipated proposal intended to reduce prescription drug prices. H.R. 3, the Lower Drug Costs Now Act of 2019, includes the following provi...
Learn MoreWeekly Policy Update: Zimmer Biomet Spine Hosts Congressman Ed Perlmutter at Westminster Facility
By: Colorado BioScience Association Date: 09/13/2019
At the end of August, Congressman Ed Perlmutter (CO-07) visited Zimmer Biomet Spine in Westminster to tour the medical education training facilities, biomechanics labs, and manufacturing area. Followi...
Learn More2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail
By: Colorado BioScience Association Date: 09/04/2019
Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...
Learn MoreWeekly Policy Update: CBSA Hosts Congressman Jason Crow (CO-06)
By: Colorado BioScience Association Date: 08/30/2019
This month CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility and Sharklet Technologies to host Congressman Jason Crow (CO-06) for a campus tour and roundtable...
Learn MoreWeekly Policy Update: CBSA Meets with Executive Director of OEDIT
By: Colorado BioScience Association Date: 08/26/2019
This week CBSA President & CEO Jennifer Jones Paton and Vice President Emily Roberts met with Betsy Markey, Executive Director of the Office of Economic Development and International Trade...
Learn MoreWeekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax
By: Colorado BioScience Association Date: 08/19/2019
Last week we asked the Colorado bioscience community to take action and urge our Members of Congress to support permanent repeal of the medical device excise tax. The tax is a threat to medical innova...
Learn MoreWeekly Policy Update: End the Device Tax
By: Colorado BioScience Association Date: 08/09/2019
The Colorado BioScience Association strongly opposes the medical device tax, a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act. Since its...
Learn MoreWeekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs
By: Colorado BioScience Association Date: 08/02/2019
This week the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) released a plan that describes the steps they will take to allow importation of certain drugs fro...
Learn MoreWeekly Policy Update: Senate Finance Committee Advances Drug Pricing Package
By: Colorado BioScience Association Date: 07/26/2019
On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...
Learn More2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail
By: Colorado BioScience Association Date: 07/24/2019
Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...
Learn MoreWeekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access
By: Colorado BioScience Association Date: 07/22/2019
This week CBSA vice president Emily Roberts joined other state advocates in Washington, DC for the We Work For Health Summit. During the two-day event, advocates met with their respective delegation t...
Learn MoreViewray to Expand to Denver, Adding 274 Jobs
By: Colorado BioScience Association Date: 07/16/2019
Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...
Learn MoreWeekly Policy Update: Trump Administration Pulls Rebate Rule
By: Colorado BioScience Association Date: 07/15/2019
Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...
Learn MoreWeekly Policy Update: Drug Pricing Bills Pass Key Senate Committees
By: Colorado BioScience Association Date: 07/08/2019
Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....
Learn MoreWeekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap
By: Colorado BioScience Association Date: 06/20/2019
The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...
Learn MoreNew State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics
By: Colorado BioScience Association Date: 06/18/2019
New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...
Learn MorePfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion
By: Colorado BioScience Association Date: 06/17/2019
Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...
Learn MoreWeekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax
By: Colorado BioScience Association Date: 06/14/2019
Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...
Learn MoreCutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals
By: Colorado BioScience Association Date: 06/13/2019
WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...
Learn MoreWeekly Policy Update: CBSA Attends the 2019 BIO International Convention
By: Colorado BioScience Association Date: 06/10/2019
Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...
Learn MoreColorado BioScience Association Celebrates State’s Collaborative Nature
By: Colorado BioScience Association Date: 06/03/2019
New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals DENVER – Colorado BioScience Association (CBSA) today launched the new issue of its annual magazine, BioSc...
Learn MoreImproving the Reimbursement Landscape for Medical Technology Innovators
By: Colorado BioScience Association Date: 05/24/2019
CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s...
Learn More27 Companies Share 6.1 Million Dollars in 2019 Advanced Industries Accelerator Grants
By: Colorado BioScience Association Date: 05/22/2019
Colorado BioScience Association congratulates the 27 companies recently recognized as valuable investments for the entire state by the Office of Economic Development and International Trade’s (OEDIT)...
Learn MoreCMS Rolls Back Harmful Proposals in Medicare Part D
By: Colorado BioScience Association Date: 05/20/2019
Last Thursday CMS finalized a rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, which included a number of significant changes to the proposed r...
Learn MoreWeekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies
By: Colorado BioScience Association Date: 05/13/2019
In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...
Learn MoreWeekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close
By: Colorado BioScience Association Date: 05/03/2019
CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...
Learn MoreWeekly Policy Update: One Week Left - What Will Make It Across the Finish Line
By: Colorado BioScience Association Date: 04/26/2019
With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...
Learn MoreCBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs
By: Colorado BioScience Association Date: 04/22/2019
Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...
Learn MoreWeekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax
By: Colorado BioScience Association Date: 04/12/2019
This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical I...
Learn MoreWeekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC
By: Colorado BioScience Association Date: 04/05/2019
This week CBSA testified in the House Health and Insurance Committee in opposition to House Bill 1296 – Prescription Drug Cost Reduction Measures. The bill requires health insurers, prescription drug...
Learn MoreCBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology
By: Colorado BioScience Association Date: 04/04/2019
Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization...
Learn MoreWeekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy
By: Colorado BioScience Association Date: 04/01/2019
This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Thro...
Learn MoreWeekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation
By: Colorado BioScience Association Date: 03/22/2019
Last week the non-partisan Legislative Council published the forecast for the economy and state government revenue through FY 2019-20. The forecast showed that while the economy will continue to grow...
Learn MoreWeekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget
By: Colorado BioScience Association Date: 03/15/2019
On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run fami...
Learn MoreWeekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol
By: Colorado BioScience Association Date: 03/08/2019
This week CBSA held our annual Day at the Capitol event, bringing healthcare innovators to the state Capitol to highlight the discoveries and advancements taking place in Colorado to improve the healt...
Learn MoreColorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium
By: Colorado BioScience Association Date: 03/04/2019
Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy DENVER – Colorado BioScience Association (CBSA) focuses on the opportunities offered by blockchain...
Learn MoreWeekly Policy Update: AdvaMed Fly-In and the Monthly Report
By: Colorado BioScience Association Date: 03/01/2019
This month CBSA Vice President Emily Roberts met with Members of the Colorado Congressional delegation as part of the AdvaMed State Medical Technology Alliance (SMTA) Fly-In. This event brings togethe...
Learn MoreWeekly Policy Update: CBSA and LivaNova Partner to Host Senator Cory Gardner
By: Colorado BioScience Association Date: 02/22/2019
This week CBSA partnered with LivaNova to host Senator Cory Gardner at LivaNova’s Arvada facility. The event included a brief meeting with the Senator and his staff, followed by a tour of the facility...
Learn MoreColorado BioScience Association connects lawmakers to patient-focused innovators at Capitol event
By: Colorado BioScience Association Date: 02/19/2019
New results highlight success of state-funded grant program for early-stage life science companies DENVER – Colorado BioScience Association (CBSA) brings healthcare innovators to the state Capitol to...
Learn MoreWeekly Policy Update: CBSA Opposes House Bill 1131, Prescription Drug Cost Education
By: Colorado BioScience Association Date: 02/15/2019
This week, CBSA attended a stakeholder meeting on House Bill 1131, Prescription Drug Cost Education. As the bill is currently written; it requires a drug manufacturer, wholesaler, agent or an employee...
Learn MoreWeekly Policy Update: Trump Administration Takes Step to Encourage Direct Discounts to Patients
By: Colorado BioScience Association Date: 02/08/2019
On Tuesday President Trump gave his State of the Union address, in which he described the need to rein in health care costs as a major priority. The President also laid out an ambitious health care ag...
Learn MoreColorado BioScience Association Appoints Emily Roberts as New Vice President
By: Colorado BioScience Association Date: 02/04/2019
Roberts to Oversee Policy and Communications at Life Science Organization DENVER – Colorado BioScience Association (CBSA) announces the appointment of Emily Roberts to vice president. Roberts takes ov...
Learn MoreWeekly Policy Update: Prescription Drug Importation and CBSA’s Day at the Capitol
By: Colorado BioScience Association Date: 02/01/2019
Yesterday the Colorado BioScience Association testified in opposition to Senate Bill 005, which tasks the department of health care policy and financing to design a program to import prescription phar...
Learn MoreWeekly Policy Update: Colorado Bioscience Championed in Denver Business Journal
By: Colorado BioScience Association Date: 01/25/2019
Colorado BioScience Association is focused on increasing our companies’ access to capital and highlighting the innovative work coming out of our state. Our team recently collaborated with the Denver B...
Learn MoreWeekly Policy Update: Importing Drugs and the Governor's Budget
By: Colorado BioScience Association Date: 01/18/2019
Last week CBSA took an opposition position to Senate Bill 005 – Import Prescription Drugs from Canada. As a reminder this bill would create the "Colorado Wholesale Importation of Prescription Drugs Ac...
Learn MoreWeekly Policy Update: New General Assembly, Inauguration, and Bill Introductions
By: Colorado BioScience Association Date: 01/11/2019
This marks the first full week of the 72nd First Regular Session of the Colorado General Assembly. It was a busy week with bill introductions, Governor Polis’ Inauguration and the State of the State (...
Learn MoreWeekly Policy Update: CBSA’s Policy Priorities for 2019
By: Colorado BioScience Association Date: 01/04/2019
Today, January 4, 2019 marks the first of 120 days of the 72nd General Assembly. CBSA looks forward to advocating on behalf of our members, industry and the patients we serve. We also look forward to...
Learn MoreColorado Bioscience Companies Raised $1 Billion in 2018
By: Colorado BioScience Association Date: 12/27/2018
International Investors Contributed to the State’s Largest Financings DENVER – Colorado’s life science sector raised $1 billion in 2018, entering a second year of fundraising exceeding the $1 billion...
Learn MoreWeekly Policy Update: More Medical Device Tax News and the 2018 Farm Bill
By: Colorado BioScience Association Date: 12/14/2018
TheHouse Ways and Means Committee this week released a new extenders package which included a 5-year extension on the medical device excise tax moratorium. The 2.3% levy on the sale of prescribed medi...
Learn MoreWeekly Policy Update: Protecting Medicare Beneficiaries and Medical Device Tax Work
By: Colorado BioScience Association Date: 12/06/2018
A recent proposal by the Centers for Medicare & Medicaid Services (CMS) would implement an unprecedented Part B demo that could harm Medicare beneficiaries. We believe this would alter the entire...
Learn MoreWeekly Policy Update: November Recap
By: Colorado BioScience Association Date: 11/30/2018
The November Focus newsletter was published this afternoon with Jennifer’s recap of the full month in policy news. Topics covered include: November Elections At the federal level Republicans have reta...
Learn MoreWeekly Policy Update: Leadership Elections in the Colorado General Assembly
By: Colorado BioScience Association Date: 11/16/2018
With final certification of ballots by the Secretary of State the final tally for the Democrats in the House is 41, leaving Republicans with only 24 seats. Democrats in the Senate hold the majority by...
Learn MoreWeekly Policy Update: Election Report
By: Colorado BioScience Association Date: 11/08/2018
Federal In the Senate, Republicans have retained their majority. The Republicans control 51 seats, the Democrats 44. In the House, Democrats will take the majority by more than 25 seats. Democrats con...
Learn MoreColorado BioScience Association Ignites the Future at Fifteenth Annual Awards Dinner
By: Colorado BioScience Association Date: 11/08/2018
miRagen Named Company of the Year, Inscripta Honored as Rising Star DENVER – Colorado’s life science sector gathered on November 8 at the Hyatt Regency in Denver to honor the bioscience companies, lea...
Learn MoreColorado BioScience Association Appoints Jennifer Jones Paton as New President and Chief Executive Officer
By: Colorado BioScience Association Date: 11/08/2018
Jones Paton Promoted to Lead Life Science Organization After Broad Search DENVER – Colorado BioScience Association (CBSA) announces the promotion of Jennifer Jones Paton to president and chief executi...
Learn MoreWeekly Policy Update: An October Recap
By: Colorado BioScience Association Date: 11/02/2018
This week, the October Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. Some of the featured content includes: GET OUT...
Learn MoreWeekly Policy Update: Get Out and Vote!
By: Colorado BioScience Association Date: 10/26/2018
We know elections are important and that they shape the outcomes of our State, the economy and ultimately impact our industry, bioscience. The Election takes place on November 6, 2018. We encourage yo...
Learn MoreWeekly Policy Update: Bills Banning Pharmacy Gag Clauses
By: Colorado BioScience Association Date: 10/19/2018
Last week President Trump signed two bills (Patient Right to Know Drug Prices Act and Know the Lowest Price Act) into law that ban gag clauses that were called for in the American Patients First bluep...
Learn MoreColorado BioScience Association to Honor Leading Companies and Life Science Pioneers at Awards Dinner
By: Colorado BioScience Association Date: 10/17/2018
ArcherDX, MiRagen, Biodesix Named Finalists for Company of the Year Award; Double Helix, Impressio and Inscripta Nominated for Rising Star Award DENVER – Leaders of Colorado’s bioscience sector gather...
Learn MoreWeekly Policy Update: Bioscience in Recent National and International News
By: Colorado BioScience Association Date: 10/12/2018
A quick recap of bioscience in recent national and international news. President Trump recently signed a bill prohibiting pharmacy benefit managers from imposing “gag orders” on pharmacists that preve...
Learn MorePrima-Temp Has Acquired Kindara, a Fellow Boulder-Based Women’s Healthtech Company
By: Colorado BioScience Association Date: 10/08/2018
Prima-Temp, a women's healthtech company, has acquired Kindara, another Boulder-based women’s healthtech company. Kindara makes an app and Bluetooth-connected thermometer to help women track their fer...
Learn MoreWeekly Policy Update: Advancing Innovation in Digital Health
By: Colorado BioScience Association Date: 10/03/2018
Over the last year, in fact, FDA Commissioner Scott Gottlieb has put an emphasis on speeding up the process in getting technology and medications out to the public. This is evidenced by the new Pre- C...
Learn MoreWeekly Policy Update: The September Report
By: Colorado BioScience Association Date: 09/28/2018
Today, the September Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update.
Learn MoreWeekly Policy Update: Advocating for Medicare Part D
By: Colorado BioScience Association Date: 09/21/2018
The Colorado Bioscience Association along with We Work for Health Colorado, Epilepsy Foundation, Colorado Gerontological Society, Scleroderma Foundation, Rocky Mountain Stroke Center and the Colorado...
Learn MoreColorado BioScience Association Congratulates Cetya Therapeutics, Winner of Venture Showcase
By: Colorado BioScience Association Date: 09/14/2018
Pitch competition wrapped up CBSA’s Colorado Life Science Innovation Forum DENVER – Colorado BioScience Association named Cetya Therapeutics the winner of its venture showcase at the Colorado Life Sci...
Learn MoreWeekly Policy Update: Dianne Primavera and Lang Sias Address the Colorado Life Science Innovation Forum
By: Colorado BioScience Association Date: 09/14/2018
The Colorado Life Science Innovation Forum is filling the Westin Westminster with interesting speakers, enlightening panelists, and Colorado’s two Lieutenant Governor candidates throughout the day tod...
Learn MoreColorado BioScience Association Welcomes Major Party Gubernatorial Running Mates to Colorado Life Science Innovation Forum on Friday
By: Colorado BioScience Association Date: 09/12/2018
Dianne Primavera and Lang Sias to share their views on the economic outlook for the state’s bioscience industry DENVER – The Colorado Life Science Innovation Forum, the state’s largest gathering of bi...
Learn MoreWeekly Policy update: Lieutenant Governor Candidates At The Colorado Life Science Innovation Forum and The State of Medicare
By: Colorado BioScience Association Date: 09/07/2018
Colorado Life Science Innovation Forum – Keynote Featuring Remarks by Gubernatorial Running Mates Join CBSA on September 14th at the Colorado Life Science Innovation Forum.Our keynote lunch speakers i...
Learn MoreWeekly Policy Update: A Month In Policy and Bioscience In the News
By: Colorado BioScience Association Date: 08/30/2018
Today, the August Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. BIOSCIENCE IN THE NEWS Energy and Commerce Ne...
Learn MoreCBSA Forum Highlights Global Impact of Colorado’s Life Science Innovators
By: Colorado BioScience Association Date: 08/28/2018
Colorado Life Science Innovation Forum brings national thought leaders and Colorado executives together DENVER – Colorado BioScience Association (CBSA) hosts the state’s largest gathering of bioscienc...
Learn MoreWeekly Policy Update: The FDA’s Initiatives For Medical Devices and the Upcoming Gubernatorial Candidate Forum
By: Colorado BioScience Association Date: 08/24/2018
FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through t...
Learn MoreWeekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat
By: Colorado BioScience Association Date: 08/17/2018
FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...
Learn MoreWeekly Policy Update: FDA Funding and Other News
By: Colorado BioScience Association Date: 08/10/2018
FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...
Learn MoreWeekly Policy Update: Medical Device Tax and Colorado State Budget
By: Colorado BioScience Association Date: 08/03/2018
Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...
Learn MoreWeekly Policy Update: House Repeals Medical Device Tax
By: Colorado BioScience Association Date: 07/27/2018
On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...
Learn MoreWeekly Policy Update: Full Repeal of the Medical Device Tax Advocacy
By: Colorado BioScience Association Date: 07/20/2018
This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...
Learn MoreColorado BioScience Association Announces Departure of President & CEO, April Giles
By: Colorado BioScience Association Date: 07/16/2018
Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for mor...
Learn MoreWeekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews
By: Colorado BioScience Association Date: 07/13/2018
CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...
Learn MoreWeekly Policy Update: Meeting with Congresswoman Degette
By: Colorado BioScience Association Date: 07/06/2018
This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...
Learn MoreWeekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing
By: Colorado BioScience Association Date: 06/28/2018
2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...
Learn MoreWeekly Policy Update: FDA Releases Important Guidances
By: Colorado BioScience Association Date: 06/21/2018
The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical...
Learn MoreWeekly Policy Update: Drug Pricing News
By: Colorado BioScience Association Date: 06/15/2018
This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summa...
Learn MoreColorado BioScience Association Highlights Innovative Spirit, Collaborative Culture in Colorado
By: Colorado BioScience Association Date: 06/13/2018
Annual Bioscience Colorado Magazine Profiles Leaders, Incubators and Ecosystems Colorado BioScience Association (CBSA) launched the new issue of its annual magazine, Colorado Bioscience: Igniting the...
Learn MoreWeekly Policy Update: BIO International Convention and Voter Registration
By: Colorado BioScience Association Date: 06/08/2018
This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to...
Learn MoreWeekly Policy Update: BIO International Convention and Voter Registration
By: Colorado BioScience Association Date: 06/01/2018
POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO I...
Learn MoreWeekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News
By: Colorado BioScience Association Date: 05/25/2018
COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-...
Learn MoreWeekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan
By: Colorado BioScience Association Date: 05/18/2018
Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 20...
Learn MoreComing Together as a Community
By: Colorado BioScience Association Date: 05/11/2018
Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cance...
Learn MoreWeekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol
By: Colorado BioScience Association Date: 05/04/2018
CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...
Learn MoreMaking a Difference for Patients
By: Colorado BioScience Association Date: 04/30/2018
Meet the Colorado Leaders Developing Breakthrough Cures and Treatments Colorado’s researchers, innovators and entrepreneurs work to develop breakthroughs start locally and impact globally. Our sector’...
Learn MoreWeekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy
By: Colorado BioScience Association Date: 04/27/2018
Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...
Learn MorePrescription Drugs: Just the Facts
By: Colorado BioScience Association Date: 04/20/2018
As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription...
Learn MoreWeekly Policy Update: Action on Two Bills and Advocacy in DC
By: Colorado BioScience Association Date: 04/20/2018
UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...
Learn MoreColorado BioScience Association Names New Board Members
By: Colorado BioScience Association Date: 04/20/2018
Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...
Learn MoreDriving Down Drug Costs
By: Colorado BioScience Association Date: 04/16/2018
Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...
Learn MoreWeekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs
By: Colorado BioScience Association Date: 04/13/2018
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...
Learn MoreWeekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!
By: Colorado BioScience Association Date: 04/06/2018
Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...
Learn MoreUnderstanding Bills at the Legislature
By: Colorado BioScience Association Date: 04/02/2018
Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...
Learn MoreWeekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update
By: Colorado BioScience Association Date: 03/30/2018
CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...
Learn MoreHow do drug companies determine prices?
By: Colorado BioScience Association Date: 03/26/2018
The Value of Innovation When you stop in to the pharmacy to pick up a prescription, you may wonder how manufacturers determine the price you pay. You may think the drug maker maintains full control ov...
Learn MoreWeekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill
By: Colorado BioScience Association Date: 03/23/2018
This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...
Learn MoreWhat are Pharmacy Benefit Managers?
By: Colorado BioScience Association Date: 03/19/2018
PBMs Largely Determine How Much Your Medicines Cost With public policy debate at Colorado’s State Capitol focused on prescription drug price transparency, it’s critical for our decision makers and the...
Learn MoreWeekly Policy Update: Continuing the Transparency Advocacy and a Business Guide for the Governor
By: Colorado BioScience Association Date: 03/16/2018
CBSA Continues to Advocate in Opposition to House Bill 1260, Prescription Drug Price Transparency As reported last week, House Bill 1260, Prescription Drug Price Transparency passed on a party line vo...
Learn MoreUnderstanding the Costs of Your Rx
By: Colorado BioScience Association Date: 03/12/2018
Who Determines What You Pay for Prescription Medicines? When you visit your pharmacy counter to pick up a prescription, do you know who determines the final cost you pay? Many people think it’s one co...
Learn MoreWeekly Policy Update: Prescription Drug Price Transparency
By: Colorado BioScience Association Date: 03/09/2018
Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Enviro...
Learn MoreHow Do Innovative Medicines Save Lives?
By: Colorado BioScience Association Date: 03/05/2018
Transforming How We Treat and Cure Diseases We support true transparency, which means working together to provide patients access to affordable medicines. While a few bad actors make headlines, millio...
Learn MoreWeekly Policy Update: House Bill 1260 Prescription Drug Transparency, plus the Advamed Fly-In in Washington, D.C.
By: Colorado BioScience Association Date: 03/02/2018
Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, Ho...
Learn MoreWhat is True Transparency?
By: Colorado BioScience Association Date: 02/26/2018
Working Together to Provide Access to Affordable Medicines It’s time to start a community conversation about prescription medicines and the out-of-pocket costs for patients. Several bills under consid...
Learn MoreWeekly Policy Update: Positions on three bills, true transparency, and a visit to D.C.
By: Colorado BioScience Association Date: 02/23/2018
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below a...
Learn MoreWeekly Policy Update: True Transparency and Medicare Stakeholder Input
By: Colorado BioScience Association Date: 02/16/2018
CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we de...
Learn MoreColorado BioScience Association highlights state’s life-saving medical breakthroughs for lawmakers
By: Colorado BioScience Association Date: 02/09/2018
Annual event brings health care innovators to share successes with legislators at the Capitol DENVER – Colorado BioScience Association (CBSA) brings life science innovators to meet lawmakers and highl...
Learn MoreWeekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers
By: Colorado BioScience Association Date: 02/09/2018
This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the fu...
Learn MoreFriday Policy Updates 2/2/2018
By: Colorado BioScience Association Date: 02/02/2018
As things continue to be active and heat up over at the Colorado State Capitol, this week the Colorado BioScience Association took formal positions on three bills, while continuing to evaluate and mak...
Learn MoreFriday Policy Updates 1/26/2018
By: Colorado BioScience Association Date: 01/26/2018
UNDER THE DOME The CBSA team will be busy this legislative session working on bills that stand to have a negative impact on our industry, with an anticipated 7 healthcare transparency bills aimed at l...
Learn MoreColorado BioScience Association Highlights Medtech Disruption
By: Colorado BioScience Association Date: 01/24/2018
Annual Medical Device Symposium discusses industry growth, innovation and federal policy outlook DENVER – On Jan. 30, 2018, the Colorado BioScience Association (CBSA) will host more than 80 medtech le...
Learn MoreColorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP
By: Colorado BioScience Association Date: 01/23/2018
Congress delays medical device tax for two years Last night, the President signed a continuing resolution (CR) package, which includes a two-year suspension of the device tax retroactive to Dec...
Learn MoreFriday Policy Update 1/19/2018
By: Colorado BioScience Association Date: 01/19/2018
Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until...
Learn MoreMillennials: Training Talent
By: Colorado BioScience Association Date: 01/17/2018
State-Funded Program Connects Interns to Bioscience Careers Colorado’s commitment to growing a strong bioscience workforce begins with training up-and-coming talent. A state-funded program focused on...
Learn MoreFriday Policy Updates 1/12/2018
By: Colorado BioScience Association Date: 01/12/2018
UNDER THE GOLD DOME – THE 71ST GENERAL ASSEMBLY The 2018 Colorado Legislative session started this week and kicked off with several industry related health care bills. The CBSA team is already hard at...
Learn MoremiRagen: Comprehensive, microRNA Targeted Therapies
By: Colorado BioScience Association Date: 01/09/2018
Tiny Molecules Modulate Cellular Processes and Can Re-Program Cells Involved in Disease Bill Marshall was in Vienna, Austria, when he got the news. A prominent researcher had, for the first time, foun...
Learn MoreInocucor Raises $9.5 Million in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million
By: Colorado BioScience Association Date: 01/08/2018
Inocucor Raises $9.5 Million USD ($12.1 Million CAD) in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million USD ($50.9 Million CAD) Ben Belldegr...
Learn MoreFriday Policy Updates – 1/5/2018
By: Colorado BioScience Association Date: 01/05/2018
Under the Gold Dome – The 71st General Assembly The 2018 Colorado Legislative session begins next Wednesday, January 10th! The CBSA team will be busy advocating on behalf of the Colorado Bioscience in...
Learn MoreMillennials in Colorado
By: Colorado BioScience Association Date: 01/03/2018
Expanding our Workforce, Inspiring Our Companies Colorado boasts the fastest-growing Millennial population in the United States. This large demographic group is generally recognized as Americans born...
Learn MoreAt the Center of Everything
By: Colorado BioScience Association Date: 12/19/2017
Our Location Gives BioScience Companies an Advantage Many factors contribute to Colorado’s reputation as an exceptional place to start, grow, commercialize or relocate a life science business. Our col...
Learn More2017 Breaks Bioscience Records
By: Colorado BioScience Association Date: 12/12/2017
$1.2 Billion Year Doubles Amount Raised in 2016 Colorado’s life science companies raised a record $1.2 billion in 2017, doubling the funds raised in the previous year. The funding came through venture...
Learn MoreSharklet Moves Out of the Startup Scene
By: Colorado BioScience Association Date: 12/05/2017
Company Readies for Global Commercialization Sharklet has turned a corner. For the last 10 years, the startup company has worked to develop the chemical-free, micropatterned coating it pioneered to no...
Learn MoreRegenerative Medicine in Colorado
By: Colorado BioScience Association Date: 11/27/2017
How Researchers and Entrepreneurs are Advancing Human and Animal Health From treating painful skin conditions in children with IPS cells to using stem cells to improve quality of life for injured peop...
Learn MoreReady for Retirees
By: Colorado BioScience Association Date: 11/14/2017
How the Sector is Preparing for the State’s Shifting Demographics Colorado consistently ranks as a top destination for retirees. With Baby Boomers reaching retirement age at the rate of 10,000 per day...
Learn MoreTranS1: Innovative Products and Partnerships
By: Colorado BioScience Association Date: 11/07/2017
Supporting Spine Surgery’s Invention Engine Minimally invasive spine surgery sounds like an oxymoron. But that’s precisely the goal at TranS1, headquartered in a restored Victorian home in Denver’s hi...
Learn MoreChampions for Bioscience
By: Colorado BioScience Association Date: 10/31/2017
Accelerating Industry Success through Advocacy The CBSA team leads advocacy efforts on behalf of the industry and our members. We work every day to create an innovation-friendly business environment....
Learn More‘It’s All About the Kids’
By: Colorado BioScience Association Date: 10/24/2017
Children Inspire the Team at Silvergate Pharmaceuticals As a pharmacist managing some of the largest consumer pharmacies in the country, Frank Segrave saw a need. The majority of medications on his sh...
Learn MoreDiversity Suits the C-Suite
By: Colorado BioScience Association Date: 10/18/2017
At Biodesix, Female Executives ‘Shake Things Up’ to Drive Growth Anyone who works in bioscience knows there are few women in executive leadership roles. Although women come into the industry at the sa...
Learn MoreCollaborative by Nature
By: Colorado BioScience Association Date: 10/10/2017
A Commitment to Working Together Supports Success There’s something different about Colorado. It’s more than our beautiful natural surroundings and abundant sunshine, favorable business climate and ta...
Learn MoreSmart, Hard-Working and Happy
By: Colorado BioScience Association Date: 10/02/2017
A Talented Workforce Powers Colorado’s Bioscience Industry Bright, passionate people make Colorado the ideal place for bioscience investment. Our state attracts leading talent from around the globe an...
Learn MoreAlloSource Strives to Advance Healing
By: Colorado BioScience Association Date: 09/26/2017
Colorado-based company balances unique mission with medical innovation AlloSource® began with a simple principle: to transform tragedy into possibility. Since that moment nearly 25 years ago, the comp...
Learn Morei2 Pharmaceuticals: Boulder Based, Global Reach
By: Colorado BioScience Association Date: 09/19/2017
Pioneering Research to Solve the Drug Discovery Puzzle Creating an effective drug to treat disease is a bit of a puzzle. Researchers shape many molecular pieces and fit them together into a therapeuti...
Learn MoreQuantifying Good Health in Colorado
By: Colorado BioScience Association Date: 09/12/2017
Using Big Data to Improve Quality of Life Over the course of one person’s life, he or she may generate more than 12 terabytes of personal health data. If you were to store that information, it would b...
Learn MoreFederal Labs in Colorado
By: Colorado BioScience Association Date: 09/05/2017
Our State’s 33 Labs Make a $2.6 Billion Impact On any given day in Colorado, scientists at federal labs including the CDC in Fort Collins, NOAA in Boulder and NREL in Golden are studying diseases that...
Learn MoreBoettcher Foundation Helps Early-Career Scientists
By: Colorado BioScience Association Date: 08/29/2017
Funding Propels Investigators’ Research The Boettcher Foundation launched its Webb-Waring Biomedical Research Awards with the goal of helping early-career investigators advance their research to a poi...
Learn MoreRxREVU Modernizes Prescription Management
By: Colorado BioScience Association Date: 08/22/2017
Digital Health Platform Informs Prescribing Decisions In the center of Denver’s construction chorus—a sign of the city’s recent economic boom—CEO Carm Huntress, and his team at RxRevu have their own r...
Learn MorePrecision Medicine in 3D
By: Colorado BioScience Association Date: 08/15/2017
Printing the Future of Medicine Precision medicine often happens invisibly, in the nuclei of cells, in the dances of proteins, in the bowels of sequencers, in the processing cores of computer servers....
Learn More8TH FOR DEVICE AND DIAGNOSTICS EMPLOYMENT
By: Colorado BioScience Association Date: 08/08/2017
COMPANIES HIGHLIGHT THE INNOVATION HAPPENING HERE From global manufacturing powerhouses to inventive startups seeking to transform patient care, hundreds of medical device companies call Colorado home...
Learn MoreSomaLogic’s Team Unlocks the Potential of Proteins
By: Colorado BioScience Association Date: 08/01/2017
Meet the Leaders Working to Develop a Breakthrough in Precision Medicine Sheri Wilcox has no regrets. As a post-doctoral research fellow in 2000, Wilcox was living in Michigan and on the verge...
Learn MoreMBio Diagnostics to Commercialize Portable Lab Device
By: Colorado BioScience Association Date: 07/25/2017
Boulder Company Uses LightDeck Technology for Mobile Disease Detection Chris Myatt knew he was on to something. At a conference in 2005, he met a scientist with a simple handheld prototype designed to...
Learn MoreWhy Choose Colorado?
By: Colorado BioScience Association Date: 07/17/2017
What makes Colorado an ideal state for bioscience? Our state’s 300 days of sunshine a year and educated workforce appeal to homegrown companies and those looking to relocate. Our top five list, part o...
Learn MoreColorado Funds Bioscience Breakthroughs
By: Colorado BioScience Association Date: 07/11/2017
Colorado promotes growth and sustainability for the state’s nine identified Advanced Industries, which make up 30% of the Centennial state’s economy, through a state-led Advanced Industry (AI) Acceler...
Learn MoreColorado BioScience Association Recognizes 2017 Boettcher Investigators
By: Colorado BioScience Association Date: 06/13/2017
DENVER, June 13, 2017 — The Colorado BioScience Association on Tuesday commended the newest class of Boettcher Investigators and expressed its gratitude to the Boettcher Foundation for its continued s...
Learn MoreNew Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State
By: Colorado BioScience Association Date: 02/27/2024
For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...
Learn MoreWeekly Policy Blog: CBSA Talks PDAB at CSBA Summit; PDAB Ad Campaign & Media Highlight
By: Colorado BioScience Association Date: 12/04/2023
Amy Goodman, CBSA’s Vice President & Counsel for Policy + Advocacy, attended the 2023 Annual Council of State Bioscience Associations (CSBA) Summit in New Orleans this past week and discussed Colo...
Learn MoreFitzsimons Innovation Community and Aimco Host Media Event Focused on Sharing Momentum, Trends, and Patient-Impact Storylines
By: Colorado BioScience Association Date: 10/30/2023
With Aimco, Fitzsimons Innovation Community hosted members of the local and national media to learn firsthand about breakthrough work from 10 of the 80+ visionary biotech and life sciences companies i...
Learn MoreWeekly Policy Blog: CBSA Joins New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions
By: Colorado BioScience Association Date: 10/09/2023
CBSA has joined a new coalition to raise awareness of the fundamental role of pro-innovation mergers and acquisitions (M&A) in advancing the next generation of treatments and cures for patients. P...
Learn MoreRockies Venture Club: Three Myths of Life Science Angel Investing
By: Colorado BioScience Association Date: 07/10/2023
By Rockies Venture Club | RVC Weekly Newsletter July 3 The Three Fallacies of Life Science Investing I'm always interested to see how angels and angel groups present themselves to the public with rega...
Learn MorePMB and Montgomery Street Partners announce approval on the first speculative purpose-built life sciences project in Boulder County, CO
By: Colorado BioScience Association Date: 08/31/2022
This new 365,000 sq. ft. facility in Boulder County will break ground in Q2 of 2023 and complete in Q3 of 2024 PMB, a leading healthcare real estate developer, in partnership with Montgomery Street Pa...
Learn MoreThink Bioscience Raises $17M in Oversubscribed Seed Round to Develop Small Molecule Drugs that Hit Undruggable Proteins
By: Colorado BioScience Association Date: 08/30/2022
Funding will enable Think Bioscience to expand its drug discovery platform and advance its internal drug development programs. Think Bioscience (“Think”), a synthetic biology company focuse...
Learn MoreHepQuant Awarded COLA Accreditation for meeting US Clinical Laboratory Improvement Act (CLIA) and other Regulatory Requirements
By: Colorado BioScience Association Date: 08/30/2022
HepQuant, LLC, a Denver, Colorado-based company with a unique, patented and patent-pending technology for evaluating the liver in patients with chronic liver disease, today announced that the HepQuan...
Learn MoreAGC Biologics Supports Altheia Science’s Gene Therapy Programs
By: Colorado BioScience Association Date: 08/03/2022
AGC Biologics, today, announced a new partnership with Altheia Science. Through this partnership, Altheia Science will advance its development of autoimmunity treatments, focused on modulati...
Learn MoreTerumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)
By: Colorado BioScience Association Date: 08/01/2022
Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialy...
Learn MoreSomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
By: Colorado BioScience Association Date: 08/01/2022
SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix pro...
Learn MoreCerebral Therapeutics, Inc. Secures $40 Million Series C Financing
By: Colorado BioScience Association Date: 07/21/2022
Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today $40 million in Series C funding led by Lynx1 Capital Management with part...
Learn MoreWeekly Policy Update: Senate Prescription Drug Pricing Legislation
By: Colorado BioScience Association Date: 07/15/2022
Democrats in the U.S. Senate continue to negotiate an economic package that advances President Joe Biden’s key priorities. Prescription drug pricing legislation that would drastically alter the Medica...
Learn MoreSecurisyn Medical Announces Strategic Manufacturing and Distribution Partnership with SunMed Group Holdings
By: Colorado BioScience Association Date: 07/14/2022
Securisyn Medical LLC, (“Securisyn” or the “Company”), an emerging medical device company dedicated to enhancing ventilated patient safety and broader smooth tube and catheter securement, and SunMed G...
Learn MorePhilips Incorporates Biodesix Blood-based Proteomic Nodule Risk Assessment Testing into Lung Cancer Orchestrator to Advance Early Lung Cancer Diagnosis
By: Colorado BioScience Association Date: 07/01/2022
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has teamed up with Biodesix, Inc. (Colorado, U.S.) (Nasdaq: BDSX), a leading data-dri...
Learn MoreMorgridge Family Foundation gifts $3M to CSU Spur and College of Agricultural Sciences
By: Colorado BioScience Association Date: 06/07/2022
The Morgridge Family Foundation has imparted a transformational gift of $3 million to support the Colorado State University College of Agricultural Sciences and educational program...
Learn MoreBiodesix Announces Research Agreement with Top US Cancer Center
By: Colorado BioScience Association Date: 06/07/2022
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it intends to develop a new novel minimal residual disease (MRD) te...
Learn MoreWatchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings
By: Colorado BioScience Association Date: 06/02/2022
Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA, today announced it had secured...
Learn MoreBrickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02
By: Colorado BioScience Association Date: 05/19/2022
Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...
Learn MoreAGC Biologics Invests in Viral Vector Suspension at New U.S. Campus
By: Colorado BioScience Association Date: 05/19/2022
AGC Biologics today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in Longmont, Col., USA...
Learn MoreWeekly Policy Update: Legislative Session Comes to a Close This Week
By: Colorado BioScience Association Date: 05/09/2022
The legislative session is scheduled to end this Wednesday, May 11th. As we enter these final three days, the CBSA team continues to weigh in on key legislation and advocate on behalf of our life scie...
Learn MoreNew 450K-square-foot life science campus planned in Broomfield
By: Colorado BioScience Association Date: 05/04/2022
Developer Scott Caldwell says life science companies needed this space "yesterday." Find out more in the Denver Business Journal article. A rendering of plans for Colorado Research ExchangeLINCOLN PRO...
Learn MoreUmoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells
By: Colorado BioScience Association Date: 05/04/2022
Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced...
Learn MoreBrickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
By: Colorado BioScience Association Date: 05/04/2022
Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...
Learn MoreEvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System
By: Colorado BioScience Association Date: 04/20/2022
EvoEndo®, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A...
Learn MoreCordenPharma Receives Supplier Recognition Award From Esperion
By: Colorado BioScience Association Date: 04/15/2022
CordenPharma is honored to announce the receipt of a Supplier Recognition Award from Esperion Therapeutics that was presented by Esperion’s Sr. Vice President of Manufacturing Planning &...
Learn MoreAllosource Recognized as the Top Colorado Bioscience Manufacturer
By: Colorado BioScience Association Date: 04/15/2022
AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufactu...
Learn MoreEdgewise-Funded Natural History Trial Of Becker Muscular Dystrophy (BMD) Now Enrolling
By: Colorado BioScience Association Date: 04/15/2022
Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, t...
Learn MoreCEO Antoinette Gawin will serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System
By: Colorado BioScience Association Date: 04/14/2022
Terumo Blood and Cell Technologies, a medical technology company, announces the appointment of Antoinette Gawin to serve as Group Managing Executive Officer (GMEO) for Terumo Corporation (TSE:4543)....
Learn MoreTerumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development
By: Colorado BioScience Association Date: 04/06/2022
Terumo Blood and Cell Technologies, a medical technology company, recently appointed Gene Stellon as Senior Vice President, Innovation and Development (I&D). He will serve on the Executive Managem...
Learn MoreGilead Jumps Out Ahead of BMS in Second-Line B-Cell Lymphoma
By: Colorado BioScience Association Date: 04/06/2022
Kite Pharma, a subsidiary of Gilead, announced that Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been approved by the U.S. Food and Dru...
Learn MoreWeekly Policy Update: State Regulation of PFAS
By: Colorado BioScience Association Date: 03/18/2022
The regulatory environment regarding the usage of perfluoroalkyl and polyfluoroalkyl chemicals (PFAS) in medical devices and other products is evolving to include potential action on the state level....
Learn MoreGelSana Therapeutics Wins UNC Entrepreneurial Challenge
By: Colorado BioScience Association Date: 03/17/2022
The University of Northern Colorado's Monfort College of Business has announced the winners of the 2022 Entrepreneurial Challenge. After making improvements to their business plans based on judges’ fe...
Learn MoreEnveda Biosciences Adds Drug Development Leaders to Scale Efforts and Accelerate Progress
By: Colorado BioScience Association Date: 03/17/2022
Enveda Biosciences, a leading biotechnology company harnessing nature’s chemistry to develop next-generation small molecule therapies, today announced the addition of three leaders to further scale an...
Learn MoreColorado's Women-founded Startups Make Huge Strides
By: Colorado BioScience Association Date: 03/17/2022
CBSA member Inscipta is mentioned in Colorado's startups success. In a record year for venture capital in Colorado, firms founded by women saw sizable gains, too. Why it matters: The VC...
Learn MoreU.S. FDA Clears Terumo Blood and Cell Technologies' New Plasma Collection Technology
By: Colorado BioScience Association Date: 03/16/2022
The U.S. Food and Drug Administration (FDA) cleared the new plasma collection system developed by Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company. Rika is a next-generati...
Learn MoreSmartTab Named as a Finalist at SXSW
By: Colorado BioScience Association Date: 03/16/2022
CBSA Member SmartTab was named a Finalist in Health, Wearables, and Wellbring at SXSW. Congratualtions! SmartTabDenver, CO SmartTab is developing an advanced platform of ingestible capsules for oral d...
Learn MoreCompanies Bet You’re Ready to Test at Home for More Than Covid-19
By: Colorado BioScience Association Date: 03/04/2022
The Covid-19 pandemic has hastened consumers’ willingness to test for more medical conditions at home, test makers said, expanding the market for self-diagnostic products. Manufacturers are devel...
Learn MoreLightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness
By: Colorado BioScience Association Date: 03/04/2022
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Exe...
Learn MoreColorado coalition a semifinalist for $100 million industry-building grant
By: Colorado BioScience Association Date: 03/04/2022
The grant, if won, would allow for construction of bioscience and cleantech projects throughout the Denver, Boulder and Fort Collins areas — and the development of programs to improve the pipelines of...
Learn MoreStatera Biopharma gets go-ahead for next phase of Crohn’s therapy trial
By: Colorado BioScience Association Date: 02/22/2022
Statera Biopharma Inc. (Nasdaq: STAB) has received approval from the Central Institutional Review Board to move forward with the third phase of its clinical trial for STAT-201, its candidate for the t...
Learn MoreRoy Smythe, M.D. and Scott Hutton Named to List of Top 25 Biotech CEOs of 2022
By: Colorado BioScience Association Date: 02/18/2022
CBSA Members' CEOs are named to Top 25 Biotech CEOs list: SomaLogic's Roy Smythe, M.D., and Biodesix's Scott Hutton. The Healthcare Technology Report is pleased to announce The Top 25 Biotech CEOs of...
Learn MoreEvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System
By: Colorado BioScience Association Date: 02/18/2022
EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administrati...
Learn MoreEvergreen Research Inc. is now ERI Group
By: Colorado BioScience Association Date: 02/02/2022
ERI Group, formerly Evergreen Research, a leader in end-to-end medical product design and development, quality assurance, regulatory affairs and contract manufacturing services, unveiled its new name...
Learn MoreBrickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors Targeting Autoimmune and Inflammatory Diseases from Carna Biosciences
By: Colorado BioScience Association Date: 02/02/2022
Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...
Learn MoreLightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M To Develop Rapid, Multiplexed Inflammation Test for Respiratory Illness
By: Colorado BioScience Association Date: 02/02/2022
LightDeck Diagnostics, the company leveraging planar waveguide technology to deliver lab-quality diagnostics in minutes, today received a $2M contract from HJF, as funded by the Joint Program Executiv...
Learn MoreMining biotech opens Denver-area lab, plans quick expansion
By: Colorado BioScience Association Date: 02/01/2022
A fivefold jump in demand for for certain metals that are key to manufacturing the wind power, solar energy, batteries and other systems needed in the clean energy transition is forecast by 2050. The...
Learn MoreColorado startups crush venture funding record in 2021 with $6.5B raised
By: Colorado BioScience Association Date: 01/21/2022
In 2021, the state smashed previous venture funding records and closed the year with never-before-seen momentum. Find out more in the Denver Business Journal article.
Learn MoreSomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic solutions
By: Colorado BioScience Association Date: 01/11/2022
SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The m...
Learn MoreAGC Biologics Appoints Whitney Sandberg as the new Vice President of Quality for its Colorado Facilities
By: Colorado BioScience Association Date: 01/10/2022
AGC Biologics announced Whitney Sandberg has been appointed as the company’s Vice President for Quality in Colorado. In this position she will have executive oversight for quality operations at the co...
Learn MoreSummit Biolabs Announces Changes to its Board of Directors
By: Colorado BioScience Association Date: 01/05/2022
Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR technology to transform the detection of infectious diseases, today announced the appointment of ...
Learn MorePharmaJet partner Zydus Cadila announces COVID-19 vaccine expansion plan to multiple countries with Korean firm
By: Colorado BioScience Association Date: 01/04/2022
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA...
Learn MoreLivaNova holds ribbon-cutting for $10.5 million sterilization facility in Arvada
By: Colorado BioScience Association Date: 12/29/2021
The Arvada manufacturing facility of LivaNova — a global medical device producer -unveiled a state-of-the-art $10.5 million sterilization facility on Dec. 15 that will allow the company to sterilize h...
Learn MorePharmStars Announces 2021 Accelerator Graduates, Includes CBSA Member SmartTab
By: Colorado BioScience Association Date: 12/23/2021
12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. PharmStars, the pharma-focused accelerator for digital health startups, is deli...
Learn MoreInscipta Named in Colorado's Top 10 Tech and Startup Fundings of 2021
By: Colorado BioScience Association Date: 12/23/2021
There have been more than a dozen deals north of $100 million in 2021, including three over $200 million in the technology space. CBSA member and Boulder-based Inscripta Inc., a digital genome enginee...
Learn MoreColorado Coalition Selected as Finalist for Economic Development Administration’s (EDA) Build Back Better Regional Challenge
By: Colorado BioScience Association Date: 12/16/2021
Colorado Coalition will Compete for up to $100 Million to Supercharge Economy through Eight Projects The Colorado Coalition, the regional stakeholder group led by Innosphere Ventures in part...
Learn MorePharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next generation DNA-based COVID-19 vaccine candidates
By: Colorado BioScience Association Date: 12/15/2021
Vaccines to be delivered via needle-free jet injection GOLDEN, Colo. — December 14, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of...
Learn MoreBiodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer
By: Colorado BioScience Association Date: 12/10/2021
Spesana, the developer of a novel electronic operating system to unify EMRs, and Biodesix Inc. (NSDQ: BDSX), a leading data-driven diagnostic solutions company with a focus in lung dis...
Learn MoreProov® to Expand Women’s Hormone Health Solutions to Advance Women’s Health and Offer More Accessible Care with $9.7M Series A Funding
By: Colorado BioScience Association Date: 12/09/2021
Proov, creator of the first and only FDA-cleared PdG-testing kit to educate and empower women about their reproductive health, announces today it raised $9.7 million in Series A Funding. The round was...
Learn MoreGenapsys Selects Colorado for Manufacturing and R&D Expansion, Brings 240 new jobs to Colorado
By: Colorado BioScience Association Date: 12/08/2021
Colorado continues to emerge as a bioscience hub. Genapsys, a life science company, has announced plans to open a second location in Westminster bringing approximately 240 new jobs to Colorado. Genap...
Learn MoreSmartTab Launches StartEngine Equity Crowdfunding Campaign on a Mission to Revolutionize Drug Delivery
By: Colorado BioScience Association Date: 12/06/2021
SmartTab has announced the launch of its crowdfunding campaign on StartEngine (https://www.startengine.com/smarttab). The digital health startup is opening up investments to the public to accelerate t...
Learn MoreVivaldi Biosciences Files PCT Patent Application for Universal Flu and Covid-19 Combination Vaccine
By: Colorado BioScience Association Date: 11/30/2021
Vivaldi Biosciences, a clinical-stage biotechnology company developing nasal-spray vaccines for viral respiratory diseases, today announced it has filed an international patent application for its com...
Learn MoreSolidAIRity Flex™ Launches First-in-Patient Limited Market Release
By: Colorado BioScience Association Date: 11/22/2021
Securisyn Medical has formally launched its FDA-registered, Adult SolidAIRity Flex™ Endotracheal Tube Securement device, at Memorial Hospital - University of Colorado Health in Colorado Springs. This...
Learn MoreAspero Medical Awarded $1M Grant
By: Colorado BioScience Association Date: 11/09/2021
Startup MedTech company improving endoscopy procedures with patented balloon technology continues to develop product line Aspero Medical, a medical device startup company focused on design and develop...
Learn MoreCBSA Member SmartTab Receives Two Awards: 2021 Colorado Company to Watch and 2021 Patient's Choice Award
By: Colorado BioScience Association Date: 10/22/2021
CBSA member SmartTab is honored with two awards: SmartTab has been selected as a top award winner for the 2021 Colorado Companies to Watch. This highly prestigious award is designated to the most, “in...
Learn MorePharmaJet , WHO and BMGF conduct Somalia Polio Vaccination Campaign
By: Colorado BioScience Association Date: 10/21/2021
PharmaJet® the maker of innovative, needle-free injection technology, today announced that its Tropis® intradermal needle-free injection system is being used in a campaign in Somalia d...
Learn MorePharmaJet Presents Needle-free delivery of COVID-19 Vaccines and Beyond at World Vaccine Congress - Europe
By: Colorado BioScience Association Date: 10/13/2021
Superior immunogenicity expands vaccine development with Needle-free delivery PharmaJet®, the maker of innovative, needle-free injection technology, announced that their latest partnerships and resear...
Learn MoreWeekly Policy Update: Prescription Drug Affordability Review Board Members Appointed
By: Colorado BioScience Association Date: 10/08/2021
This week, Governor Polis announced the appointment of the inaugural five members of the Prescription Drug Affordability Review Board (PDAB). The PDAB was created through the legislature’s passage and...
Learn MoreGates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta
By: Colorado BioScience Association Date: 10/07/2021
The Gates Biomanufacturing Facility (GBF) today announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells. As part of this col...
Learn MoreBrickell Biotech Announces Positive Topline Results, Achieving Statistical Significance on all Primary and Secondary Endpoints, from Both U.S. Phase 3 Pivotal Clinical Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis Patients
By: Colorado BioScience Association Date: 10/07/2021
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for...
Learn MoreNew fund expands its investments into the Mid-America Mountain Plains region focusing on B2B SaaS, Cleantech, and Medtech Startups
By: Colorado BioScience Association Date: 10/05/2021
Innosphere Ventures announced the launch of its second venture capital fund, Innosphere Ventures Fund II (Fund II), that focuses on leading early-stage investments for companies who are driving innova...
Learn MoreInotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
By: Colorado BioScience Association Date: 10/05/2021
Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, today...
Learn MoreLive Fully, Inc awarded a $299,000 SBIR Grant to develop Breathe Away devices for Long Term Oxygen Therapy Patients so they can confidently go about their daily activities of living without worrying about running out of oxygen
By: Colorado BioScience Association Date: 09/30/2021
Live Fully, Inc., a medical device design company is focused on improving the daily lives of lung disease patients through the development of products dedicated to improving outcomes and quality of li...
Learn MoreViridian raising $85M on new shares
By: Colorado BioScience Association Date: 09/23/2021
Viridian Therapeutics Inc. (Nasdaq: VRDN) is selling 6.2 million common shares at $11 apiece and about 23,000 shares of series B preferred stock at $733.37 to raise $85 million to continue its develop...
Learn MoreClovis pays off notes, raises $40M+ in ATM offering
By: Colorado BioScience Association Date: 09/23/2021
In an effort to clean up its balance sheet, cancer-drug manufacturer Clovis Oncology Inc. (NYSE: CLVS) has paid off $64.4 million in maturing convertible senior notes due in 2021 and raised more than...
Learn MoreAccure Acne Inc.™ announces the appointment of Jeffrey O'Donnell, Sr. to the Board
By: Colorado BioScience Association Date: 09/23/2021
Accure Acne, Inc. announced today that Jeffrey O'Donnell, Sr. has joined Accure Acne's Board of Directors. Along with Chairman and Founder Christopher Carlton and Founder Ed B...
Learn MoreSen. Michael Bennet reintroduces much needed bill to fight superbugs: PASTEUR Act
By: Colorado BioScience Association Date: 09/23/2021
As the pandemic rages on, Colorado’s senator is working to prevent the next one. With all the marvels of modern medicine, could humans still die from a paper cut? For years we’ve taken the ability to...
Learn MorePegasus Announces New Location in Denver, Colorado
By: Colorado BioScience Association Date: 09/23/2021
Pegasus, a leading provider in comprehensive cleaning and decontamination services announced today that they have opened a new office in Denver, Colorado. The new location is 3190 S. Vaughn...
Learn MoreSecurisyn Medical Awarded a $1.95M SBIR Fast-Track Grant to Develop SolidAIRity Flex™ Pediatric and Neonatal Endotracheal Securement Devices for Improved Clinical Safety
By: Colorado BioScience Association Date: 09/22/2021
Securisyn Medical LLC, a provider of novel breathing and smooth tube and catheter securement products dedicated to improving patient outcomes, today announced the award of a Fast-Track Small Business...
Learn MoreInnosphere Ventures Fund leads investment into bioscience company, GelSana Therapeutics
By: Colorado BioScience Association Date: 09/21/2021
Innosphere Ventures Fund (Fund), a venture capital fund leading early-stage investments, has announced its second seed-stage investment into GelSana Therapeutics (GelSana). GelSana will use...
Learn MoreColorado Life Sciences Community Members Recognized in Regulatory Affairs Professional Society Awards
By: Colorado BioScience Association Date: 09/13/2021
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, phar...
Learn MoreTech transfer key to products spun off from CU Boulder, federal labs research
By: Colorado BioScience Association Date: 09/13/2021
A chance meeting on a Boulder-area trail could lead to a better understanding of particles suspended in the air that have major impacts on weather, climate and air quality. Find out more in the Daily...
Learn MoreInnosphere to build new 7,500-square-foot lab space in Fort Collins
By: Colorado BioScience Association Date: 09/09/2021
In order to keep Colorado companies from relocating out of state because they can’t find a lab, Innosphere is building a new one. Read more in the Denver Business Journal's article about the new life...
Learn MoreKromaTiD Announces Launch of dGH SCREEN™ for Unbiased Whole Genome Analysis of Chromosomal Structural Rearrangements
By: Colorado BioScience Association Date: 09/09/2021
KromaTiD is pleased to announce the launch of dGH Screen™, their new service for mapping the human genome in single cells. dGH SCREEN™ is built upon KromaTiD’s proprietary directional Genomic Hy...
Learn MoreColorado Springs-area science teacher receives $2,000 STEM grant, intensive biotech training
By: Colorado BioScience Association Date: 09/08/2021
A Pikes Peak-area science teacher recently received a STEM grant from the Air Force Academy after completing an intensive biotechnology training program that she said will help make classes more inter...
Learn MoreLightDeck Diagnostics Strengthens Leadership Team to Spearhead Commercialization of Rapid, Point-of-Care Diagnostics
By: Colorado BioScience Association Date: 09/08/2021
LightDeck Diagnostics today announced additions to its executive leadership team, naming Russ Peloquin as Chief Commercial Officer and Frank Gill as Chief Product Officer. The two will be joining newl...
Learn MoreTriSalus enrolls first patient in pressure-enabled drug delivery trial for treating melanoma
By: Colorado BioScience Association Date: 09/07/2021
TriSalus Life Sciences announced today that it enrolled the first patient in its clinical study of a treatment for metastatic uveal melanoma. The PERIO-01 clinical study evaluates SD-101, an inve...
Learn MoreBoettcher Foundation Stories on Boettcher Investigators, COVID Fund
By: Colorado BioScience Association Date: 09/03/2021
2021 Boettcher Investigators In late May we announced the names of six leading Colorado researchers who are the newest recipients of grant funding through the Webb-Waring Biomedical Research Awards Pr...
Learn MoreBrickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer
By: Colorado BioScience Association Date: 09/03/2021
Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...
Learn MoreBrickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases
By: Colorado BioScience Association Date: 09/03/2021
Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...
Learn MoreCytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”
By: Colorado BioScience Association Date: 09/03/2021
Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpor...
Learn MoreHeads Up Health Extends Seed Round to $2.25M Led by Innosphere Ventures
By: Colorado BioScience Association Date: 09/03/2021
Innosphere Ventures’ seed-stage venture capital fund has announced its second investment into Heads Up Health (Heads Up) which gives Heads Up the ability to close out their seed round at $2.25 millio...
Learn MoreCSURF announces the departure of Todd Headley, VP of Technology Transfer
By: Colorado BioScience Association Date: 09/02/2021
It is with mixed emotions that CSURF announces the departure of Todd Headley, Vice President of Technology Transfer. Todd’s contributions and impact at CSURF and Colorado State University have b...
Learn MoreSomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq Stock Exchange
By: Colorado BioScience Association Date: 09/01/2021
SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it has completed its business combination with CM Life Sciences II, Inc. (Nasdaq: CMIIU), a special purpose acqu...
Learn MoreZalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa
By: Colorado BioScience Association Date: 08/31/2021
Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever (LF), today announced its contract with t...
Learn MorePharmaJet Partner Zydus Cadila Announces Emergency Use Authorization Approval for World’s First Plasmid DNA COVID-19 Vaccine
By: Colorado BioScience Association Date: 08/25/2021
Vaccine delivered exclusively with the PharmaJet Needle-free System GOLDEN, Colo.- PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila...
Learn MoreGolden-based BioIntelliSense ramps up with $45M in financing to scale vital-monitoring sticker
By: Colorado BioScience Association Date: 08/19/2021
The Golden-based company received FDA approval and insurance reimbursement approval for a remote monitoring wearable that can continuously collect vital signs data from a patient. Find out more in the...
Learn MoreEdgewise Receives U.S. FDA Fast Track Designation for EDG-5506 for the Treatment of Individuals with Becker Muscular Dystrophy (BMD)
By: Colorado BioScience Association Date: 08/16/2021
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, today announced t...
Learn MoreKromaTiD Appoints Nathan Wood as Chief Executive Officer
By: Colorado BioScience Association Date: 08/16/2021
KromaTiD, Inc. announces that Nathan Wood, will be joining as its Chief Executive Officer. Wood is a seasoned executive with thirty years of experience in the life science industry and is the for...
Learn MoreFitzsimons Innovation Community Accelerates Growth
By: Colorado BioScience Association Date: 08/12/2021
Breaks ground on first full-scale commercial manufacturing facility, for cell and gene therapy AURORA, Colo. (August 12, 2021) – Today, Fitzsimons Innovation Community breaks ground on its new bioscie...
Learn MoreTerumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
By: Colorado BioScience Association Date: 08/11/2021
Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood component collection, therapeutic apheresis and cellula...
Learn MoreAGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
By: Colorado BioScience Association Date: 08/06/2021
AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the finalization of the purchase of a state-of-the-art commercial manufacturing...
Learn MoreBoulder iQ Names Larry Blankenship as Director, Helping Life Sciences Companies with Product Development
By: Colorado BioScience Association Date: 08/05/2021
Boulder iQ has named Larry Blankenship director. Blankenship is a veteran medical device industry professional, with more than 30 years of experience in product development, manufacturing, regulatory...
Learn MoreCSU Receives $2 Million Grant to Help Prevent Future Pandemics
By: Colorado BioScience Association Date: 07/28/2021
Building on its response to the COVID-19 pandemic, Colorado State University has received a $2 million commitment from The Anschutz Foundation to further the development of new solutions for building...
Learn MoreEvergreen Research Appoints New President, Natasha Bond
By: Colorado BioScience Association Date: 07/28/2021
Evergreen Research, Inc. (Evergreen), a leading provider of contract development, manufacturing, and regulatory/quality assurance services, is pleased to announce the appointment of Natasha (Tasha) Bo...
Learn MoreNasal-Spray Combined Vaccine for Covid and Flu Shows Protection
By: Colorado BioScience Association Date: 07/27/2021
Vivaldi Biosciences, a clinical-stage biotechnology company developing genetically engineered intranasal vaccines for viral respiratorydiseases, today announced positive preclinical data supporting fu...
Learn MoreOutlook Therapeutics Appoints C. Russell Trenary III as President and Chief Executive Officer
By: Colorado BioScience Association Date: 07/27/2021
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, t...
Learn MoreLightDeck Diagnostics Appoints Nick Traggis as CEO to Scale Company Operations Through Next Phase of Growth
By: Colorado BioScience Association Date: 07/21/2021
LightDeck Diagnostics today announced that Nick Traggis has transitioned from executive vice president of Corporate Development to Chief Executive Officer (CEO). Chris Myatt, who precedes M...
Learn MoreTANOVEA® (rabacfosadine for injection) Receives Full FDA Approval as First Treatment for Lymphoma in Dogs; Elanco Acquires Product from VetDC, Inc
By: Colorado BioScience Association Date: 07/19/2021
Elanco Animal Health Incorporated (NYSE: ELAN) announced that the FDA has granted full approval of Tanovea for the treatment of lymphoma in dogs, making this the first conditionally approved new...
Learn MoreFDA Grants First Full Approval for Treatment of Lymphoma in Dogs
By: Colorado BioScience Association Date: 07/15/2021
Today, the U.S. Food and Drug Administration fully approved Tanovea (rabacfosadine injection) to treat lymphoma in dogs. Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many s...
Learn MoreLong-time CBSA Member Aerotek to Change Name
By: Colorado BioScience Association Date: 07/13/2021
Aerotek, a leading talent solutions provider, today revealed that its three highly specialized business units—Industrial, Professional, and Engineering and Sciences—have separated into independen...
Learn MoreARCA Biopharma Provides Update On Aspen-COVID-19 Phase 2B Clinical Trial Evaluating RNAPC2 as a Potential Treatment for COVID-19
By: Colorado BioScience Association Date: 07/13/2021
CBSA Member ARCA Biopharama is receiving approvals from regulators in Argentina and Brazil to test your possible COVID-19 treatment. Find out more in the press release.
Learn MoreVitriVax Announces Series A Financing to Further Demonstrate Feasibility of its Thermostable, Single-Dose Vaccine Technology, Aiming to Make Life-Saving Biologics Widely Accessible to Underserved Populations Globally
By: Colorado BioScience Association Date: 07/08/2021
VitriVax, developer of a novel stabilization and delivery platform for vaccines and therapeutics, today announced it has closed its first institutional financing round with Adjuvant Capital. Series A...
Learn MoreDOD, HHS Awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19
By: Colorado BioScience Association Date: 07/08/2021
On July 8, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $35.1 million contract to LightDeck Diagnostic...
Learn MorePharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine
By: Colorado BioScience Association Date: 07/07/2021
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Control...
Learn MoreAGC Biologics Enters Agreement to Acquire Facility in Longmont, CO, Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities and Offerings
By: Colorado BioScience Association Date: 07/02/2021
AGC Biologics, a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy...
Learn MoreVaporox Closes on a $4M Series A Fund Raising Round Led by Bioventus
By: Colorado BioScience Association Date: 06/29/2021
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has completed a minority investment in Vaporox, Inc., a developer of a highly innovative...
Learn MoreAt-home fertility test kit maker Proov expands to EU after landing CE clearance
By: Colorado BioScience Association Date: 06/25/2021
At-home fertility test maker Proov is expanding its footprint to Europe after receiving CE marking for its ovulation-confirming test kit. Proov’s ovulation testing kit got clearance by the F...
Learn MoreBrickell Biotech Announces Initiation of a Phase 1 Study of Sofpironium Bromide Gel in Primary Palmoplantar Hyperhidrosis Patients by its Development Partner, Kaken Pharmaceutical in Japan
By: Colorado BioScience Association Date: 06/24/2021
Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatm...
Learn MoreInside Medtronic's plans for its new 400,000-square-foot Lafayette campus
By: Colorado BioScience Association Date: 06/24/2021
The company is preparing to break ground on its new campus, which will prioritize collaboration and innovation. Find out more in the Denver Business Journal article.
Learn MoreEnveda Biosciences Closes $51M Series A Financing Led by Lux Capital
By: Colorado BioScience Association Date: 06/22/2021
Enveda Biosciences, a leading biotechnology company harnessing the power of nature’s chemistry to develop next-gen small molecule therapeutics, today announced an oversubscribed $51M Series A funding...
Learn MoreThe Top 25 Women Leaders in Consumer HealthTech of 2021, CBSA Congratulates Tasha Bond from member company Sana Health
By: Colorado BioScience Association Date: 06/15/2021
The Healthcare Technology Report is pleased to announce the Top 25 Women Leaders in Consumer HealthTech of 2021. From developing new technologies and products for often overlooked areas of women’s hea...
Learn MoreLohocla Research to Present at 2021 BIO
By: Colorado BioScience Association Date: 06/11/2021
Lohocla Research announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled June 10-11 & 14-18, 2021. Jim...
Learn MoreEvoEndo Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians
By: Colorado BioScience Association Date: 06/08/2021
EvoEndo® Inc., (“EvoEndo” or “the Company”) a preclinical medical device company developing systems for unsedated Transnasal Endoscopy (TNE), announced it has secured $10.1M in equity financing....
Learn MoreFDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
By: Colorado BioScience Association Date: 06/07/2021
-- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for ADUHELM™ (aducanumab-a...
Learn MoreForesight Diagnostics Completes Series A Financing to Accelerate Development of its Industry-Leading Minimal Residual Disease (MRD) Technology
By: Colorado BioScience Association Date: 06/03/2021
Foresight Diagnostics today announced the close of its $12.5M Series A financing led by Civilization Ventures and Bluebird Ventures, with participation by Pear Ventures, to commercialize the...
Learn MoreFlagship Biosciences Expands Tissue Image Analysis Capabilities at New Colorado Location in Support of Pharmaceutical and Clinical Clients
By: Colorado BioScience Association Date: 06/01/2021
Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that the company has moved its headquarters to a new location in Broomfield, Colorado, just north of Den...
Learn MoreFDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
By: Colorado BioScience Association Date: 06/01/2021
Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved LUMAKRAS™ (sotorasib) for the treatment of adult patients with KRAS G12...
Learn MoreProov Announces New Patented Test Method for Assessing Ovarian Quality
By: Colorado BioScience Association Date: 05/26/2021
– Proov, a science-based hormone testing company and the leader in testing urine for PdG to confirm ovulation, is announcing today that it has received patent issue notification for a utility patent c...
Learn MoreSomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth
By: Colorado BioScience Association Date: 05/20/2021
SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort aimed at equipping healthcare providers with the po...
Learn MoreLightDeck Diagnostics Honored as Bronze Stevie® Award Winner in 2021 American Business Awards® for Its Lab-Quality, 5-Minute Diagnostics Platform
By: Colorado BioScience Association Date: 05/13/2021
LightDeck Diagnostics was named the winner of a Bronze Stevie® Award in the Startup of the Year category in The 19th Annual American Business Awards® today. The company was recognized for it...
Learn MoreKromaTiD receives $2M of growth investment from BroadOak Capital Partners
By: Colorado BioScience Association Date: 05/06/2021
KromaTiD announced BroadOak Capital Partners made a $2M investment in the company. KromaTiD said its sales and operations are rapidly accelerating, driven by growing market adoption of their products...
Learn MoreCerapedics Announces FDA Breakthrough Device Designation Granted for P-15L Bone Graft for the Treatment of Degenerative Disc Disease
By: Colorado BioScience Association Date: 04/29/2021
Cerapedics Inc., an ortho-biologics companydedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device desi...
Learn MoreThe World's First Fully Automated Benchtop Digital Genome Engineering Platform Is Here
By: Colorado BioScience Association Date: 04/28/2021
As synthetic biology continues to grow, advanced benchtop systems are becoming available to make research and product development easier. Now, Inscripta, a digital genome engineering company, has...
Learn MoreAccure Acne, Inc(R) has Launched a Private Placement Offering on the M-Vest Platform to raise up to $20.0 Million
By: Colorado BioScience Association Date: 04/23/2021
Accure Acne, Inc. ("Accure Acne" or the "Company") has launched a private placement offering on the M-Vest platform to raise up to $20.0 million. Accure has developed an energy-based device (the...
Learn MoreCereHealth Corporation Names James Chomas, Ph.D., as New CEO
By: Colorado BioScience Association Date: 04/21/2021
Dr. Chomas brings an added level of industry firepower to CereHealth's accelerated growth and capital investment plans for its innovative brands of medical technology. DENVER, April 20, 2021...
Learn MoreEvergreen Research Hires Geoffrey Uhl as Director of Product Development
By: Colorado BioScience Association Date: 04/19/2021
Evergreen Research, Inc. (Evergreen), leaders in medical device services, today announced Geoffrey (Geoff) Uhl has joined the company as the newest member of the Evergreen executive team. Geoff will o...
Learn MoreProfessor Larry Gold to Receive a Lifetime Achievement Award at Aptamers 2021
By: Colorado BioScience Association Date: 04/14/2021
We are delighted that Professor Larry Gold will receive a Lifetime Achievement Award on behalf of the International Society on Aptamers (INSOAP) for his pioneering and extraordinary contributions to t...
Learn MoreCogent Biosciences Announces Creation of Cogent Research Team
By: Colorado BioScience Association Date: 04/14/2021
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the formation of the Cogent Research Team l...
Learn MoreAlan Greene Joins Securisyn Medical, LLC as Chief Marketing Officer
By: Colorado BioScience Association Date: 04/13/2021
Securisyn Medical LLC, (“Securisyn” or the “Company”), is pleased to announce that Alan (Al) Greene has joined the Company as its Chief Marketing Officer, effective April 1st, 2021. Securisyn Medical,...
Learn MoreTriSalus Life Sciences and MD Anderson Announce Strategic Research Collaboration to Evaluate Treatment of Solid Tumors
By: Colorado BioScience Association Date: 04/08/2021
The University of Texas MD Anderson Cancer Center and TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, tod...
Learn MoreApplied Spectral Imaging and KromaTiD Announce Strategic Commercial Partnership
By: Colorado BioScience Association Date: 04/07/2021
Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced today that they have entered into a strategic commercial partnership, granting ASI worldwide rights to market KromaTiD’s proprietary Pinpoin...
Learn MoreInscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing
By: Colorado BioScience Association Date: 04/05/2021
Inscripta, Inc., the digital genome engineering company, today announced the first commercial shipment of its Onyx™ platform and the closing of a $150 million Series E financing round led by Fide...
Learn MoreCU Anschutz Schools and Colleges Rank Among Nation’s Best in 2022 U.S. News & World Report Listing
By: Colorado BioScience Association Date: 03/31/2021
The University of Colorado School of Medicine has moved up in rankings for primary care and research; first time in top 30 for research. Colorado School of Public Health makes Top 20 best programs in...
Learn MoreSomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform
By: Colorado BioScience Association Date: 03/29/2021
SomaLogic, a global leader in proteomics technology, powered by a proprietary platform, the largest clinical proteomic database and next generation artificial intelligence and machine learning, and CM...
Learn MoreEdgewise Therapeutics Announces Pricing of Initial Public Offering
By: Colorado BioScience Association Date: 03/26/2021
Edgewise Therapeutics, Inc., (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for rare muscle disorders, announced today t...
Learn MoreAytu BioScience Announces Close of Merger with Neos Therapeutics
By: Colorado BioScience Association Date: 03/22/2021
Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced the closing of its merger with N...
Learn MoreFlagship Biosciences Announces Strategic Executive Team Additions
By: Colorado BioScience Association Date: 03/12/2021
Flagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced strategic additions to its executive team. Dr. Roberto Gianani, MD has been promoted to Chief Medical Of...
Learn MoreRare disease biotech Edgewise Therapeutics files for a $100 million IPO
By: Colorado BioScience Association Date: 03/09/2021
Edgewise Therapeutics, a Phase 1 biotech developing small molecule therapies for rare muscle disorders, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Edgewise...
Learn MoreMedtronic's plans for 42-acre campus in Lafayette approved by City Council
By: Colorado BioScience Association Date: 03/03/2021
The approval marks a win for both the biotechnology giant as well as Colorado economic development leaders, who offered the company millions in tax credits in hopes of drawing new high-paying jobs. Le...
Learn MoreRxRevu Launches SwiftMx - Healthcare's First and Only Complete Price Transparency Solution
By: Colorado BioScience Association Date: 02/26/2021
RxRevu, the leading provider of prescription price transparency solutions, has announced the expansion of its services to include the delivery of medical benefit coverage and cost information to elect...
Learn MoreCSU Vaccine Research Advances, Groundwork Begins to Develop Coronavirus Vaccine for the Next Pandemic
By: Colorado BioScience Association Date: 02/26/2021
As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other universities to c...
Learn MoreBiodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021
By: Colorado BioScience Association Date: 02/25/2021
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Report announced Chief Executive Off...
Learn MoreGates Biomanufacturing Facility reaches protein biologic manufacturing milestone
By: Colorado BioScience Association Date: 02/23/2021
The Gates Biomanufacturing Facility (GBF) has completed the manufacturing and release of a protein-based biologic under Good Manufacturing Practice for Phase 1 Investigational Drugs for first-in-human...
Learn MoreLightDeck Diagnostics Gets $5.65 Million for Rapid, Portable SARS-CoV-2 Antigen Test
By: Colorado BioScience Association Date: 02/23/2021
LightDeck Diagnostics was awarded a $5.65 million contract to develop a rapid antigen test to detect SARS-CoV-2. The funding, provided by the Biomedical Advanced Research and Development Authorit...
Learn MoreFlagship Biosciences Announces Patent
By: Colorado BioScience Association Date: 02/19/2021
Flagship Biosciences, the leader in data-centric pathology tissue analysis, today announced that the United States Patent and Trademark Office has issued Flagship a new patent, number 10,839,512 entit...
Learn MoreBiodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools
By: Colorado BioScience Association Date: 02/16/2021
Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with Chicago Public Schools (CP...
Learn MoreCongratulations from Colorado Life Sciences Ecosystem to Richard C. Duke, Ph.D. Named 2020 Tibbetts Award Winner
By: Colorado BioScience Association Date: 02/09/2021
Dr. Duke has made a career out of innovating, teaching, learning, and successfully commercializing technologies. His efforts have led to numerous policies benefitting innovation and business as well a...
Learn MoreInvitae (formerly ArcherDX) Announces Pricing of Public Offering of Common Stock
By: Colorado BioScience Association Date: 01/27/2021
Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 7,766,990 shares of its common stock at a price to the public of $51.50 per share. All of the shares...
Learn MoreEditas Medicine Announces Pricing Of Offering Of Common Stock
By: Colorado BioScience Association Date: 01/26/2021
Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66....
Learn MoreCompany Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
By: Colorado BioScience Association Date: 01/22/2021
miRagen Therapeutics, Inc. (NASDAQ: MGEN), a development-stage biotechnology company, today announced its name change to Viridian Therapeutics, Inc. (“Viridian”). Beginning tomorrow, Viridian will tra...
Learn MoreAGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
By: Colorado BioScience Association Date: 01/22/2021
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operatio...
Learn MoreColorado Researchers Received Almost Half a Billion Dollars in 2020 NIH Grants
By: Colorado BioScience Association Date: 01/13/2021
The University of Colorado Denver and the Anschutz Medical Campus received the majority of health research grants, including $1.8 million for projects specific to Covid-19. Find out more in the Denver...
Learn MoreSomaLogic Appoints Jason Cleveland, Ph.D. as Chief Technology Officer
By: Colorado BioScience Association Date: 01/11/2021
SomaLogic Inc., a global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, today announced the appointment of Jason Cleveland, Ph.D. as the com...
Learn MoreDU scientists develop breakthrough COVID-19 antibody test
By: Colorado BioScience Association Date: 01/07/2021
The test is so accurate, it can determine whether a person's symptoms will be mild or severe. Scientists at the University of Denver's (DU) Knoebel Institute for Healthy Aging, in collaboration with t...
Learn MorePurdue partners with Colorado company to offer rapid testing for students ahead of spring 2021 semester
By: Colorado BioScience Association Date: 01/06/2021
Purdue University is partnering with a Colorado company led by a Purdue alum to offer rapid antigen COVID-19 testing for undergraduate, graduate and professional students taking classes on the West La...
Learn MoreSomaLogic Expands Its Commercial Capabilities with Three New Senior Leaders
By: Colorado BioScience Association Date: 01/05/2021
SomaLogic Inc., a privately held health information company, announced today the appointments of Angela Bakker Lee, Ph.D. as executive vice president for healthcare markets, Tracy Hervey, MBA as execu...
Learn MoreBolder Surgical launches CoolSeal™ Vessel Sealing Platform
By: Colorado BioScience Association Date: 01/04/2021
Bolder Surgical, today announced the launch of its CoolSeal™ Vessel Sealing platform. Founded in 2010 as JustRight Surgical, Bolder Surgical provides surgeons right-sized surgical instruments to safe...
Learn MoreColorado Bioscience Companies Ramp Up Vaccine Development in 2021
By: Colorado BioScience Association Date: 01/04/2021
Several Colorado companies are working on vaccines or technology to enhance vaccine distribution. Find out more in the Denver Business Journal article.
Learn MoreSomaLogic Adds $81M to Series A Financing Totaling $214M
By: Colorado BioScience Association Date: 12/23/2020
SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that it added $81M to its current funding round with...
Learn MoreEdgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
By: Colorado BioScience Association Date: 12/09/2020
Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, today announced the closing of a $95 million Se...
Learn MoreSomaLogic Closes $121M Series A Financing Led by Casdin Capital
By: Colorado BioScience Association Date: 11/25/2020
SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial S...
Learn More$7.7 Million Advanced Industries Awards Fuel 37 Colorado Start-ups
By: Colorado BioScience Association Date: 11/19/2020
Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 37 Colorado start-ups approved for funding. A total of...
Learn MorePrima-Temp Awarded Groundbreaking Patent Using Artificial Intelligence For Ovulation Prediction
By: Colorado BioScience Association Date: 11/19/2020
Prima-Temp, Inc., a leader in developing digital health solutions through chronobiology, has been awarded a patent recognizing its innovative approach to applying artificial intelligence (AI) to women...
Learn MoreBoulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration
By: Colorado BioScience Association Date: 11/11/2020
It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be c...
Learn MoreL7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test
By: Colorado BioScience Association Date: 11/10/2020
L7 Informatics announced that it has deployed L7 | ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Ins...
Learn MoreTo Support Go/No-Go Decisions in Early Drug Development, Inotiv Got It Together — Fast
By: Colorado BioScience Association Date: 11/02/2020
Pharmaceutical and medical device companies are always under pressure to improve research productivity. Increasingly, they rely on contract research organizations (CROs) for access to specific experti...
Learn MoreLightDeck Diagnostics Raises $11 Million Series B to Offer Five-Minute Affordable COVID-19 Tests, Taking the ‘Point-of-Care’ Anywhere
By: Colorado BioScience Association Date: 10/29/2020
LightDeck Diagnostics today announced $11 million in Series B financing from Incubic, Entrada and Boulder Ventures. The funds will support the development and commercialization of in vitro multiplex t...
Learn MoreBoulder biotech Biodesix CEO: Why timing was right for IPO
By: Colorado BioScience Association Date: 10/28/2020
In an exclusive interview, CEO Scott Hutton talks about the next steps for the company, which specializes in blood-based diagnostic tests for lung diseases. Find out more in the Denver Business Journa...
Learn MoreBoulder biotech company Inscripta names new CEO
By: Colorado BioScience Association Date: 10/27/2020
The company has been growing over the past several years, and recently went to market with its genomic engineering platform. Learn more in the Denver Business Journal article.
Learn MoreMBio Diagnostics Announces Rebrand to LightDeck Diagnostics to Reflect Commitment to Its Innovative Waveguide Product Platform
By: Colorado BioScience Association Date: 10/21/2020
MBio Diagnostics, the company taking the point-of-care anywhere with on-the-spot, central lab-quality diagnostics, announced today that it is changing its corporate name to LightDeck Diagnostics. The...
Learn MoreDenver-Boulder among top U.S. life science clusters for the first time
By: Colorado BioScience Association Date: 10/21/2020
The Denver metro area has ranked among the largest U.S. life science markets for the first time, in a new report from CBRE. The report on U.S. life sciences ranks the top clusters in the country. On t...
Learn MoreSummit Biolabs Announces Strategic Collaboration to Develop and Commercialize Saliva Liquid-biopsy Tests for COVID-19 and Head & Neck Cancers
By: Colorado BioScience Association Date: 10/16/2020
Summit Biolabs, Inc., an early-stage molecular diagnostics company specializing in saliva-based testing for COVID-19 and head & neck cancer, and the Colorado Center for Personalized Medicine (CCPM...
Learn MorePharmaJet’s Needle-free System to be used in Australian Clinical COVID-19 Trial
By: Colorado BioScience Association Date: 10/07/2020
PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Stratis® Needle-free Injection System will be used to deliver a vaccine against SARS-CoV-2 in a clinical...
Learn MoreInvitae completes its $1.4B acquisition of Boulder-based ArcherDX
By: Colorado BioScience Association Date: 10/06/2020
ArcherDX had previously applied for an IPO before the public company its acquisition was announced. Learn more in the Denver Business Journal.
Learn MoreBrickell Biotech Announces Initiation of U.S. Phase 3 Program Evaluating Sofpironium Bromide Gel, 15% for the Treatment of Primary Axillary Hyperhidrosis
By: Colorado BioScience Association Date: 10/06/2020
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...
Learn MoreWestminster biotech company shares new strategy for cancer treatments.
By: Colorado BioScience Association Date: 09/29/2020
A Westminster biotech company has a new clinical development strategy following a recent acquisition it made. TriSalus Life Sciences is an emerging immuno-oncology company that has developed technolog...
Learn MoreAspero Medical Receives $310,000 Grant for Development of Pillar™ Micro-Textured Gastrointestinal Endoscopic Balloon Overtube
By: Colorado BioScience Association Date: 09/24/2020
Gastrointestinal endoscopy focused startup company to expand development effort for novel endoscopic single balloon overtube product line. Aspero Medical, a medical device startup focused on developin...
Learn MoreARCA Biopharma files application for Covid-19 drug treatment
By: Colorado BioScience Association Date: 09/22/2020
The company has a drug in its arsenal that it believes could be effective in the treatment of Covid-19 patients. Find out more in the Denver Business Journal.
Learn MoreAmpio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients
By: Colorado BioScience Association Date: 09/11/2020
Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scaleAmpion-treated patients showed greater improvement compared to patients trea...
Learn MoreProov Lands VC Funds as Demand Surges for its At Home Test Kits
By: Colorado BioScience Association Date: 09/11/2020
Proov, an at-home hormone testing kit company, has announced funding from two venture capital firms that aim to build up underrepresented founders. The investment – the amount was not disclosed – from...
Learn MoreMaker of Mask Designed to treat Chronic Pain Raises 5.8M
By: Colorado BioScience Association Date: 09/11/2020
Hear from Richard Hanbury, Sana Health Founder, the story of how the company started and the drive behind it all. Hanbury has created a Lafayette-based company known as Sana Health, which produces med...
Learn MoreAnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.
By: Colorado BioScience Association Date: 09/08/2020
AnGes, Inc. (“AnGes”), announced today a collaboration agreement with Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company, through which Brickell has the right t...
Learn MoreAveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
By: Colorado BioScience Association Date: 09/02/2020
AveXis is now known as Novartis Gene Therapies, marking another milestone in their journey to be the world’s leading gene therapy company. Novartis has renamed the previously acquired AveXis to Novart...
Learn MoreEY Entrepreneur of the Year Finalist list for the Mountain Desert
By: Colorado BioScience Association Date: 08/31/2020
CBSA sponsor, EY, released the EY Entrepreneur of the Year Finalist list for the Mountain Desert region today. Congratulations and amazing job to CBSA member DMC Biotechnologies, Inc. for being named...
Learn MoreBond Pet Foods Develops Lab-grown Meat Prototype, Plans for 2023 Commercialization
By: Colorado BioScience Association Date: 08/26/2020
A Boulder food technology company is looking to change the way people think about pet food. Bond Pet Foods has developed a prototype for lab-grown pet food using real meat protein. While the startup i...
Learn MoreCBSA Member Mentioned in Crisis Innovators
By: Colorado BioScience Association Date: 08/25/2020
CBSA members PharmaJet and CirrusMD Inc. are featured in The Business Journals Crisis Innovators: How 8 Colorado Startups are Fighting COVID-19. Across the state, Colorado’s tech and startup innovator...
Learn MoreBiodesix to Provide COVID-19 Testing for Colorado State University Campus
By: Colorado BioScience Association Date: 08/12/2020
Biodesix, Inc., a leading diagnostic company with a focus in lung disease, today announced plans to provide COVID-19 ddPCR diagnostic testing for Colorado State University (CSU) as students return to...
Learn MoreTerumo BCT Revamps Brand
By: Colorado BioScience Association Date: 08/11/2020
Terumo BCT is revamping its brand to Terumo Blood and Cell Technologies to reflect the company promise to unlock the potential of blood and cells and its heritage to innovate with customers to serve m...
Learn MoreSana Health raises $5.8M to get through clinical trials
By: Colorado BioScience Association Date: 08/06/2020
Sana Health Inc., is currently in the middle of its trials for the behavioral health device that uses a relaxation mask to relieve chronic pain and stress. Sana has raised $5.8 million in new venture...
Learn MoreTriSalus Life Sciences Acquires Dynavax’s SD-101 Oncology Program in Purchase Agreement for up to $250 million in Milestone Payments plus Royalties on Future Net Sales
By: Colorado BioScience Association Date: 08/03/2020
SD-101 is a proprietary investigational, second-generation, Toll-like receptor 9 (TLR9) agonist CpG-C class oligodeoxynucleotide. TriSalus plans to further develop SD-101 as an oncology therapeutic. F...
Learn MoreColorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry
By: Colorado BioScience Association Date: 07/17/2020
New Iridium, a company developing commercialized photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Tech...
Learn MoreKromaTiD Announces Launch of New Product, dGH In-Site™
By: Colorado BioScience Association Date: 06/30/2020
KromaTiD, Inc. announced today the launch of its new product dGH In-Site™, a single-cell, high resolution, genome-wide DNA insert tracking assay. dGH In-Site™ enables researchers to directly measure t...
Learn MoreBoulder Biotech Company to be Acquired for $1.4B
By: Colorado BioScience Association Date: 06/22/2020
Just a few weeks ago, the company filed for an IPO. Now, it's being acquired. Find out more in the article from Denver Business Journal.
Learn MoreBrickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
By: Colorado BioScience Association Date: 06/18/2020
Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitati...
Learn MoreEdgewise Therapeutics Appoints Kirsten L. Gruis, M.D., M.S. as Chief Medical Officer
By: Colorado BioScience Association Date: 06/18/2020
Edgewise Therapeutics, a biopharmaceutical company developing small molecule therapies for musculoskeletal diseases, today announced the appointment of Kirsten L. Gruis, M.D., M.S. to the newly create...
Learn MoreArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM™) to Clinical Research
By: Colorado BioScience Association Date: 06/18/2020
ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM™) assays to understand the potential benefits of minim...
Learn MoreCetya Therapeutics Announces Issuance of New Patents Covering its HDAC Inhibitor CT-102
By: Colorado BioScience Association Date: 06/12/2020
Cetya Therapeutics, Inc. today announced issuance of US Patent No. 10,676,504 and Australian Patent No. 2016229324 covering CT-102, Cetya’s proprietary HDAC inhibitor. CT-102 has demonstrated excellen...
Learn MoreFlagship Biosciences Names Aymii Couzelis as Chief Information Officer
By: Colorado BioScience Association Date: 06/03/2020
Flagship Biosciences, providers of expert tissue data insights, today announced that Aymii Couzelis has been named to its executive team as Chief Information Officer. Aymii brings over 20 years of exp...
Learn MoreARCA Biopharma Announces AB201 Development Program For Treatment of COVID-19 Associated Coagulopathy
By: Colorado BioScience Association Date: 05/28/2020
ARCA biopharma, Inc. (Nasdaq: ABIO) today announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue factor (TF), as a potential treatment for COVID-19 ass...
Learn More$7.3 Million Advanced Industries Awards Fuel 27 Colorado Start-ups
By: Colorado BioScience Association Date: 05/26/2020
Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 27 Colorado start-ups approved for funding. A total of...
Learn MoreArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
By: Colorado BioScience Association Date: 05/20/2020
ArcherDX, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its next-generation sequencing (NGS) device under development as a compa...
Learn MoreAccure Receives CE Mark Approval for First-Ever 1726nm Laser Platform to treat Acne
By: Colorado BioScience Association Date: 05/16/2020
Groundbreaking platform combines novel laser wavelength with fully integrated tissue temperature monitoring and control systems to deliver a paradigm-shifting non-systemic solution for acne sufferers....
Learn MoreBayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing (NGS)-based Companion Diagnostic (CDx) for VITRAKVI® (larotrectinib)
By: Colorado BioScience Association Date: 05/14/2020
Collaboration will focus on development of a companion diagnostic (CDx) for Vitrakvi®, the first-in-class tyrosine kinase (TRK) inhibitor approved in the U.S. and Europe for adult pediatric patients w...
Learn MoreTolmar Pharmaceuticals Receives FDA Approval
By: Colorado BioScience Association Date: 05/05/2020
FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty. Fensolvi is the only six-month, subcutaneously administered leuprolide ace...
Learn MoreGlobal Plasma Leaders Collaborate to Accelerate Development of Potential Covid-19 Hyperimmune Therapy
By: Colorado BioScience Association Date: 04/09/2020
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19. Learn more in the press release.
Learn MoreMBio to Seek FDA Approval for LightDeck® Platform
By: Colorado BioScience Association Date: 04/07/2020
MBio Diagnostics today announced an expanded scope contract with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress...
Learn MoreAmgen and Adaptive Biotechnologies Announce Strategic Partnership to Develop a Therapeutic to Prevent or Treat COVID-19
By: Colorado BioScience Association Date: 04/02/2020
Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) today announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and deve...
Learn MoreAktivax, Inc. has been awarded a $16 million contract from the Biomedical Advanced Research and Development Authority (BARDA)
By: Colorado BioScience Association Date: 04/01/2020
Shortly after receiving a $24.5 million project from the Department of Defense (DOD) to develop a scopolamine auto-injector, Aktivax, Inc. has been awarded a $16 million contract from the Biomedical A...
Learn MoreFlagship Biosciences Hires New Vice President of Clinical Diagnostics
By: Colorado BioScience Association Date: 03/31/2020
Flagship Biosciences, providers of expert tissue data insights, today announced that Geoff Metcalf, MBA, PMP, will join its executive team as Vice President Clinical Diagnostics. Geoff brings 25 years...
Learn MoreSOPHiA GENETICS and Paragon Genomics Join Forces Against COVID-19 Coronavirus Pandemic
By: Colorado BioScience Association Date: 03/26/2020
SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next...
Learn MoreAktivax, Inc. Awarded a $24.5M US Government Project
By: Colorado BioScience Association Date: 03/25/2020
Aktivax, Inc. has been awarded a $24.5 million US government project to develop an autoinjector treatment for exposure to nerve agents. The award is an Other Transaction (OT) prototype project by the...
Learn MorePharmaJet Received Multi-Year, Multi-Million Dollar Award to Support Next-Generation Needle-free Delivery Devices
By: Colorado BioScience Association Date: 03/18/2020
PharmaJet®, the maker of innovative, needle-free injection technology, announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of the U.S. Defense...
Learn MorePfizer Outlines Five-Point Plan to Battle COVID-19
By: Colorado BioScience Association Date: 03/17/2020
Chairman and CEO Albert Bourla Calls on Biopharma Industry to Collaborate on Combatting the Global Pandemic. Read the plan here.
Learn MoreBiodesix Announces New Commercial Organization and Executive Appointments
By: Colorado BioScience Association Date: 03/10/2020
Biodesix, Inc., a leading diagnostic company in lung cancer, today announced the realignment of their commercial executive team. Kieran O’Kane will be promoted to Chief Commercial Officer (CCO) and Bo...
Learn MoreCSU, Zoetis leaders herald launch of new research lab
By: Colorado BioScience Association Date: 01/30/2020
Officials from Zoetis, the world’s leading animal health company, and Colorado State University gathered on the Foothills Campus on Jan. 28 to celebrate the opening of a new lab. The 3,000-square-foot...
Learn MoreNew Investments Boost Colorado's Life Sciences Community
By: Colorado BioScience Association Date: 01/23/2020
The Rockies Venture Club and Colorado BioScience Association (CBSA) announced a partnership to mobilize Colorado’s capital resources to support early-stage bioscience companies in the state. “Co...
Learn MoreHealth Scholars, the Virtual Reality Healthcare Training Platform, Raises $17M in Series B funding
By: Colorado BioScience Association Date: 01/16/2020
Health Scholars, known for their VR simulations and cloud-based training platform utilized for management, delivery, and analysis of clinical training, is excited to announce the successful completion...
Learn MoreArpeggio Bio Raises $3.2 Million in Seed Funding and CEO Named to the 2020 Forbes 30 Under 30 List in Healthcare
By: Colorado BioScience Association Date: 01/15/2020
Arpeggio Bio, a preclinical company whose technology provides a mechanistic understanding of how drugs work, today announced that it has closed a $3.2 million seed financing round, which was oversubsc...
Learn MoreMedtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stimulation Therapy
By: Colorado BioScience Association Date: 01/14/2020
Medtronic plc (NYSE:MDT) announced it has acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as...
Learn MoreCrestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to Treat NTM Infections
By: Colorado BioScience Association Date: 01/13/2020
Crestone, Inc. today announced an award from the Cystic Fibrosis Foundation (CFF) for the preclinical development of its antibiotic lead series to treat nontuberculous mycobacteria (NTM) infections, f...
Learn MoreInnosphere Client Company, Vaporox, Raises $1.5M in Seed Funding
By: Colorado BioScience Association Date: 01/13/2020
Vaporox, a Denver-based Innosphere Client Company dedicated to healing diabetic foot ulcers (DFUs), announced this week the closing of its initial round of funding. The $1.5M investment will be used t...
Learn MoreCerebral Therapeutics Completes $35 Million Series B Financing
By: Colorado BioScience Association Date: 01/09/2020
Cerebral Therapeutics, a clinical-stage pharmaceutical company developing innovative treatments for uncontrolled neurological diseases, announced today a $35 million Series B financing led by RA Capit...
Learn MoreMedtronic Expands Surgical Synergy(SM) with FDA Clearance of the Stealth Autoguide™ System for Cranial Procedures
By: Colorado BioScience Association Date: 12/20/2019
Medtronic plc (NYSE:MDT) announced that the U.S. Food and Drug Administration (FDA) recently cleared the Stealth Autoguide™ system, the first cranial robotic platform that integrates with Medtronic’s...
Learn MoreFitzsimons Innovation Community Expands with $55Million Bioscience Facility
By: Colorado BioScience Association Date: 12/13/2019
Fitzsimons Innovation Community, a leading innovation community for visionaries working to transform health and care, announces the expansion of its life sciences campus with the opening of its third...
Learn MoreInscripta Raises $125M in Series D Financing to Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform
By: Colorado BioScience Association Date: 12/10/2019
Inscripta, Inc., today announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/F...
Learn MoreAVITA Medical Teams With Gates Center to Advance Therapeutic Skin Restoration
By: Colorado BioScience Association Date: 12/05/2019
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the...
Learn MoreBond Pet Foods Completes $1.2 Million Seed Funding Round
By: Colorado BioScience Association Date: 12/05/2019
Bond Pet Foods, Inc., the Boulder-based company working with biotechnology to make nutritious, animal-free and protein-rich pet food, announced today that it has completed its Seed funding, totaling $...
Learn MoreArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests
By: Colorado BioScience Association Date: 12/04/2019
ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive partnership with...
Learn More$5.2 Million Advanced Industries Awards in Fall 2019 Will Fuel 24 Colorado Start-ups
By: Colorado BioScience Association Date: 11/22/2019
A Colorado company with the transformative technology behind a revolutionary prosthetic socket design that provides easier application and release was among 24 Colorado start-ups approved for funding...
Learn MoreSecurisyn Medical Awarded Fourth Air Force Contract for Innovation
By: Colorado BioScience Association Date: 11/13/2019
Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (USAF) has awarded the Company a $750,000 Smal...
Learn MoreAMPIO PROVIDES UPDATE ON CONTINUED PROGRESS OF AP-013 PHASE III CLINICAL TRIAL AND MANUFACTURING FACILITY
By: Colorado BioScience Association Date: 11/12/2019
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled “Evaluating the Efficacy...
Learn MoreBiodesix Appoints Scott Hutton as Chief Executive Officer
By: Colorado BioScience Association Date: 11/05/2019
Biodesix, Inc., the leader in lung cancer diagnostic solutions, today announced that current Chief Operating Officer Scott Hutton will become Chief Executive Officer on January 1, 2020. Current CEO Da...
Learn MoreIM Therapeutics Is Developing A Novel Targeted Therapy Pipeline in Autoimmune Disease
By: Colorado BioScience Association Date: 10/28/2019
Type 1 Diabetes Therapy Being Readied for Clinical Trials; Celiac Disease in Drug Development Autoimmune diseases affect about 4% of the world’s population and comprise over 80 disorders, many of whic...
Learn MoreSomaLogic significantly expands key strategic collaboration with Novartis
By: Colorado BioScience Association Date: 10/23/2019
Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...
Learn MoreRegulatory Affairs Professionals Society (RAPS) Welcomes New RAPS Colorado Chapter
By: Colorado BioScience Association Date: 10/17/2019
Rockville, MD, USA, Oct. 17, 2019 (GLOBE NEWSWIRE) The Regulatory Affairs Professionals Society (RAPS) announced the official launch of the RAPS Colorado Chapter. The group first began as a RAPS...
Learn MoreSecurisyn Medical Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System
By: Colorado BioScience Association Date: 10/14/2019
HIGHLANDS RANCH – October 9, 2019 – Securisyn Medical, LLC, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its SolidAIRity™ III Airw...
Learn MoreIM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
By: Colorado BioScience Association Date: 10/09/2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures Funding will Advance Lead Drug in Type 1 Diabetes and Develop HLA-Targeted Therapeutic Platform in Autoimm...
Learn MoreAmideBio Awarded SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism
By: Colorado BioScience Association Date: 09/30/2019
BOULDER, CO, September 30, 2019 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Researc...
Learn MoreGREFFEX, Inc. Awarded $18.7 Million Contract with NIH to Develop a Plug-and-Play Technology Platform to Expedite Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
By: Colorado BioScience Association Date: 09/27/2019
GREFFEX, Inc. (Aurora, CO), a Fitzsimons Innovation Community company, is a transformative leader in genetic engineering. The company was recently awarded an $18.7 million contract with the National I...
Learn MoreWeekly Policy Update: CBSA Submits Comment Letter to CMS Advocating for Patient Access to Timely Precision Diagnostic Information
By: Colorado BioScience Association Date: 09/27/2019
In July the Centers for Medicare and Medicaid Services (CMS) issued the CY 2020 Hospital Outpatient Prospective Payment System (HOPPS) Proposed Rule, which included concerning proposed revisions to th...
Learn MoreBoulder Based Edgewise Therapeutics Closes $50 Million Series B Financing
By: Colorado BioScience Association Date: 09/17/2019
Financing to Support Advancing Company’s Lead Product Candidate for Muscular Dystrophy- Boulder, Colo., (September 17, 2019) – Edgewise Therapeutics, a preclinical company developing small molecule th...
Learn MoreNymbl Science Releases Their August Update
By: Colorado BioScience Association Date: 09/09/2019
Below please find an overview of our progress for the month of August: • We continue to move forward towards closing out our round. We have about $235k remaining with 4 angel pitches lined up in the n...
Learn MoreDenver Business Journal Highlights Colorado’s Life Sciences Ecosystem and Our Leadership In Gene Editing
By: Colorado BioScience Association Date: 09/09/2019
Gene editing is becoming an increasingly common remedy for a variety of ailments, and Boulder area bioscience companies are leading those advancements. Building on research and technology originating...
Learn MoreSomaLogic launches its first SomaSignal™ tests in select medical practices
By: Colorado BioScience Association Date: 09/04/2019
Novel tests based on large-scale protein measurements will first offer personal and precise information about an individual’s cardiometabolic health status and trajectory Boulder, Colo., September 4,...
Learn MoreSecurisyn Medical Partners with Leading Medical Device Design and Development Firm, Meddux
By: Colorado BioScience Association Date: 08/12/2019
HIGHLANDS RANCH, Colo., August 12, 2019 — Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, has announced a new partnership with Meddux™ Developm...
Learn MoreAllosource Celebrates 25 Years Of Doing More With Life
By: Colorado BioScience Association Date: 08/12/2019
Milestone highlights organization’s growth into one of the largest tissue banks in the U.S. Centennial, Colo. — August 9, 2019 — AlloSource®, an organization dedicated to advancing the science and use...
Learn MoreZoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock
By: Colorado BioScience Association Date: 07/30/2019
Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target ne...
Learn MoreAgilent Announces Purchase of Boulder Facility
By: Colorado BioScience Association Date: 07/25/2019
Agilent Technologies has announced it is purchasing the building in Boulder where they have been manufacturing therapeutic oligonucleotides (“oligos") for over a decade. This $12 million purchase, alo...
Learn MoreSilvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum
By: Colorado BioScience Association Date: 07/10/2019
Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals. While it might...
Learn MoreCerapedics Announces Expansion of Colorado Headquarters
By: Colorado BioScience Association Date: 07/08/2019
WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the company's headquarters located in the Denver metropolitan area. Ove...
Learn MoreSeven Researchers Named Boettcher Investigators
By: Colorado BioScience Association Date: 05/28/2019
Newest Class Marks 10th Group Selected Under Webb-Waring Program Back row (l-r): Kara Mould, M. Cecilia Caino, Seonil Kim Front row (l-r): Neelanjan Mukherjee, Robert Dietz, Tara Cepon Robins Not pict...
Learn MoreArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio
By: Colorado BioScience Association Date: 05/15/2019
BOULDER, Colo., May, 15, 2019 /PRNEWSWIRE/-- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine...
Learn MorePrima-Temp Announces New Leadership, Investment, and CE Mark Certification
By: Colorado BioScience Association Date: 05/08/2019
BOULDER, Colo., May 3, 2019 /PRNewswire/ -- Boulder, Colorado based Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, announced today that in March, it raised...
Learn MoreAdvaMed President and CEO Releases Statement On the House Bill To Repeal the Medical Device Tax
By: Colorado BioScience Association Date: 04/11/2019
WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in t...
Learn MoreInscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M
By: Colorado BioScience Association Date: 04/08/2019
Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new...
Learn MoreColorado BioScience Association Applauds Expansion by Novartis Company AveXis to Longmont
By: Colorado BioScience Association Date: 04/01/2019
April 1, 2019 Background: AveXis, a Novartis company, announced the growth of its global advanced gene therapy manufacturing capacity with the acquisition of an advanced biologics therapy facility in...
Learn MoreDavid Perez Is Leaving Terumo BCT, But He'll Still Be Active In The Bioscience Community
By: Colorado BioScience Association Date: 03/01/2019
Terumo BCT's CEO David Perez may be retiring, but he isn't leaving the Colorado bioscience community. He sat down with the Denver Business Journal’s James Rodriguez to discuss his successes at Terumo...
Learn MoreSapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply
By: Colorado BioScience Association Date: 06/27/2018
Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphir...
Learn MoreNew Office Location Helps Packaging Compliance Labs Accelerate Growth In Healthcare Packaging
By: Colorado BioScience Association Date: 06/25/2018
Packaging Compliance Labs, a top medical device and pharmaceutical packaging engineering and validation firm, recently opened a new office in the heart of downtown Denver, Colorado, to accommodate rap...
Learn MoreColorado BioScience Association Congratulates Researchers Honored with Boettcher Foundation Webb-Waring Awards
By: Colorado BioScience Association Date: 06/07/2018
Seven biomedical researchers at Colorado’s top research institutions have been selected to receive $1.41 million in total funding from the Boettcher Foundation’s Webb-Waring Biomedical Research Awards...
Learn MoreNational Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth
By: Colorado BioScience Association Date: 06/05/2018
A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital inves...
Learn MoreJust-Released Economic Data Finds Improving Education in Colorado Would Generate Billions for the Economy
By: Colorado BioScience Association Date: 05/15/2018
New statewide polling shows education is a top tier issue for Colorado voters and employers, alignment on improvement strategies May 15, 2018 – Denver – If Colorado schools were the best in the nation...
Learn MoreGates Biomanufacturing Facility readies first shipment of clinical trial cancer treatments
By: Colorado BioScience Association Date: 05/07/2018
Groundbreaking moment represents years of planning, training and biomedical expertise The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus has passed an important...
Learn MoreArticulus Bio to Present at 6th Annual Venture Summit West Investor Conference
By: Colorado BioScience Association Date: 03/12/2018
Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 6th...
Learn MoreCSU’s BioMARC Wins HIV Vaccine Manufacturing Project
By: Colorado BioScience Association Date: 03/02/2018
BioMARC, a non-profit biologics contract development and manufacturing organization (CDMO) owned and operated by Colorado State University (CSU), has won a large new contract with Sumagen Co., Ltd, a...
Learn MoreCleanroom World Opens Training Center
By: Colorado BioScience Association Date: 02/26/2018
Colorado-Based Controlled Environment Supplier Provides Fully-Operational Cleanroom Training Center for Industry Specific Needs Cleanroom World has announced the opening of its on-site training...
Learn MoreBIO Business Solutions Introduces Cyber Insurance Coverages through Aon and Chubb
By: Colorado BioScience Association Date: 02/23/2018
As a leading life sciences firm, it’s your mission to drive innovation and ensure your people and assets are protected. The pervasiveness of Cyber in day-to-day business operations introduces s...
Learn MoreVivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study
By: Colorado BioScience Association Date: 02/12/2018
FORT COLLINS, Colorado – February 12, 2018 − Vivaldi Biosciences, based at the Research Innovation Center at Colorado State University and Vienna, Austria, today announced that its deltaFLU infl...
Learn MoreRxRevu Unveils New SwiftRx® Platform at 36th Annual J.P.Morgan Healthcare Conference
By: Colorado BioScience Association Date: 01/10/2018
RxRevu, the industry leader in Prescription Decision Support, will unveil its new SwiftRx® platform while attending the 36th Annual J.P.Morgan Healthcare Conference on January 8th in San Francisco, CA...
Learn MoreARTICULUS BIO TO PRESENT AT 10TH ANNUAL BIOTECH SHOWCASE CONFERENCE DURING JP MORGAN HEALTHCARE WEEK
By: Colorado BioScience Association Date: 01/08/2018
Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 10t...
Learn MoreNew Consortium Launches Colorado Hub for Health Impact, a National Economic Development Campaign to Attract Health Innovation Companies to the State
By: Colorado BioScience Association Date: 02/27/2024
For Immediate Release: February 27, 2024 NEWS RELEASE 20+ Life Sciences Organizations, Economic Development Groups, Local Governments, Developers, and Builders Invest to Bring New, High-Growth Compani...
Learn MoreWeekly Policy Blog: CBSA Talks PDAB at CSBA Summit; PDAB Ad Campaign & Media Highlight
By: Colorado BioScience Association Date: 12/04/2023
Amy Goodman, CBSA’s Vice President & Counsel for Policy + Advocacy, attended the 2023 Annual Council of State Bioscience Associations (CSBA) Summit in New Orleans this past week and discussed Colo...
Learn MoreFitzsimons Innovation Community and Aimco Host Media Event Focused on Sharing Momentum, Trends, and Patient-Impact Storylines
By: Colorado BioScience Association Date: 10/30/2023
With Aimco, Fitzsimons Innovation Community hosted members of the local and national media to learn firsthand about breakthrough work from 10 of the 80+ visionary biotech and life sciences companies i...
Learn MoreWeekly Policy Blog: CBSA Joins New Partnership to Promote Benefits of Pro-Innovation Mergers & Acquisitions
By: Colorado BioScience Association Date: 10/09/2023
CBSA has joined a new coalition to raise awareness of the fundamental role of pro-innovation mergers and acquisitions (M&A) in advancing the next generation of treatments and cures for patients. P...
Learn MoreRockies Venture Club: Three Myths of Life Science Angel Investing
By: Colorado BioScience Association Date: 07/10/2023
By Rockies Venture Club | RVC Weekly Newsletter July 3 The Three Fallacies of Life Science Investing I'm always interested to see how angels and angel groups present themselves to the public with rega...
Learn More